"Year","Gender","Age_at_Diagnosis","Geography_code","Geography_name","ICD10_code","Site_description","Count","Type_of_rate","Rate","LCI","UCI","Flag"
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",30,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",668,"Age-specific",3.2,3,3.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",27677,"Age-specific",133.7,132.2,135.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",23531,"Age-specific",113.7,112.3,115.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",50125,"Age-specific",242.2,240.1,244.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",45,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",134,"Age-specific",0.6,0.5,0.8,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",27,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",51,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",44,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",33,"Age-specific",0.2,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",74,"Age-specific",0.4,0.3,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",20,"Age-specific",0.1,0.1,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",104,"Age-specific",0.5,0.4,0.6,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",13,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",46,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",14,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",15,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",18,"Age-specific",0.1,0.1,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",270,"Age-specific",1.3,1.2,1.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",334,"Age-specific",1.6,1.4,1.8,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",56,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",755,"Age-specific",3.6,3.4,3.9,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1273,"Age-specific",6.2,5.8,6.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",102,"Age-specific",0.5,0.4,0.6,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",416,"Age-specific",2,1.8,2.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",94,"Age-specific",0.5,0.4,0.6,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",132,"Age-specific",0.6,0.5,0.8,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",17,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",21,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",254,"Age-specific",1.2,1.1,1.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",24,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",37,"Age-specific",0.2,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",24,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",120,"Age-specific",0.6,0.5,0.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",1001,"Age-specific",4.8,4.5,5.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",997,"Age-specific",4.8,4.5,5.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",16,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",24,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",61,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",57,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2089,"Age-specific",10.1,9.7,10.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4146,"Age-specific",20,19.4,20.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",46,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",57,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",31,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",44,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",221,"Age-specific",1.1,0.9,1.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",6901,"Age-specific",33.3,32.6,34.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",428,"Age-specific",2.1,1.9,2.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",23,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",7,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",260,"Age-specific",1.3,1.1,1.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",6,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",56,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",14,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",764,"Age-specific",3.7,3.4,4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",25,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",522,"Age-specific",2.5,2.3,2.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",31,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",24,"Age-specific",0.1,0.1,0.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",64,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",60,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",171,"Age-specific",0.8,0.7,1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",76,"Age-specific",0.4,0.3,0.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",197,"Age-specific",1,0.8,1.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",659,"Age-specific",3.2,2.9,3.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",244,"Age-specific",1.2,1,1.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1148,"Age-specific",5.5,5.2,5.9,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",381,"Age-specific",1.8,1.7,2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",98,"Age-specific",0.5,0.4,0.6,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",425,"Age-specific",2.1,1.9,2.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",5,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",151,"Age-specific",0.7,0.6,0.9,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",220,"Age-specific",1.1,0.9,1.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",666,"Age-specific",3.2,3,3.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",410,"Age-specific",2,1.8,2.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",16,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",8,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",12,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",9,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",10,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",48,"Age-specific",0.2,0.2,0.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",6,"Age-specific",0,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",432,"Age-specific",2.1,1.9,2.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",521,"Age-specific",2.5,2.3,2.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19093,"Age-specific",183.8,181.2,186.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",334,"Age-specific",1.6,1.4,1.8,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",114,"Age-specific",0.6,0.5,0.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",251,"Age-specific",1.2,1.1,1.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",216,"Age-specific",1,0.9,1.2,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",161,"Age-specific",0.8,0.7,0.9,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",119,"Age-specific",0.6,0.5,0.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",15,"Age-specific",0.1,0,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",134,"Age-specific",1.3,1.1,1.5,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",43,"Age-specific",0.4,0.3,0.6,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",229,"Age-specific",1.1,1,1.3,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",19,"Age-specific",0.1,0.1,0.1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",115,"Age-specific",0.6,0.5,0.7,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",66,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",68,"Age-specific",0.3,0.3,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",56,"Age-specific",0.3,0.2,0.4,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",186,"Age-specific",0.9,0.8,1,""
2001,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",212,"Age-specific",1,0.9,1.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",31,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",662,"Age-specific",3.2,2.9,3.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",27194,"Age-specific",130.9,129.3,132.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",22977,"Age-specific",110.6,109.2,112,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",49733,"Age-specific",239.3,237.2,241.5,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",45,"Age-specific",0.2,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",145,"Age-specific",0.7,0.6,0.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",20,"Age-specific",0.1,0.1,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",32,"Age-specific",0.2,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",38,"Age-specific",0.2,0.1,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",35,"Age-specific",0.2,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",66,"Age-specific",0.3,0.2,0.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",29,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",107,"Age-specific",0.5,0.4,0.6,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",14,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",56,"Age-specific",0.3,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",18,"Age-specific",0.1,0.1,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",5,"Age-specific",0,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",21,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",271,"Age-specific",1.3,1.2,1.5,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",323,"Age-specific",1.6,1.4,1.7,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",61,"Age-specific",0.3,0.2,0.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",771,"Age-specific",3.7,3.5,4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1325,"Age-specific",6.4,6,6.7,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",95,"Age-specific",0.5,0.4,0.6,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",459,"Age-specific",2.2,2,2.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",105,"Age-specific",0.5,0.4,0.6,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",135,"Age-specific",0.6,0.5,0.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",15,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",31,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",241,"Age-specific",1.2,1,1.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",22,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",19,"Age-specific",0.1,0.1,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",19,"Age-specific",0.1,0.1,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",109,"Age-specific",0.5,0.4,0.6,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",7,"Age-specific",0,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",935,"Age-specific",4.5,4.2,4.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",928,"Age-specific",4.5,4.2,4.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",22,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",25,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",55,"Age-specific",0.3,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",61,"Age-specific",0.3,0.2,0.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2029,"Age-specific",9.8,9.3,10.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4217,"Age-specific",20.3,19.7,20.9,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",37,"Age-specific",0.2,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",56,"Age-specific",0.3,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",22,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",23,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",238,"Age-specific",1.1,1,1.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",6819,"Age-specific",32.8,32,33.6,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",471,"Age-specific",2.3,2.1,2.5,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",23,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",228,"Age-specific",1.1,1,1.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",9,"Age-specific",0,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",69,"Age-specific",0.3,0.3,0.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",13,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",761,"Age-specific",3.7,3.4,3.9,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",24,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",561,"Age-specific",2.7,2.5,2.9,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",27,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",24,"Age-specific",0.1,0.1,0.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",92,"Age-specific",0.4,0.4,0.5,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",77,"Age-specific",0.4,0.3,0.5,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",145,"Age-specific",0.7,0.6,0.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",54,"Age-specific",0.3,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",181,"Age-specific",0.9,0.7,1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",636,"Age-specific",3.1,2.8,3.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",226,"Age-specific",1.1,1,1.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1063,"Age-specific",5.1,4.8,5.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",388,"Age-specific",1.9,1.7,2.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",81,"Age-specific",0.4,0.3,0.5,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",368,"Age-specific",1.8,1.6,2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",7,"Age-specific",0,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",150,"Age-specific",0.7,0.6,0.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",224,"Age-specific",1.1,0.9,1.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",629,"Age-specific",3,2.8,3.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",376,"Age-specific",1.8,1.6,2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",15,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",3,"Age-specific",0,0,0,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",11,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",13,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",18,"Age-specific",0.1,0.1,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",45,"Age-specific",0.2,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",7,"Age-specific",0,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",438,"Age-specific",2.1,1.9,2.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",526,"Age-specific",2.5,2.3,2.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19161,"Age-specific",183.7,181.1,186.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",326,"Age-specific",1.6,1.4,1.7,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",132,"Age-specific",0.6,0.5,0.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",256,"Age-specific",1.2,1.1,1.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",207,"Age-specific",1,0.9,1.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",169,"Age-specific",0.8,0.7,0.9,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",125,"Age-specific",0.6,0.5,0.7,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",94,"Age-specific",0.9,0.7,1.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",26,"Age-specific",0.3,0.2,0.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",216,"Age-specific",1,0.9,1.2,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",18,"Age-specific",0.1,0.1,0.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",100,"Age-specific",0.5,0.4,0.6,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",63,"Age-specific",0.3,0.2,0.4,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",149,"Age-specific",0.7,0.6,0.8,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",55,"Age-specific",0.3,0.2,0.3,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",205,"Age-specific",1,0.9,1.1,""
2002,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",192,"Age-specific",0.9,0.8,1.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",691,"Age-specific",3.3,3.1,3.6,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",28221,"Age-specific",135.2,133.6,136.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",23725,"Age-specific",113.7,112.2,115.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",50803,"Age-specific",243.4,241.3,245.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",44,"Age-specific",0.2,0.2,0.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",150,"Age-specific",0.7,0.6,0.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",18,"Age-specific",0.1,0.1,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",54,"Age-specific",0.3,0.2,0.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",34,"Age-specific",0.2,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",44,"Age-specific",0.2,0.2,0.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",60,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",19,"Age-specific",0.1,0.1,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",136,"Age-specific",0.7,0.5,0.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",12,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",60,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",24,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",5,"Age-specific",0,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",15,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",273,"Age-specific",1.3,1.2,1.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",332,"Age-specific",1.6,1.4,1.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",63,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",764,"Age-specific",3.7,3.4,3.9,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1335,"Age-specific",6.4,6.1,6.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",91,"Age-specific",0.4,0.4,0.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",480,"Age-specific",2.3,2.1,2.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",103,"Age-specific",0.5,0.4,0.6,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",144,"Age-specific",0.7,0.6,0.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",19,"Age-specific",0.1,0.1,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",31,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",227,"Age-specific",1.1,1,1.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",23,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",29,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",17,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",119,"Age-specific",0.6,0.5,0.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",958,"Age-specific",4.6,4.3,4.9,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",955,"Age-specific",4.6,4.3,4.9,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",22,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",30,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",73,"Age-specific",0.3,0.3,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",58,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2061,"Age-specific",9.9,9.5,10.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4496,"Age-specific",21.5,20.9,22.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",42,"Age-specific",0.2,0.1,0.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",83,"Age-specific",0.4,0.3,0.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",23,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",39,"Age-specific",0.2,0.1,0.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",221,"Age-specific",1.1,0.9,1.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7197,"Age-specific",34.5,33.7,35.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",496,"Age-specific",2.4,2.2,2.6,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",11,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",197,"Age-specific",0.9,0.8,1.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",7,"Age-specific",0,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",64,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",19,"Age-specific",0.1,0.1,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",708,"Age-specific",3.4,3.1,3.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",24,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",610,"Age-specific",2.9,2.7,3.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",21,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",27,"Age-specific",0.1,0.1,0.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",69,"Age-specific",0.3,0.3,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",71,"Age-specific",0.3,0.3,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",127,"Age-specific",0.6,0.5,0.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",64,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",164,"Age-specific",0.8,0.7,0.9,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",600,"Age-specific",2.9,2.6,3.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",232,"Age-specific",1.1,1,1.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1132,"Age-specific",5.4,5.1,5.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",456,"Age-specific",2.2,2,2.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",76,"Age-specific",0.4,0.3,0.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",368,"Age-specific",1.8,1.6,2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",9,"Age-specific",0,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",173,"Age-specific",0.8,0.7,1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",242,"Age-specific",1.2,1,1.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",717,"Age-specific",3.4,3.2,3.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",451,"Age-specific",2.2,2,2.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",5,"Age-specific",0,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",6,"Age-specific",0,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",13,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",11,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",18,"Age-specific",0.1,0.1,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",91,"Age-specific",0.4,0.4,0.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",18,"Age-specific",0.1,0.1,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",465,"Age-specific",2.2,2,2.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",519,"Age-specific",2.5,2.3,2.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19177,"Age-specific",183.1,180.6,185.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",314,"Age-specific",1.5,1.3,1.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",110,"Age-specific",0.5,0.4,0.6,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",264,"Age-specific",1.3,1.1,1.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",223,"Age-specific",1.1,0.9,1.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",189,"Age-specific",0.9,0.8,1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",133,"Age-specific",0.6,0.5,0.8,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",102,"Age-specific",1,0.8,1.2,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",39,"Age-specific",0.4,0.3,0.5,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",192,"Age-specific",0.9,0.8,1.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",15,"Age-specific",0.1,0,0.1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",96,"Age-specific",0.5,0.4,0.6,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",67,"Age-specific",0.3,0.2,0.4,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",130,"Age-specific",0.6,0.5,0.7,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",56,"Age-specific",0.3,0.2,0.3,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",174,"Age-specific",0.8,0.7,1,""
2003,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",181,"Age-specific",0.9,0.7,1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",17,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",687,"Age-specific",3.3,3,3.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",29244,"Age-specific",139.3,137.7,140.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",24448,"Age-specific",116.4,115,117.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",51715,"Age-specific",246.3,244.2,248.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",53,"Age-specific",0.3,0.2,0.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",129,"Age-specific",0.6,0.5,0.7,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",21,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",48,"Age-specific",0.2,0.2,0.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",36,"Age-specific",0.2,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",30,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",64,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",33,"Age-specific",0.2,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",126,"Age-specific",0.6,0.5,0.7,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",18,"Age-specific",0.1,0.1,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",58,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",23,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",22,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",271,"Age-specific",1.3,1.1,1.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",321,"Age-specific",1.5,1.4,1.7,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",70,"Age-specific",0.3,0.3,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",834,"Age-specific",4,3.7,4.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1413,"Age-specific",6.7,6.4,7.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",112,"Age-specific",0.5,0.4,0.6,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",467,"Age-specific",2.2,2,2.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",101,"Age-specific",0.5,0.4,0.6,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",146,"Age-specific",0.7,0.6,0.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",29,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",23,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",208,"Age-specific",1,0.9,1.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",17,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",24,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",16,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",92,"Age-specific",0.4,0.4,0.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",962,"Age-specific",4.6,4.3,4.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",958,"Age-specific",4.6,4.3,4.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",17,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",24,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",54,"Age-specific",0.3,0.2,0.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",65,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2404,"Age-specific",11.4,11,11.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4796,"Age-specific",22.8,22.2,23.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",44,"Age-specific",0.2,0.2,0.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",65,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",27,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",39,"Age-specific",0.2,0.1,0.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",256,"Age-specific",1.2,1.1,1.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7369,"Age-specific",35.1,34.3,35.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",492,"Age-specific",2.3,2.1,2.6,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",13,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",10,"Age-specific",0,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",233,"Age-specific",1.1,1,1.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",7,"Age-specific",0,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",59,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",12,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",717,"Age-specific",3.4,3.2,3.7,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",34,"Age-specific",0.2,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",663,"Age-specific",3.2,2.9,3.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",25,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",23,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",62,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",73,"Age-specific",0.3,0.3,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",133,"Age-specific",0.6,0.5,0.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",80,"Age-specific",0.4,0.3,0.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",170,"Age-specific",0.8,0.7,0.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",649,"Age-specific",3.1,2.9,3.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",245,"Age-specific",1.2,1,1.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1153,"Age-specific",5.5,5.2,5.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",473,"Age-specific",2.3,2.1,2.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",94,"Age-specific",0.4,0.4,0.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",341,"Age-specific",1.6,1.5,1.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",6,"Age-specific",0,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",167,"Age-specific",0.8,0.7,0.9,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",231,"Age-specific",1.1,1,1.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",649,"Age-specific",3.1,2.9,3.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",386,"Age-specific",1.8,1.7,2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",5,"Age-specific",0,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",21,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",16,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",18,"Age-specific",0.1,0.1,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",80,"Age-specific",0.4,0.3,0.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",19,"Age-specific",0.1,0.1,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",496,"Age-specific",2.4,2.2,2.6,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",591,"Age-specific",2.8,2.6,3.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",18789,"Age-specific",178.4,175.9,181,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",346,"Age-specific",1.6,1.5,1.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",132,"Age-specific",0.6,0.5,0.7,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",291,"Age-specific",1.4,1.2,1.6,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",187,"Age-specific",0.9,0.8,1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",250,"Age-specific",1.2,1,1.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",144,"Age-specific",0.7,0.6,0.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0,0.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",103,"Age-specific",1,0.8,1.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",39,"Age-specific",0.4,0.3,0.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",231,"Age-specific",1.1,1,1.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",22,"Age-specific",0.1,0.1,0.2,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",85,"Age-specific",0.4,0.3,0.5,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",61,"Age-specific",0.3,0.2,0.4,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",133,"Age-specific",0.6,0.5,0.8,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",55,"Age-specific",0.3,0.2,0.3,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",197,"Age-specific",0.9,0.8,1.1,""
2004,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",189,"Age-specific",0.9,0.8,1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",733,"Age-specific",3.4,3.2,3.7,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",30464,"Age-specific",143.3,141.7,144.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",25519,"Age-specific",120,118.6,121.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",54639,"Age-specific",257,254.8,259.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",50,"Age-specific",0.2,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",141,"Age-specific",0.7,0.6,0.8,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",17,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",57,"Age-specific",0.3,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",44,"Age-specific",0.2,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",46,"Age-specific",0.2,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",73,"Age-specific",0.3,0.3,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",26,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",138,"Age-specific",0.6,0.5,0.8,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",20,"Age-specific",0.1,0.1,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",59,"Age-specific",0.3,0.2,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",23,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",8,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",15,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",237,"Age-specific",1.1,1,1.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",290,"Age-specific",1.4,1.2,1.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",75,"Age-specific",0.4,0.3,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",914,"Age-specific",4.3,4,4.6,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1515,"Age-specific",7.1,6.8,7.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",124,"Age-specific",0.6,0.5,0.7,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",477,"Age-specific",2.2,2,2.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",116,"Age-specific",0.5,0.5,0.7,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",159,"Age-specific",0.7,0.6,0.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",18,"Age-specific",0.1,0.1,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",32,"Age-specific",0.2,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",249,"Age-specific",1.2,1,1.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",29,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",27,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",20,"Age-specific",0.1,0.1,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",111,"Age-specific",0.5,0.4,0.6,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",6,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",968,"Age-specific",4.6,4.3,4.8,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",962,"Age-specific",4.5,4.2,4.8,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",19,"Age-specific",0.1,0.1,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",30,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",73,"Age-specific",0.3,0.3,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",65,"Age-specific",0.3,0.2,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2511,"Age-specific",11.8,11.4,12.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4945,"Age-specific",23.3,22.6,23.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",28,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",88,"Age-specific",0.4,0.3,0.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",32,"Age-specific",0.2,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",56,"Age-specific",0.3,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",277,"Age-specific",1.3,1.2,1.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7550,"Age-specific",35.5,34.7,36.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",520,"Age-specific",2.4,2.2,2.7,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",19,"Age-specific",0.1,0.1,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",9,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",238,"Age-specific",1.1,1,1.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",10,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",74,"Age-specific",0.3,0.3,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",14,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",787,"Age-specific",3.7,3.4,4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",27,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",700,"Age-specific",3.3,3.1,3.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",34,"Age-specific",0.2,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",24,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",53,"Age-specific",0.2,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",68,"Age-specific",0.3,0.2,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",160,"Age-specific",0.8,0.6,0.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",70,"Age-specific",0.3,0.3,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",164,"Age-specific",0.8,0.7,0.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",636,"Age-specific",3,2.8,3.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",227,"Age-specific",1.1,0.9,1.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1185,"Age-specific",5.6,5.3,5.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",509,"Age-specific",2.4,2.2,2.6,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",75,"Age-specific",0.4,0.3,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",374,"Age-specific",1.8,1.6,1.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",6,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",183,"Age-specific",0.9,0.7,1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",247,"Age-specific",1.2,1,1.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",713,"Age-specific",3.4,3.1,3.6,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",428,"Age-specific",2,1.8,2.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",8,"Age-specific",0,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",21,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",20,"Age-specific",0.1,0.1,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",23,"Age-specific",0.1,0.1,0.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",88,"Age-specific",0.4,0.3,0.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",628,"Age-specific",3,2.7,3.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",643,"Age-specific",3,2.8,3.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19936,"Age-specific",186.9,184.4,189.6,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",367,"Age-specific",1.7,1.6,1.9,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",133,"Age-specific",0.6,0.5,0.7,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",331,"Age-specific",1.6,1.4,1.7,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",235,"Age-specific",1.1,1,1.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",243,"Age-specific",1.1,1,1.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",152,"Age-specific",0.7,0.6,0.8,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",16,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",106,"Age-specific",1,0.8,1.2,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",30,"Age-specific",0.3,0.2,0.4,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",278,"Age-specific",1.3,1.2,1.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",15,"Age-specific",0.1,0,0.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",112,"Age-specific",0.5,0.4,0.6,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",85,"Age-specific",0.4,0.3,0.5,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",189,"Age-specific",0.9,0.8,1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",51,"Age-specific",0.2,0.2,0.3,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",211,"Age-specific",1,0.9,1.1,""
2005,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",290,"Age-specific",1.4,1.2,1.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",27,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",800,"Age-specific",3.7,3.5,4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",31447,"Age-specific",146.6,145,148.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",26347,"Age-specific",122.9,121.4,124.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",55361,"Age-specific",258.1,256,260.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",61,"Age-specific",0.3,0.2,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",153,"Age-specific",0.7,0.6,0.8,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",14,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",44,"Age-specific",0.2,0.1,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",41,"Age-specific",0.2,0.1,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",53,"Age-specific",0.2,0.2,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",74,"Age-specific",0.3,0.3,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",18,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",179,"Age-specific",0.8,0.7,1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",17,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",68,"Age-specific",0.3,0.2,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",20,"Age-specific",0.1,0.1,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",10,"Age-specific",0,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",21,"Age-specific",0.1,0.1,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",265,"Age-specific",1.2,1.1,1.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",314,"Age-specific",1.5,1.3,1.6,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",83,"Age-specific",0.4,0.3,0.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",974,"Age-specific",4.5,4.3,4.8,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1615,"Age-specific",7.5,7.2,7.9,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",127,"Age-specific",0.6,0.5,0.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",514,"Age-specific",2.4,2.2,2.6,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",95,"Age-specific",0.4,0.4,0.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",180,"Age-specific",0.8,0.7,1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",20,"Age-specific",0.1,0.1,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",32,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",269,"Age-specific",1.3,1.1,1.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",24,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",25,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",25,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",124,"Age-specific",0.6,0.5,0.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",976,"Age-specific",4.6,4.3,4.8,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",975,"Age-specific",4.5,4.3,4.8,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",21,"Age-specific",0.1,0.1,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",34,"Age-specific",0.2,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",72,"Age-specific",0.3,0.3,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",50,"Age-specific",0.2,0.2,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2689,"Age-specific",12.5,12.1,13,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",5100,"Age-specific",23.8,23.1,24.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",48,"Age-specific",0.2,0.2,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",114,"Age-specific",0.5,0.4,0.6,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",28,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",58,"Age-specific",0.3,0.2,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",251,"Age-specific",1.2,1,1.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7592,"Age-specific",35.4,34.6,36.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",533,"Age-specific",2.5,2.3,2.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",13,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",201,"Age-specific",0.9,0.8,1.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",12,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",65,"Age-specific",0.3,0.2,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",18,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",789,"Age-specific",3.7,3.4,3.9,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",38,"Age-specific",0.2,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",804,"Age-specific",3.7,3.5,4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",33,"Age-specific",0.2,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",32,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",45,"Age-specific",0.2,0.2,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",89,"Age-specific",0.4,0.3,0.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",160,"Age-specific",0.7,0.6,0.9,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",68,"Age-specific",0.3,0.2,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",159,"Age-specific",0.7,0.6,0.9,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",682,"Age-specific",3.2,2.9,3.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",251,"Age-specific",1.2,1,1.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1168,"Age-specific",5.4,5.1,5.8,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",479,"Age-specific",2.2,2,2.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",121,"Age-specific",0.6,0.5,0.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",317,"Age-specific",1.5,1.3,1.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",7,"Age-specific",0,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",187,"Age-specific",0.9,0.8,1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",246,"Age-specific",1.1,1,1.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",698,"Age-specific",3.3,3,3.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",423,"Age-specific",2,1.8,2.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",2,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",18,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",21,"Age-specific",0.1,0.1,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",32,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",120,"Age-specific",0.6,0.5,0.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",14,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",698,"Age-specific",3.3,3,3.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",688,"Age-specific",3.2,3,3.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19567,"Age-specific",181.7,179.2,184.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",382,"Age-specific",1.8,1.6,2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",131,"Age-specific",0.6,0.5,0.7,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",315,"Age-specific",1.5,1.3,1.6,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",241,"Age-specific",1.1,1,1.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",224,"Age-specific",1,0.9,1.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",199,"Age-specific",0.9,0.8,1.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0,0.1,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",137,"Age-specific",1.3,1.1,1.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",29,"Age-specific",0.3,0.2,0.4,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",251,"Age-specific",1.2,1,1.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",24,"Age-specific",0.1,0.1,0.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",101,"Age-specific",0.5,0.4,0.6,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",86,"Age-specific",0.4,0.3,0.5,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",147,"Age-specific",0.7,0.6,0.8,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",58,"Age-specific",0.3,0.2,0.3,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",229,"Age-specific",1.1,0.9,1.2,""
2006,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",230,"Age-specific",1.1,0.9,1.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",21,"Age-specific",0.1,0.1,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",812,"Age-specific",3.8,3.5,4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",32406,"Age-specific",149.9,148.3,151.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",26389,"Age-specific",122.1,120.6,123.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",57655,"Age-specific",266.7,264.5,268.9,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",62,"Age-specific",0.3,0.2,0.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",166,"Age-specific",0.8,0.7,0.9,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",10,"Age-specific",0,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",54,"Age-specific",0.2,0.2,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",42,"Age-specific",0.2,0.1,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",43,"Age-specific",0.2,0.1,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",77,"Age-specific",0.4,0.3,0.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",22,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",183,"Age-specific",0.8,0.7,1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",27,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",70,"Age-specific",0.3,0.3,0.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",13,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",11,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",11,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",279,"Age-specific",1.3,1.1,1.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",301,"Age-specific",1.4,1.2,1.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",93,"Age-specific",0.4,0.3,0.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",909,"Age-specific",4.2,3.9,4.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1547,"Age-specific",7.2,6.8,7.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",136,"Age-specific",0.6,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",502,"Age-specific",2.3,2.1,2.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",123,"Age-specific",0.6,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",172,"Age-specific",0.8,0.7,0.9,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",21,"Age-specific",0.1,0.1,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",36,"Age-specific",0.2,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",269,"Age-specific",1.2,1.1,1.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",23,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",30,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",27,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",98,"Age-specific",0.5,0.4,0.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",6,"Age-specific",0,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",944,"Age-specific",4.4,4.1,4.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",938,"Age-specific",4.3,4.1,4.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",23,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",29,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",83,"Age-specific",0.4,0.3,0.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",81,"Age-specific",0.4,0.3,0.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2535,"Age-specific",11.7,11.3,12.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",6017,"Age-specific",27.8,27.1,28.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",37,"Age-specific",0.2,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",109,"Age-specific",0.5,0.4,0.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",30,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",56,"Age-specific",0.3,0.2,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",257,"Age-specific",1.2,1,1.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7559,"Age-specific",35,34.2,35.8,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",586,"Age-specific",2.7,2.5,2.9,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",19,"Age-specific",0.1,0.1,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",8,"Age-specific",0,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",207,"Age-specific",1,0.8,1.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",5,"Age-specific",0,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",81,"Age-specific",0.4,0.3,0.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",14,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",822,"Age-specific",3.8,3.5,4.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",46,"Age-specific",0.2,0.2,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",846,"Age-specific",3.9,3.7,4.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",32,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",29,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",44,"Age-specific",0.2,0.1,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",90,"Age-specific",0.4,0.3,0.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",118,"Age-specific",0.5,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",52,"Age-specific",0.2,0.2,0.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",145,"Age-specific",0.7,0.6,0.8,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",721,"Age-specific",3.3,3.1,3.6,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",291,"Age-specific",1.3,1.2,1.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1275,"Age-specific",5.9,5.6,6.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",560,"Age-specific",2.6,2.4,2.8,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",130,"Age-specific",0.6,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",294,"Age-specific",1.4,1.2,1.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",9,"Age-specific",0,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",176,"Age-specific",0.8,0.7,0.9,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",242,"Age-specific",1.1,1,1.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",710,"Age-specific",3.3,3,3.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",439,"Age-specific",2,1.8,2.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",11,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",4,"Age-specific",0,0,0,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",14,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",16,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",36,"Age-specific",0.2,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",134,"Age-specific",0.6,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",13,"Age-specific",0.1,0,0.1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",680,"Age-specific",3.1,2.9,3.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",689,"Age-specific",3.2,3,3.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",20867,"Age-specific",192.3,189.7,195,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",393,"Age-specific",1.8,1.6,2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",122,"Age-specific",0.6,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",327,"Age-specific",1.5,1.4,1.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",250,"Age-specific",1.2,1,1.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",256,"Age-specific",1.2,1,1.3,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",187,"Age-specific",0.9,0.7,1,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",23,"Age-specific",0.1,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",127,"Age-specific",1.2,1,1.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",32,"Age-specific",0.3,0.2,0.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",236,"Age-specific",1.1,1,1.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",34,"Age-specific",0.2,0.1,0.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",97,"Age-specific",0.4,0.4,0.5,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",70,"Age-specific",0.3,0.3,0.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",128,"Age-specific",0.6,0.5,0.7,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",67,"Age-specific",0.3,0.2,0.4,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",224,"Age-specific",1,0.9,1.2,""
2007,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",257,"Age-specific",1.2,1,1.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",24,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",883,"Age-specific",4.1,3.8,4.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",34917,"Age-specific",160.4,158.7,162.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",27795,"Age-specific",127.7,126.2,129.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",62769,"Age-specific",288.4,286.1,290.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",68,"Age-specific",0.3,0.2,0.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",172,"Age-specific",0.8,0.7,0.9,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",18,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",55,"Age-specific",0.3,0.2,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",49,"Age-specific",0.2,0.2,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",63,"Age-specific",0.3,0.2,0.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",101,"Age-specific",0.5,0.4,0.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",34,"Age-specific",0.2,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",174,"Age-specific",0.8,0.7,0.9,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",22,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",54,"Age-specific",0.2,0.2,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",20,"Age-specific",0.1,0.1,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",11,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",18,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",276,"Age-specific",1.3,1.1,1.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",308,"Age-specific",1.4,1.3,1.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",98,"Age-specific",0.5,0.4,0.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",941,"Age-specific",4.3,4.1,4.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1603,"Age-specific",7.4,7,7.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",136,"Age-specific",0.6,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",526,"Age-specific",2.4,2.2,2.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",119,"Age-specific",0.5,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",217,"Age-specific",1,0.9,1.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",19,"Age-specific",0.1,0.1,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",36,"Age-specific",0.2,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",282,"Age-specific",1.3,1.1,1.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",27,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",44,"Age-specific",0.2,0.1,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",16,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",129,"Age-specific",0.6,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",958,"Age-specific",4.4,4.1,4.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",955,"Age-specific",4.4,4.1,4.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",22,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",28,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",88,"Age-specific",0.4,0.3,0.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",67,"Age-specific",0.3,0.2,0.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2753,"Age-specific",12.6,12.2,13.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",7122,"Age-specific",32.7,32,33.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",35,"Age-specific",0.2,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",117,"Age-specific",0.5,0.4,0.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",33,"Age-specific",0.2,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",49,"Age-specific",0.2,0.2,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",309,"Age-specific",1.4,1.3,1.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7943,"Age-specific",36.5,35.7,37.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",635,"Age-specific",2.9,2.7,3.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",17,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",11,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",234,"Age-specific",1.1,0.9,1.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",5,"Age-specific",0,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",74,"Age-specific",0.3,0.3,0.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",16,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",844,"Age-specific",3.9,3.6,4.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",41,"Age-specific",0.2,0.1,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",894,"Age-specific",4.1,3.8,4.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",41,"Age-specific",0.2,0.1,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",28,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",47,"Age-specific",0.2,0.2,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",73,"Age-specific",0.3,0.3,0.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",126,"Age-specific",0.6,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",52,"Age-specific",0.2,0.2,0.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",133,"Age-specific",0.6,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",744,"Age-specific",3.4,3.2,3.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",294,"Age-specific",1.4,1.2,1.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1261,"Age-specific",5.8,5.5,6.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",587,"Age-specific",2.7,2.5,2.9,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",120,"Age-specific",0.6,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",260,"Age-specific",1.2,1.1,1.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",4,"Age-specific",0,0,0,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",224,"Age-specific",1,0.9,1.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",275,"Age-specific",1.3,1.1,1.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",770,"Age-specific",3.5,3.3,3.8,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",468,"Age-specific",2.2,2,2.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",17,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",23,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",25,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",144,"Age-specific",0.7,0.6,0.8,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0,0.1,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",785,"Age-specific",3.6,3.4,3.9,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",768,"Age-specific",3.5,3.3,3.8,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",22645,"Age-specific",207.3,204.6,210,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",451,"Age-specific",2.1,1.9,2.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",121,"Age-specific",0.6,0.5,0.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",350,"Age-specific",1.6,1.4,1.8,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",250,"Age-specific",1.1,1,1.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",304,"Age-specific",1.4,1.2,1.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",226,"Age-specific",1,0.9,1.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",28,"Age-specific",0.1,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",155,"Age-specific",1.4,1.2,1.7,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",33,"Age-specific",0.3,0.2,0.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",317,"Age-specific",1.5,1.3,1.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",37,"Age-specific",0.2,0.1,0.2,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",110,"Age-specific",0.5,0.4,0.6,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",89,"Age-specific",0.4,0.3,0.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",253,"Age-specific",1.2,1,1.3,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",87,"Age-specific",0.4,0.3,0.5,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",263,"Age-specific",1.2,1.1,1.4,""
2008,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",398,"Age-specific",1.8,1.7,2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",26,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",884,"Age-specific",4,3.8,4.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",35945,"Age-specific",164.6,162.9,166.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",28838,"Age-specific",132.1,130.6,133.6,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",69329,"Age-specific",317.5,315.2,319.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",71,"Age-specific",0.3,0.3,0.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",185,"Age-specific",0.8,0.7,1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",28,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",41,"Age-specific",0.2,0.1,0.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",52,"Age-specific",0.2,0.2,0.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",56,"Age-specific",0.3,0.2,0.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",87,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",35,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",176,"Age-specific",0.8,0.7,0.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",26,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",63,"Age-specific",0.3,0.2,0.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",14,"Age-specific",0.1,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",12,"Age-specific",0.1,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",12,"Age-specific",0.1,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",284,"Age-specific",1.3,1.2,1.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",321,"Age-specific",1.5,1.3,1.6,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",91,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1018,"Age-specific",4.7,4.4,5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1711,"Age-specific",7.8,7.5,8.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",112,"Age-specific",0.5,0.4,0.6,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",581,"Age-specific",2.7,2.4,2.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",131,"Age-specific",0.6,0.5,0.7,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",235,"Age-specific",1.1,0.9,1.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",24,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",36,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",300,"Age-specific",1.4,1.2,1.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",33,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",48,"Age-specific",0.2,0.2,0.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",18,"Age-specific",0.1,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",121,"Age-specific",0.6,0.5,0.7,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",1017,"Age-specific",4.7,4.4,5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",1013,"Age-specific",4.6,4.4,4.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",24,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",20,"Age-specific",0.1,0.1,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",71,"Age-specific",0.3,0.3,0.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",89,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2826,"Age-specific",12.9,12.5,13.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",7107,"Age-specific",32.5,31.8,33.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",37,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",79,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",36,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",56,"Age-specific",0.3,0.2,0.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",298,"Age-specific",1.4,1.2,1.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8171,"Age-specific",37.4,36.6,38.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",653,"Age-specific",3,2.8,3.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",25,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",8,"Age-specific",0,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",231,"Age-specific",1.1,0.9,1.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",8,"Age-specific",0,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",65,"Age-specific",0.3,0.2,0.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",22,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",801,"Age-specific",3.7,3.4,3.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",39,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",960,"Age-specific",4.4,4.1,4.7,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",36,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",26,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",37,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",91,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",108,"Age-specific",0.5,0.4,0.6,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",55,"Age-specific",0.3,0.2,0.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",143,"Age-specific",0.7,0.6,0.8,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",750,"Age-specific",3.4,3.2,3.7,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",289,"Age-specific",1.3,1.2,1.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1320,"Age-specific",6,5.7,6.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",587,"Age-specific",2.7,2.5,2.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",153,"Age-specific",0.7,0.6,0.8,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",291,"Age-specific",1.3,1.2,1.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",10,"Age-specific",0,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",236,"Age-specific",1.1,0.9,1.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",275,"Age-specific",1.3,1.1,1.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",789,"Age-specific",3.6,3.4,3.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",479,"Age-specific",2.2,2,2.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",10,"Age-specific",0,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",5,"Age-specific",0,0,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",20,"Age-specific",0.1,0.1,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",25,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",1,"Age-specific",NA,NA,NA,"s"
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",21,"Age-specific",0.1,0.1,0.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",173,"Age-specific",0.8,0.7,0.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",29,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",751,"Age-specific",3.4,3.2,3.7,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",797,"Age-specific",3.7,3.4,3.9,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",28209,"Age-specific",257.3,254.3,260.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",502,"Age-specific",2.3,2.1,2.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",144,"Age-specific",0.7,0.6,0.8,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",332,"Age-specific",1.5,1.4,1.7,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",214,"Age-specific",1,0.9,1.1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",266,"Age-specific",1.2,1.1,1.4,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",258,"Age-specific",1.2,1,1.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",25,"Age-specific",0.1,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",146,"Age-specific",1.3,1.1,1.6,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",41,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",297,"Age-specific",1.4,1.2,1.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",39,"Age-specific",0.2,0.1,0.2,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",112,"Age-specific",0.5,0.4,0.6,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",97,"Age-specific",0.4,0.4,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",187,"Age-specific",0.9,0.7,1,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",84,"Age-specific",0.4,0.3,0.5,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",261,"Age-specific",1.2,1.1,1.3,""
2009,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",398,"Age-specific",1.8,1.6,2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",20,"Age-specific",0.1,0.1,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",898,"Age-specific",4.1,3.8,4.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",36775,"Age-specific",167.5,165.8,169.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",29224,"Age-specific",133.1,131.6,134.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",64023,"Age-specific",291.7,289.4,293.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",72,"Age-specific",0.3,0.3,0.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",168,"Age-specific",0.8,0.7,0.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",18,"Age-specific",0.1,0,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",49,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",53,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",53,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",83,"Age-specific",0.4,0.3,0.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",34,"Age-specific",0.2,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",221,"Age-specific",1,0.9,1.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",25,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",54,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",17,"Age-specific",0.1,0,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0,0,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",22,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",292,"Age-specific",1.3,1.2,1.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",355,"Age-specific",1.6,1.5,1.8,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",84,"Age-specific",0.4,0.3,0.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1010,"Age-specific",4.6,4.3,4.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1703,"Age-specific",7.8,7.4,8.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",117,"Age-specific",0.5,0.4,0.6,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",576,"Age-specific",2.6,2.4,2.8,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",128,"Age-specific",0.6,0.5,0.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",218,"Age-specific",1,0.9,1.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",27,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",36,"Age-specific",0.2,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",296,"Age-specific",1.3,1.2,1.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",25,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",41,"Age-specific",0.2,0.1,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",19,"Age-specific",0.1,0.1,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",113,"Age-specific",0.5,0.4,0.6,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",1032,"Age-specific",4.7,4.4,5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",1029,"Age-specific",4.7,4.4,5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",22,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",28,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",87,"Age-specific",0.4,0.3,0.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",77,"Age-specific",0.4,0.3,0.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2819,"Age-specific",12.8,12.4,13.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",7551,"Age-specific",34.4,33.6,35.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",36,"Age-specific",0.2,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",85,"Age-specific",0.4,0.3,0.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",30,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",48,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",333,"Age-specific",1.5,1.4,1.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8618,"Age-specific",39.3,38.4,40.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",686,"Age-specific",3.1,2.9,3.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",23,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",5,"Age-specific",0,0,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",222,"Age-specific",1,0.9,1.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",94,"Age-specific",0.4,0.3,0.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",16,"Age-specific",0.1,0,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",795,"Age-specific",3.6,3.4,3.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",48,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1052,"Age-specific",4.8,4.5,5.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",31,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",32,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",43,"Age-specific",0.2,0.1,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",74,"Age-specific",0.3,0.3,0.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",121,"Age-specific",0.6,0.5,0.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",49,"Age-specific",0.2,0.2,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",140,"Age-specific",0.6,0.5,0.8,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",794,"Age-specific",3.6,3.4,3.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",337,"Age-specific",1.5,1.4,1.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1361,"Age-specific",6.2,5.9,6.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",644,"Age-specific",2.9,2.7,3.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",128,"Age-specific",0.6,0.5,0.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",252,"Age-specific",1.1,1,1.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",4,"Age-specific",0,0,0,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",223,"Age-specific",1,0.9,1.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",277,"Age-specific",1.3,1.1,1.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",789,"Age-specific",3.6,3.3,3.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",464,"Age-specific",2.1,1.9,2.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",13,"Age-specific",0.1,0,0.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",4,"Age-specific",0,0,0,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",31,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",29,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",43,"Age-specific",0.2,0.1,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",162,"Age-specific",0.7,0.6,0.9,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",30,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",786,"Age-specific",3.6,3.3,3.8,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",751,"Age-specific",3.4,3.2,3.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",22269,"Age-specific",202.1,199.4,204.8,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",466,"Age-specific",2.1,1.9,2.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",136,"Age-specific",0.6,0.5,0.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",340,"Age-specific",1.5,1.4,1.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",246,"Age-specific",1.1,1,1.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",258,"Age-specific",1.2,1,1.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",214,"Age-specific",1,0.8,1.1,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",23,"Age-specific",0.1,0.1,0.2,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",126,"Age-specific",1.1,1,1.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",30,"Age-specific",0.3,0.2,0.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",294,"Age-specific",1.3,1.2,1.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",41,"Age-specific",0.2,0.1,0.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",123,"Age-specific",0.6,0.5,0.7,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",94,"Age-specific",0.4,0.3,0.5,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",147,"Age-specific",0.7,0.6,0.8,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",79,"Age-specific",0.4,0.3,0.4,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",244,"Age-specific",1.1,1,1.3,""
2010,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",346,"Age-specific",1.6,1.4,1.8,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",28,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",904,"Age-specific",4.1,3.8,4.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",36915,"Age-specific",167.2,165.5,168.9,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",29225,"Age-specific",132.4,130.9,133.9,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",64973,"Age-specific",294.3,292,296.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",82,"Age-specific",0.4,0.3,0.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",208,"Age-specific",0.9,0.8,1.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",16,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",48,"Age-specific",0.2,0.2,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",47,"Age-specific",0.2,0.2,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",45,"Age-specific",0.2,0.1,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",92,"Age-specific",0.4,0.3,0.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",22,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",189,"Age-specific",0.9,0.7,1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",21,"Age-specific",0.1,0.1,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",58,"Age-specific",0.3,0.2,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",18,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",12,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",18,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",239,"Age-specific",1.1,0.9,1.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",311,"Age-specific",1.4,1.3,1.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",109,"Age-specific",0.5,0.4,0.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1157,"Age-specific",5.2,4.9,5.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1825,"Age-specific",8.3,7.9,8.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",118,"Age-specific",0.5,0.4,0.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",550,"Age-specific",2.5,2.3,2.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",159,"Age-specific",0.7,0.6,0.8,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",177,"Age-specific",0.8,0.7,0.9,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",33,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",38,"Age-specific",0.2,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",302,"Age-specific",1.4,1.2,1.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",18,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",32,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",13,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",121,"Age-specific",0.5,0.5,0.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",5,"Age-specific",0,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",923,"Age-specific",4.2,3.9,4.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",918,"Age-specific",4.2,3.9,4.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",39,"Age-specific",0.2,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",27,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",2,"Age-specific",NA,NA,NA,"s"
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",67,"Age-specific",0.3,0.2,0.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",76,"Age-specific",0.3,0.3,0.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2826,"Age-specific",12.8,12.3,13.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",7690,"Age-specific",34.8,34.1,35.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",25,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",90,"Age-specific",0.4,0.3,0.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",28,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",49,"Age-specific",0.2,0.2,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",312,"Age-specific",1.4,1.3,1.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8456,"Age-specific",38.3,37.5,39.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",724,"Age-specific",3.3,3,3.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",17,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",9,"Age-specific",0,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",211,"Age-specific",1,0.8,1.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",7,"Age-specific",0,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",81,"Age-specific",0.4,0.3,0.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",18,"Age-specific",0.1,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",843,"Age-specific",3.8,3.6,4.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",41,"Age-specific",0.2,0.1,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1139,"Age-specific",5.2,4.9,5.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",30,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",27,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",23,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",86,"Age-specific",0.4,0.3,0.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",105,"Age-specific",0.5,0.4,0.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",49,"Age-specific",0.2,0.2,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",155,"Age-specific",0.7,0.6,0.8,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",779,"Age-specific",3.5,3.3,3.8,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",341,"Age-specific",1.5,1.4,1.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1374,"Age-specific",6.2,5.9,6.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",644,"Age-specific",2.9,2.7,3.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",117,"Age-specific",0.5,0.4,0.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",272,"Age-specific",1.2,1.1,1.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",5,"Age-specific",0,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",239,"Age-specific",1.1,0.9,1.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",283,"Age-specific",1.3,1.1,1.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",771,"Age-specific",3.5,3.2,3.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",456,"Age-specific",2.1,1.9,2.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0,0,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",3,"Age-specific",0,0,0,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",20,"Age-specific",0.1,0.1,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",26,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",38,"Age-specific",0.2,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",199,"Age-specific",0.9,0.8,1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",28,"Age-specific",0.1,0.1,0.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",830,"Age-specific",3.8,3.5,4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",902,"Age-specific",4.1,3.8,4.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",22791,"Age-specific",205.9,203.3,208.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",517,"Age-specific",2.3,2.1,2.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",127,"Age-specific",0.6,0.5,0.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",319,"Age-specific",1.4,1.3,1.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",228,"Age-specific",1,0.9,1.2,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",261,"Age-specific",1.2,1,1.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",221,"Age-specific",1,0.9,1.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",20,"Age-specific",0.1,0.1,0.1,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",129,"Age-specific",1.2,1,1.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",36,"Age-specific",0.3,0.2,0.5,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",311,"Age-specific",1.4,1.3,1.6,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",43,"Age-specific",0.2,0.1,0.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",121,"Age-specific",0.5,0.5,0.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",76,"Age-specific",0.3,0.3,0.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",135,"Age-specific",0.6,0.5,0.7,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",76,"Age-specific",0.3,0.3,0.4,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",245,"Age-specific",1.1,1,1.3,""
2011,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",405,"Age-specific",1.8,1.7,2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",25,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",978,"Age-specific",4.4,4.2,4.7,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",38429,"Age-specific",174.1,172.3,175.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",30256,"Age-specific",137.1,135.5,138.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",67257,"Age-specific",304.7,302.4,307,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",71,"Age-specific",0.3,0.3,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",194,"Age-specific",0.9,0.8,1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",27,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",54,"Age-specific",0.2,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",50,"Age-specific",0.2,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",67,"Age-specific",0.3,0.2,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",88,"Age-specific",0.4,0.3,0.5,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",45,"Age-specific",0.2,0.1,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",222,"Age-specific",1,0.9,1.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",22,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",61,"Age-specific",0.3,0.2,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",25,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",15,"Age-specific",0.1,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",12,"Age-specific",0.1,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",290,"Age-specific",1.3,1.2,1.5,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",338,"Age-specific",1.5,1.4,1.7,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",102,"Age-specific",0.5,0.4,0.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1272,"Age-specific",5.8,5.4,6.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2065,"Age-specific",9.4,9,9.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",115,"Age-specific",0.5,0.4,0.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",678,"Age-specific",3.1,2.8,3.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",123,"Age-specific",0.6,0.5,0.7,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",210,"Age-specific",1,0.8,1.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",20,"Age-specific",0.1,0.1,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",39,"Age-specific",0.2,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",316,"Age-specific",1.4,1.3,1.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",22,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",41,"Age-specific",0.2,0.1,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",25,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",118,"Age-specific",0.5,0.4,0.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",5,"Age-specific",0,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",1006,"Age-specific",4.6,4.3,4.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",1001,"Age-specific",4.5,4.3,4.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",20,"Age-specific",0.1,0.1,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",33,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",88,"Age-specific",0.4,0.3,0.5,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",75,"Age-specific",0.3,0.3,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2892,"Age-specific",13.1,12.6,13.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8173,"Age-specific",37,36.2,37.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",36,"Age-specific",0.2,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",76,"Age-specific",0.3,0.3,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",26,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",51,"Age-specific",0.2,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",318,"Age-specific",1.4,1.3,1.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8641,"Age-specific",39.1,38.3,40,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",775,"Age-specific",3.5,3.3,3.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",12,"Age-specific",0.1,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",13,"Age-specific",0.1,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",215,"Age-specific",1,0.8,1.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",9,"Age-specific",0,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",101,"Age-specific",0.5,0.4,0.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",820,"Age-specific",3.7,3.5,4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",46,"Age-specific",0.2,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1232,"Age-specific",5.6,5.3,5.9,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",30,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",26,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",18,"Age-specific",0.1,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",78,"Age-specific",0.4,0.3,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",106,"Age-specific",0.5,0.4,0.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",49,"Age-specific",0.2,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",133,"Age-specific",0.6,0.5,0.7,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",740,"Age-specific",3.4,3.1,3.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",297,"Age-specific",1.3,1.2,1.5,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1395,"Age-specific",6.3,6,6.7,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",653,"Age-specific",3,2.7,3.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",163,"Age-specific",0.7,0.6,0.9,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",282,"Age-specific",1.3,1.1,1.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",8,"Age-specific",0,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",269,"Age-specific",1.2,1.1,1.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",274,"Age-specific",1.2,1.1,1.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",782,"Age-specific",3.5,3.3,3.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",475,"Age-specific",2.2,2,2.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",6,"Age-specific",0,0,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",21,"Age-specific",0.1,0.1,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",20,"Age-specific",0.1,0.1,0.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",53,"Age-specific",0.2,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",234,"Age-specific",1.1,0.9,1.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",23,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",881,"Age-specific",4,3.7,4.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1069,"Age-specific",4.8,4.6,5.1,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",23449,"Age-specific",211.8,209.1,214.5,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",488,"Age-specific",2.2,2,2.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",81,"Age-specific",0.4,0.3,0.5,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",366,"Age-specific",1.7,1.5,1.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",235,"Age-specific",1.1,0.9,1.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",228,"Age-specific",1,0.9,1.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",153,"Age-specific",0.7,0.6,0.8,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",23,"Age-specific",0.1,0.1,0.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",109,"Age-specific",1,0.8,1.2,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",34,"Age-specific",0.3,0.2,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",378,"Age-specific",1.7,1.5,1.9,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",64,"Age-specific",0.3,0.2,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",138,"Age-specific",0.6,0.5,0.7,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",79,"Age-specific",0.4,0.3,0.4,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",109,"Age-specific",0.5,0.4,0.6,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",60,"Age-specific",0.3,0.2,0.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",261,"Age-specific",1.2,1,1.3,""
2012,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",312,"Age-specific",1.4,1.3,1.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",29,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",973,"Age-specific",4.4,4.1,4.7,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",39271,"Age-specific",178.1,176.3,179.8,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",30895,"Age-specific",140.1,138.5,141.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",69926,"Age-specific",317,314.7,319.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",81,"Age-specific",0.4,0.3,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",197,"Age-specific",0.9,0.8,1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",18,"Age-specific",0.1,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",50,"Age-specific",0.2,0.2,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",55,"Age-specific",0.2,0.2,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",62,"Age-specific",0.3,0.2,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",98,"Age-specific",0.4,0.4,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",32,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",228,"Age-specific",1,0.9,1.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",22,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",65,"Age-specific",0.3,0.2,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",20,"Age-specific",0.1,0.1,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",10,"Age-specific",0,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",6,"Age-specific",0,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",264,"Age-specific",1.2,1.1,1.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",295,"Age-specific",1.3,1.2,1.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",119,"Age-specific",0.5,0.4,0.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1300,"Age-specific",5.9,5.6,6.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2028,"Age-specific",9.2,8.8,9.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",116,"Age-specific",0.5,0.4,0.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",612,"Age-specific",2.8,2.6,3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",141,"Age-specific",0.6,0.5,0.8,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",217,"Age-specific",1,0.9,1.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",29,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",32,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",341,"Age-specific",1.5,1.4,1.7,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",15,"Age-specific",0.1,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",43,"Age-specific",0.2,0.1,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",26,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",119,"Age-specific",0.5,0.4,0.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",932,"Age-specific",4.2,4,4.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",929,"Age-specific",4.2,3.9,4.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",42,"Age-specific",0.2,0.1,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",29,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",82,"Age-specific",0.4,0.3,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",76,"Age-specific",0.3,0.3,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",3034,"Age-specific",13.8,13.3,14.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8376,"Age-specific",38,37.2,38.8,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",22,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",77,"Age-specific",0.3,0.3,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",9,"Age-specific",0,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",46,"Age-specific",0.2,0.2,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",359,"Age-specific",1.6,1.5,1.8,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8889,"Age-specific",40.3,39.5,41.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",865,"Age-specific",3.9,3.7,4.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",25,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",11,"Age-specific",0,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",217,"Age-specific",1,0.9,1.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",12,"Age-specific",0.1,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",98,"Age-specific",0.4,0.4,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",18,"Age-specific",0.1,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",877,"Age-specific",4,3.7,4.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",47,"Age-specific",0.2,0.2,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1318,"Age-specific",6,5.7,6.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",23,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",40,"Age-specific",0.2,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",14,"Age-specific",0.1,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",79,"Age-specific",0.4,0.3,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",82,"Age-specific",0.4,0.3,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",153,"Age-specific",0.7,0.6,0.8,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",42,"Age-specific",0.2,0.1,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",756,"Age-specific",3.4,3.2,3.7,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",293,"Age-specific",1.3,1.2,1.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1256,"Age-specific",5.7,5.4,6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",615,"Age-specific",2.8,2.6,3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",121,"Age-specific",0.5,0.5,0.7,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",201,"Age-specific",0.9,0.8,1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",26,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",80,"Age-specific",0.4,0.3,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",291,"Age-specific",1.3,1.2,1.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",295,"Age-specific",1.3,1.2,1.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",815,"Age-specific",3.7,3.4,4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",478,"Age-specific",2.2,2,2.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",24,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",12,"Age-specific",0.1,0,0.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",35,"Age-specific",0.2,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",52,"Age-specific",0.2,0.2,0.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",234,"Age-specific",1.1,0.9,1.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",30,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",965,"Age-specific",4.4,4.1,4.7,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1228,"Age-specific",5.6,5.3,5.9,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",24660,"Age-specific",223.1,220.3,225.9,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",490,"Age-specific",2.2,2,2.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",315,"Age-specific",1.4,1.3,1.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",430,"Age-specific",1.9,1.8,2.1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",287,"Age-specific",1.3,1.2,1.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",310,"Age-specific",1.4,1.3,1.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",177,"Age-specific",0.8,0.7,0.9,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",31,"Age-specific",0.1,0.1,0.2,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",185,"Age-specific",1.7,1.4,1.9,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",31,"Age-specific",0.3,0.2,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",186,"Age-specific",0.8,0.7,1,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",66,"Age-specific",0.3,0.2,0.4,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",159,"Age-specific",0.7,0.6,0.8,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",103,"Age-specific",0.5,0.4,0.6,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",86,"Age-specific",0.4,0.3,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",90,"Age-specific",0.4,0.3,0.5,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",244,"Age-specific",1.1,1,1.3,""
2013,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",294,"Age-specific",1.3,1.2,1.5,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",23,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",962,"Age-specific",4.4,4.1,4.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",39925,"Age-specific",181,179.3,182.8,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",31022,"Age-specific",140.7,139.1,142.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",70990,"Age-specific",321.9,319.5,324.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",94,"Age-specific",0.4,0.3,0.5,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",211,"Age-specific",1,0.8,1.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",31,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",53,"Age-specific",0.2,0.2,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",50,"Age-specific",0.2,0.2,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",43,"Age-specific",0.2,0.1,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",95,"Age-specific",0.4,0.3,0.5,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",27,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",218,"Age-specific",1,0.9,1.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",20,"Age-specific",0.1,0.1,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",64,"Age-specific",0.3,0.2,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",22,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",8,"Age-specific",0,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",252,"Age-specific",1.1,1,1.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",315,"Age-specific",1.4,1.3,1.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",105,"Age-specific",0.5,0.4,0.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1318,"Age-specific",6,5.7,6.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2033,"Age-specific",9.2,8.8,9.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",119,"Age-specific",0.5,0.4,0.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",596,"Age-specific",2.7,2.5,2.9,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",151,"Age-specific",0.7,0.6,0.8,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",250,"Age-specific",1.1,1,1.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",31,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",45,"Age-specific",0.2,0.1,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",339,"Age-specific",1.5,1.4,1.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",15,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",48,"Age-specific",0.2,0.2,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",14,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",104,"Age-specific",0.5,0.4,0.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",966,"Age-specific",4.4,4.1,4.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",962,"Age-specific",4.4,4.1,4.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",30,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",35,"Age-specific",0.2,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",75,"Age-specific",0.3,0.3,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",62,"Age-specific",0.3,0.2,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",3124,"Age-specific",14.2,13.7,14.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8903,"Age-specific",40.4,39.5,41.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.1,0.1,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",75,"Age-specific",0.3,0.3,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",31,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",380,"Age-specific",1.7,1.6,1.9,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8653,"Age-specific",39.2,38.4,40.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",928,"Age-specific",4.2,3.9,4.5,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",18,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",9,"Age-specific",0,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",220,"Age-specific",1,0.9,1.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",111,"Age-specific",0.5,0.4,0.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",11,"Age-specific",0,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",898,"Age-specific",4.1,3.8,4.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",57,"Age-specific",0.3,0.2,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1304,"Age-specific",5.9,5.6,6.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",25,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",40,"Age-specific",0.2,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",9,"Age-specific",0,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",55,"Age-specific",0.2,0.2,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",73,"Age-specific",0.3,0.3,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",144,"Age-specific",0.7,0.6,0.8,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",12,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",783,"Age-specific",3.6,3.3,3.8,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",263,"Age-specific",1.2,1.1,1.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1236,"Age-specific",5.6,5.3,5.9,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",647,"Age-specific",2.9,2.7,3.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",124,"Age-specific",0.6,0.5,0.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",171,"Age-specific",0.8,0.7,0.9,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",31,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",76,"Age-specific",0.3,0.3,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",256,"Age-specific",1.2,1,1.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",306,"Age-specific",1.4,1.2,1.6,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",918,"Age-specific",4.2,3.9,4.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",555,"Age-specific",2.5,2.3,2.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",15,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",22,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",20,"Age-specific",0.1,0.1,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",38,"Age-specific",0.2,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",67,"Age-specific",0.3,0.2,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",238,"Age-specific",1.1,0.9,1.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",30,"Age-specific",0.1,0.1,0.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",1035,"Age-specific",4.7,4.4,5,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1325,"Age-specific",6,5.7,6.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",24963,"Age-specific",226.1,223.3,228.9,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",456,"Age-specific",2.1,1.9,2.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",367,"Age-specific",1.7,1.5,1.8,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",469,"Age-specific",2.1,1.9,2.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",331,"Age-specific",1.5,1.3,1.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",340,"Age-specific",1.5,1.4,1.7,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",1,"Age-specific",NA,NA,NA,"s"
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",186,"Age-specific",0.8,0.7,1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",17,"Age-specific",0.1,0,0.1,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",140,"Age-specific",1.3,1.1,1.5,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",21,"Age-specific",0.2,0.1,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",150,"Age-specific",0.7,0.6,0.8,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",57,"Age-specific",0.3,0.2,0.3,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",163,"Age-specific",0.7,0.6,0.9,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",79,"Age-specific",0.4,0.3,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",62,"Age-specific",0.3,0.2,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",76,"Age-specific",0.3,0.3,0.4,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",226,"Age-specific",1,0.9,1.2,""
2014,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",266,"Age-specific",1.2,1.1,1.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",18,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",946,"Age-specific",4.3,4,4.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",39532,"Age-specific",179.1,177.3,180.9,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",30719,"Age-specific",139.2,137.6,140.7,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",70069,"Age-specific",317.4,315.1,319.8,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",85,"Age-specific",0.4,0.3,0.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",195,"Age-specific",0.9,0.8,1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",18,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",44,"Age-specific",0.2,0.1,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",50,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",64,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",89,"Age-specific",0.4,0.3,0.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",25,"Age-specific",0.1,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",245,"Age-specific",1.1,1,1.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",21,"Age-specific",0.1,0.1,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",46,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",26,"Age-specific",0.1,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",12,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",8,"Age-specific",0,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",236,"Age-specific",1.1,0.9,1.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",316,"Age-specific",1.4,1.3,1.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",116,"Age-specific",0.5,0.4,0.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1352,"Age-specific",6.1,5.8,6.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2086,"Age-specific",9.4,9,9.9,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",114,"Age-specific",0.5,0.4,0.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",620,"Age-specific",2.8,2.6,3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",182,"Age-specific",0.8,0.7,1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",224,"Age-specific",1,0.9,1.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",20,"Age-specific",0.1,0.1,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",51,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",323,"Age-specific",1.5,1.3,1.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",11,"Age-specific",0,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",51,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",18,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",114,"Age-specific",0.5,0.4,0.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",5,"Age-specific",0,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",980,"Age-specific",4.4,4.2,4.7,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",975,"Age-specific",4.4,4.1,4.7,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",48,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",21,"Age-specific",0.1,0.1,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",91,"Age-specific",0.4,0.3,0.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",62,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2984,"Age-specific",13.5,13,14,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8813,"Age-specific",39.9,39.1,40.8,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.1,0.1,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",71,"Age-specific",0.3,0.3,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",16,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",47,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",347,"Age-specific",1.6,1.4,1.7,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8629,"Age-specific",39.1,38.3,39.9,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",920,"Age-specific",4.2,3.9,4.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",21,"Age-specific",0.1,0.1,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",13,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",197,"Age-specific",0.9,0.8,1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",9,"Age-specific",0,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",113,"Age-specific",0.5,0.4,0.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",13,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",943,"Age-specific",4.3,4,4.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",50,"Age-specific",0.2,0.2,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1373,"Age-specific",6.2,5.9,6.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",38,"Age-specific",0.2,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",27,"Age-specific",0.1,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",5,"Age-specific",0,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",71,"Age-specific",0.3,0.3,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",63,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",148,"Age-specific",0.7,0.6,0.8,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",821,"Age-specific",3.7,3.5,4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",278,"Age-specific",1.3,1.1,1.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1238,"Age-specific",5.6,5.3,5.9,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",646,"Age-specific",2.9,2.7,3.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",121,"Age-specific",0.5,0.5,0.7,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",159,"Age-specific",0.7,0.6,0.8,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",34,"Age-specific",0.2,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",81,"Age-specific",0.4,0.3,0.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",234,"Age-specific",1.1,0.9,1.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",317,"Age-specific",1.4,1.3,1.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",886,"Age-specific",4,3.8,4.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",521,"Age-specific",2.4,2.2,2.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",15,"Age-specific",0.1,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",22,"Age-specific",0.1,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",11,"Age-specific",0,0,0.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",43,"Age-specific",0.2,0.1,0.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",69,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",280,"Age-specific",1.3,1.1,1.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",22,"Age-specific",0.1,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",1070,"Age-specific",4.8,4.6,5.1,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1315,"Age-specific",6,5.6,6.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",24336,"Age-specific",220.4,217.7,223.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",470,"Age-specific",2.1,1.9,2.3,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",391,"Age-specific",1.8,1.6,2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",498,"Age-specific",2.3,2.1,2.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",314,"Age-specific",1.4,1.3,1.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",324,"Age-specific",1.5,1.3,1.6,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",167,"Age-specific",0.8,0.6,0.9,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",26,"Age-specific",0.1,0.1,0.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",143,"Age-specific",1.3,1.1,1.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",32,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",121,"Age-specific",0.5,0.5,0.7,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",69,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",159,"Age-specific",0.7,0.6,0.8,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",88,"Age-specific",0.4,0.3,0.5,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",64,"Age-specific",0.3,0.2,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",74,"Age-specific",0.3,0.3,0.4,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",241,"Age-specific",1.1,1,1.2,""
2015,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",263,"Age-specific",1.2,1.1,1.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",25,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",957,"Age-specific",4.3,4.1,4.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",39975,"Age-specific",180.9,179.1,182.7,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",31106,"Age-specific",140.8,139.2,142.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",67101,"Age-specific",303.7,301.4,306,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",116,"Age-specific",0.5,0.4,0.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",172,"Age-specific",0.8,0.7,0.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",29,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",48,"Age-specific",0.2,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",44,"Age-specific",0.2,0.1,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",43,"Age-specific",0.2,0.1,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",84,"Age-specific",0.4,0.3,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",26,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",246,"Age-specific",1.1,1,1.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",22,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",67,"Age-specific",0.3,0.2,0.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",11,"Age-specific",0,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",23,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",1,"Age-specific",NA,NA,NA,"s"
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",267,"Age-specific",1.2,1.1,1.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",287,"Age-specific",1.3,1.2,1.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",119,"Age-specific",0.5,0.4,0.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1452,"Age-specific",6.6,6.2,6.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2226,"Age-specific",10.1,9.7,10.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",117,"Age-specific",0.5,0.4,0.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",657,"Age-specific",3,2.8,3.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",159,"Age-specific",0.7,0.6,0.8,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",221,"Age-specific",1,0.9,1.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",30,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",44,"Age-specific",0.2,0.1,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",352,"Age-specific",1.6,1.4,1.8,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",14,"Age-specific",0.1,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",40,"Age-specific",0.2,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",21,"Age-specific",0.1,0.1,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",93,"Age-specific",0.4,0.3,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",966,"Age-specific",4.4,4.1,4.7,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",965,"Age-specific",4.4,4.1,4.7,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",43,"Age-specific",0.2,0.1,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",24,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",81,"Age-specific",0.4,0.3,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",58,"Age-specific",0.3,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",3031,"Age-specific",13.7,13.2,14.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8869,"Age-specific",40.1,39.3,41,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",27,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",74,"Age-specific",0.3,0.3,0.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",16,"Age-specific",0.1,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",47,"Age-specific",0.2,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",378,"Age-specific",1.7,1.5,1.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8629,"Age-specific",39.1,38.2,39.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",963,"Age-specific",4.4,4.1,4.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",16,"Age-specific",0.1,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",11,"Age-specific",0,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",190,"Age-specific",0.9,0.7,1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",9,"Age-specific",0,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",112,"Age-specific",0.5,0.4,0.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",26,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",939,"Age-specific",4.2,4,4.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",39,"Age-specific",0.2,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1476,"Age-specific",6.7,6.3,7,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",40,"Age-specific",0.2,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",16,"Age-specific",0.1,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",5,"Age-specific",0,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",55,"Age-specific",0.2,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",52,"Age-specific",0.2,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",167,"Age-specific",0.8,0.6,0.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",789,"Age-specific",3.6,3.3,3.8,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",259,"Age-specific",1.2,1,1.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1247,"Age-specific",5.6,5.3,6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",616,"Age-specific",2.8,2.6,3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",145,"Age-specific",0.7,0.6,0.8,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",189,"Age-specific",0.9,0.7,1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",38,"Age-specific",0.2,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",82,"Age-specific",0.4,0.3,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",241,"Age-specific",1.1,1,1.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",320,"Age-specific",1.4,1.3,1.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",837,"Age-specific",3.8,3.5,4.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",478,"Age-specific",2.2,2,2.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",13,"Age-specific",0.1,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",20,"Age-specific",0.1,0.1,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",6,"Age-specific",0,0,0.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",50,"Age-specific",0.2,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",59,"Age-specific",0.3,0.2,0.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",268,"Age-specific",1.2,1.1,1.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",28,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",1012,"Age-specific",4.6,4.3,4.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1292,"Age-specific",5.8,5.5,6.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",21017,"Age-specific",190.7,188.1,193.3,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",441,"Age-specific",2,1.8,2.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",386,"Age-specific",1.7,1.6,1.9,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",482,"Age-specific",2.2,2,2.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",327,"Age-specific",1.5,1.3,1.6,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",277,"Age-specific",1.3,1.1,1.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",3,"Age-specific",0,0,0,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",242,"Age-specific",1.1,1,1.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",22,"Age-specific",0.1,0.1,0.2,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",95,"Age-specific",0.9,0.7,1.1,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",36,"Age-specific",0.3,0.2,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",94,"Age-specific",0.4,0.3,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",82,"Age-specific",0.4,0.3,0.5,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",160,"Age-specific",0.7,0.6,0.8,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",77,"Age-specific",0.3,0.3,0.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",76,"Age-specific",0.3,0.3,0.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",78,"Age-specific",0.4,0.3,0.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",280,"Age-specific",1.3,1.1,1.4,""
2016,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",292,"Age-specific",1.3,1.2,1.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",949,"Age-specific",4.3,4,4.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",38802,"Age-specific",176,174.2,177.7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",30360,"Age-specific",137.7,136.1,139.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",65209,"Age-specific",295.7,293.5,298,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",92,"Age-specific",0.4,0.3,0.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",202,"Age-specific",0.9,0.8,1.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",29,"Age-specific",0.1,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",43,"Age-specific",0.2,0.1,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",48,"Age-specific",0.2,0.2,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",66,"Age-specific",0.3,0.2,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",82,"Age-specific",0.4,0.3,0.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",23,"Age-specific",0.1,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",247,"Age-specific",1.1,1,1.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",16,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",51,"Age-specific",0.2,0.2,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",23,"Age-specific",0.1,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",2,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",249,"Age-specific",1.1,1,1.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",285,"Age-specific",1.3,1.1,1.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",127,"Age-specific",0.6,0.5,0.7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1266,"Age-specific",5.7,5.4,6.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2084,"Age-specific",9.5,9,9.9,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",148,"Age-specific",0.7,0.6,0.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",670,"Age-specific",3,2.8,3.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",174,"Age-specific",0.8,0.7,0.9,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",221,"Age-specific",1,0.9,1.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",38,"Age-specific",0.2,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",41,"Age-specific",0.2,0.1,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",319,"Age-specific",1.4,1.3,1.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",17,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",47,"Age-specific",0.2,0.2,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",18,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",108,"Age-specific",0.5,0.4,0.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",0,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",855,"Age-specific",3.9,3.6,4.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",855,"Age-specific",3.9,3.6,4.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",55,"Age-specific",0.2,0.2,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",22,"Age-specific",0.1,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",72,"Age-specific",0.3,0.3,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",72,"Age-specific",0.3,0.3,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2847,"Age-specific",12.9,12.4,13.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8442,"Age-specific",38.3,37.5,39.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",34,"Age-specific",0.2,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",68,"Age-specific",0.3,0.2,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",15,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",44,"Age-specific",0.2,0.1,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",344,"Age-specific",1.6,1.4,1.7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8493,"Age-specific",38.5,37.7,39.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",974,"Age-specific",4.4,4.1,4.7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",12,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",10,"Age-specific",0,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",161,"Age-specific",0.7,0.6,0.9,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",104,"Age-specific",0.5,0.4,0.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",11,"Age-specific",0,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",920,"Age-specific",4.2,3.9,4.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",44,"Age-specific",0.2,0.1,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1464,"Age-specific",6.6,6.3,7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",33,"Age-specific",0.1,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",36,"Age-specific",0.2,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",2,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",36,"Age-specific",0.2,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",68,"Age-specific",0.3,0.2,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",153,"Age-specific",0.7,0.6,0.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",1,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",858,"Age-specific",3.9,3.6,4.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",275,"Age-specific",1.2,1.1,1.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1185,"Age-specific",5.4,5.1,5.7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",565,"Age-specific",2.6,2.4,2.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",136,"Age-specific",0.6,0.5,0.7,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",170,"Age-specific",0.8,0.7,0.9,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",39,"Age-specific",0.2,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",98,"Age-specific",0.4,0.4,0.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",262,"Age-specific",1.2,1,1.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",315,"Age-specific",1.4,1.3,1.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",878,"Age-specific",4,3.7,4.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",520,"Age-specific",2.4,2.2,2.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",26,"Age-specific",0.1,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",8,"Age-specific",0,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",38,"Age-specific",0.2,0.1,0.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",54,"Age-specific",0.2,0.2,0.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",233,"Age-specific",1.1,0.9,1.2,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",20,"Age-specific",0.1,0.1,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",1059,"Age-specific",4.8,4.5,5.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1326,"Age-specific",6,5.7,6.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19826,"Age-specific",180.2,177.7,182.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",528,"Age-specific",2.4,2.2,2.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",366,"Age-specific",1.7,1.5,1.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",513,"Age-specific",2.3,2.1,2.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",367,"Age-specific",1.7,1.5,1.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",307,"Age-specific",1.4,1.2,1.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",426,"Age-specific",1.9,1.8,2.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",18,"Age-specific",0.1,0,0.1,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",118,"Age-specific",1.1,0.9,1.3,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",34,"Age-specific",0.3,0.2,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",81,"Age-specific",0.4,0.3,0.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",77,"Age-specific",0.3,0.3,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",151,"Age-specific",0.7,0.6,0.8,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",78,"Age-specific",0.4,0.3,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",79,"Age-specific",0.4,0.3,0.4,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",81,"Age-specific",0.4,0.3,0.5,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",317,"Age-specific",1.4,1.3,1.6,""
2017,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",346,"Age-specific",1.6,1.4,1.7,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",20,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",932,"Age-specific",4.2,4,4.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",39171,"Age-specific",177.9,176.1,179.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",30867,"Age-specific",140.2,138.6,141.7,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",64800,"Age-specific",294.2,292,296.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",118,"Age-specific",0.5,0.4,0.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",169,"Age-specific",0.8,0.7,0.9,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",24,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",43,"Age-specific",0.2,0.1,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",46,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",46,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",103,"Age-specific",0.5,0.4,0.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",33,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",216,"Age-specific",1,0.9,1.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",21,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",47,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",20,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",22,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",4,"Age-specific",0,0,0,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",265,"Age-specific",1.2,1.1,1.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",298,"Age-specific",1.4,1.2,1.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",136,"Age-specific",0.6,0.5,0.7,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1321,"Age-specific",6,5.7,6.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2205,"Age-specific",10,9.6,10.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",140,"Age-specific",0.6,0.5,0.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",744,"Age-specific",3.4,3.1,3.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",135,"Age-specific",0.6,0.5,0.7,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",208,"Age-specific",0.9,0.8,1.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",20,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",41,"Age-specific",0.2,0.1,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",356,"Age-specific",1.6,1.5,1.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",8,"Age-specific",0,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",43,"Age-specific",0.2,0.1,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",33,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",114,"Age-specific",0.5,0.4,0.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",996,"Age-specific",4.5,4.2,4.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",993,"Age-specific",4.5,4.2,4.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",55,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",30,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",81,"Age-specific",0.4,0.3,0.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",70,"Age-specific",0.3,0.2,0.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2933,"Age-specific",13.3,12.8,13.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8304,"Age-specific",37.7,36.9,38.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",50,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",21,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",45,"Age-specific",0.2,0.1,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",311,"Age-specific",1.4,1.3,1.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8473,"Age-specific",38.5,37.7,39.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",929,"Age-specific",4.2,4,4.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",33,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",181,"Age-specific",0.8,0.7,1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",8,"Age-specific",0,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",93,"Age-specific",0.4,0.3,0.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",10,"Age-specific",0,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",904,"Age-specific",4.1,3.8,4.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",49,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1529,"Age-specific",6.9,6.6,7.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",33,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",28,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",10,"Age-specific",0,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",41,"Age-specific",0.2,0.1,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",59,"Age-specific",0.3,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",155,"Age-specific",0.7,0.6,0.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",1,"Age-specific",NA,NA,NA,"s"
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",806,"Age-specific",3.7,3.4,3.9,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",250,"Age-specific",1.1,1,1.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1148,"Age-specific",5.2,4.9,5.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",569,"Age-specific",2.6,2.4,2.8,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",98,"Age-specific",0.4,0.4,0.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",200,"Age-specific",0.9,0.8,1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",31,"Age-specific",0.1,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",90,"Age-specific",0.4,0.3,0.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",261,"Age-specific",1.2,1,1.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",324,"Age-specific",1.5,1.3,1.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",874,"Age-specific",4,3.7,4.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",494,"Age-specific",2.2,2,2.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",14,"Age-specific",0.1,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",35,"Age-specific",0.2,0.1,0.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",48,"Age-specific",0.2,0.2,0.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",68,"Age-specific",0.3,0.2,0.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",240,"Age-specific",1.1,1,1.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",20,"Age-specific",0.1,0.1,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",1117,"Age-specific",5.1,4.8,5.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1299,"Age-specific",5.9,5.6,6.2,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19088,"Age-specific",173.8,171.4,176.3,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",509,"Age-specific",2.3,2.1,2.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",386,"Age-specific",1.8,1.6,1.9,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",503,"Age-specific",2.3,2.1,2.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",310,"Age-specific",1.4,1.3,1.6,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",295,"Age-specific",1.3,1.2,1.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",3,"Age-specific",0,0,0,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",420,"Age-specific",1.9,1.7,2.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",13,"Age-specific",0.1,0,0.1,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",133,"Age-specific",1.2,1,1.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",36,"Age-specific",0.3,0.2,0.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",68,"Age-specific",0.3,0.2,0.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",76,"Age-specific",0.3,0.3,0.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",162,"Age-specific",0.7,0.6,0.9,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",69,"Age-specific",0.3,0.2,0.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",83,"Age-specific",0.4,0.3,0.5,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",75,"Age-specific",0.3,0.3,0.4,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",333,"Age-specific",1.5,1.4,1.7,""
2018,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",323,"Age-specific",1.5,1.3,1.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",902,"Age-specific",4.1,3.8,4.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",39102,"Age-specific",178.1,176.3,179.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",31084,"Age-specific",141.5,140,143.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",64981,"Age-specific",295.9,293.6,298.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",100,"Age-specific",0.5,0.4,0.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",148,"Age-specific",0.7,0.6,0.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",20,"Age-specific",0.1,0.1,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",32,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",56,"Age-specific",0.3,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",47,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",99,"Age-specific",0.5,0.4,0.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",23,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",228,"Age-specific",1,0.9,1.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",42,"Age-specific",0.2,0.1,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",52,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",15,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",21,"Age-specific",0.1,0.1,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",237,"Age-specific",1.1,0.9,1.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",351,"Age-specific",1.6,1.4,1.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",155,"Age-specific",0.7,0.6,0.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1378,"Age-specific",6.3,5.9,6.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2290,"Age-specific",10.4,10,10.9,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",127,"Age-specific",0.6,0.5,0.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",785,"Age-specific",3.6,3.3,3.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",166,"Age-specific",0.8,0.6,0.9,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",219,"Age-specific",1,0.9,1.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",35,"Age-specific",0.2,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",43,"Age-specific",0.2,0.1,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",352,"Age-specific",1.6,1.4,1.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",48,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",27,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",93,"Age-specific",0.4,0.3,0.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",934,"Age-specific",4.3,4,4.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",930,"Age-specific",4.2,4,4.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",48,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",19,"Age-specific",0.1,0.1,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",85,"Age-specific",0.4,0.3,0.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",78,"Age-specific",0.4,0.3,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2887,"Age-specific",13.1,12.7,13.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",8018,"Age-specific",36.5,35.7,37.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",23,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",46,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",26,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",51,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",341,"Age-specific",1.6,1.4,1.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8532,"Age-specific",38.9,38,39.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",953,"Age-specific",4.3,4.1,4.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",14,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",11,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",205,"Age-specific",0.9,0.8,1.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",130,"Age-specific",0.6,0.5,0.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",15,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",867,"Age-specific",3.9,3.7,4.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",42,"Age-specific",0.2,0.1,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1569,"Age-specific",7.1,6.8,7.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",67,"Age-specific",0.3,0.2,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",63,"Age-specific",0.3,0.2,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",12,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",34,"Age-specific",0.2,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",44,"Age-specific",0.2,0.1,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",145,"Age-specific",0.7,0.6,0.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",1,"Age-specific",NA,NA,NA,"s"
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",822,"Age-specific",3.7,3.5,4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",270,"Age-specific",1.2,1.1,1.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1213,"Age-specific",5.5,5.2,5.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",569,"Age-specific",2.6,2.4,2.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",138,"Age-specific",0.6,0.5,0.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",204,"Age-specific",0.9,0.8,1.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",32,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",70,"Age-specific",0.3,0.2,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",254,"Age-specific",1.2,1,1.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",289,"Age-specific",1.3,1.2,1.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",822,"Age-specific",3.7,3.5,4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",481,"Age-specific",2.2,2,2.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",14,"Age-specific",0.1,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",31,"Age-specific",0.1,0.1,0.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0,0,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",51,"Age-specific",0.2,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",72,"Age-specific",0.3,0.3,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",285,"Age-specific",1.3,1.2,1.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",20,"Age-specific",0.1,0.1,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",1158,"Age-specific",5.3,5,5.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1294,"Age-specific",5.9,5.6,6.2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19174,"Age-specific",175.2,172.7,177.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",571,"Age-specific",2.6,2.4,2.8,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",423,"Age-specific",1.9,1.7,2.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",479,"Age-specific",2.2,2,2.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",264,"Age-specific",1.2,1.1,1.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",315,"Age-specific",1.4,1.3,1.6,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",399,"Age-specific",1.8,1.6,2,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",21,"Age-specific",0.1,0.1,0.1,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",140,"Age-specific",1.3,1.1,1.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",39,"Age-specific",0.4,0.3,0.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",55,"Age-specific",0.3,0.2,0.3,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",82,"Age-specific",0.4,0.3,0.5,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",172,"Age-specific",0.8,0.7,0.9,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",62,"Age-specific",0.3,0.2,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",79,"Age-specific",0.4,0.3,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",74,"Age-specific",0.3,0.3,0.4,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",343,"Age-specific",1.6,1.4,1.7,""
2019,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",356,"Age-specific",1.6,1.5,1.8,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",27,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",797,"Age-specific",3.6,3.4,3.9,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",33823,"Age-specific",154.3,152.6,155.9,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",27484,"Age-specific",125.4,123.9,126.9,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",54746,"Age-specific",249.7,247.6,251.8,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",90,"Age-specific",0.4,0.3,0.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",125,"Age-specific",0.6,0.5,0.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",17,"Age-specific",0.1,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",36,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",36,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",47,"Age-specific",0.2,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",64,"Age-specific",0.3,0.2,0.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",22,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",200,"Age-specific",0.9,0.8,1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",55,"Age-specific",0.3,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",57,"Age-specific",0.3,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",11,"Age-specific",0.1,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",10,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",212,"Age-specific",1,0.8,1.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",300,"Age-specific",1.4,1.2,1.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",102,"Age-specific",0.5,0.4,0.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",1287,"Age-specific",5.9,5.6,6.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",2059,"Age-specific",9.4,9,9.8,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",111,"Age-specific",0.5,0.4,0.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",661,"Age-specific",3,2.8,3.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",138,"Age-specific",0.6,0.5,0.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",229,"Age-specific",1,0.9,1.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",28,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",43,"Age-specific",0.2,0.1,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",331,"Age-specific",1.5,1.4,1.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",9,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",46,"Age-specific",0.2,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",23,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",74,"Age-specific",0.3,0.3,0.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",6,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",860,"Age-specific",3.9,3.7,4.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",854,"Age-specific",3.9,3.6,4.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",68,"Age-specific",0.3,0.2,0.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",25,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",88,"Age-specific",0.4,0.3,0.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",69,"Age-specific",0.3,0.2,0.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",2329,"Age-specific",10.6,10.2,11.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",6339,"Age-specific",28.9,28.2,29.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",16,"Age-specific",0.1,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",37,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",22,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",45,"Age-specific",0.2,0.1,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",284,"Age-specific",1.3,1.1,1.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7772,"Age-specific",35.5,34.7,36.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",732,"Age-specific",3.3,3.1,3.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",20,"Age-specific",0.1,0.1,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",16,"Age-specific",0.1,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",167,"Age-specific",0.8,0.7,0.9,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",6,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",101,"Age-specific",0.5,0.4,0.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",13,"Age-specific",0.1,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",755,"Age-specific",3.4,3.2,3.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",34,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1382,"Age-specific",6.3,6,6.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",38,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",48,"Age-specific",0.2,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",10,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",24,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",41,"Age-specific",0.2,0.1,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",140,"Age-specific",0.6,0.5,0.8,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",9,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",813,"Age-specific",3.7,3.5,4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",227,"Age-specific",1,0.9,1.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",1079,"Age-specific",4.9,4.6,5.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",551,"Age-specific",2.5,2.3,2.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",92,"Age-specific",0.4,0.3,0.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",176,"Age-specific",0.8,0.7,0.9,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",33,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",69,"Age-specific",0.3,0.2,0.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",210,"Age-specific",1,0.8,1.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",281,"Age-specific",1.3,1.1,1.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",780,"Age-specific",3.6,3.3,3.8,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",449,"Age-specific",2,1.9,2.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",15,"Age-specific",0.1,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",25,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",10,"Age-specific",0,0,0.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",39,"Age-specific",0.2,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",48,"Age-specific",0.2,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",300,"Age-specific",1.4,1.2,1.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",23,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",789,"Age-specific",3.6,3.4,3.9,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",984,"Age-specific",4.5,4.2,4.8,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",15497,"Age-specific",142.1,139.9,144.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",515,"Age-specific",2.3,2.2,2.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",339,"Age-specific",1.5,1.4,1.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",427,"Age-specific",1.9,1.8,2.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",220,"Age-specific",1,0.9,1.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",201,"Age-specific",0.9,0.8,1.1,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",316,"Age-specific",1.4,1.3,1.6,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",24,"Age-specific",0.1,0.1,0.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",110,"Age-specific",1,0.8,1.2,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",35,"Age-specific",0.3,0.2,0.4,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",48,"Age-specific",0.2,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",87,"Age-specific",0.4,0.3,0.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",129,"Age-specific",0.6,0.5,0.7,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",53,"Age-specific",0.2,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",59,"Age-specific",0.3,0.2,0.3,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",82,"Age-specific",0.4,0.3,0.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",300,"Age-specific",1.4,1.2,1.5,""
2020,"Persons","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",337,"Age-specific",1.5,1.4,1.7,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",7,"Age-specific",0.1,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",244,"Age-specific",2.3,2.1,2.7,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",17514,"Age-specific",168.6,166.1,171.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",15314,"Age-specific",147.5,145.1,149.8,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",38795,"Age-specific",373.5,369.8,377.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",13,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",55,"Age-specific",0.5,0.4,0.7,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",6,"Age-specific",0.1,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",14,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",30,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",13,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",38,"Age-specific",0.4,0.3,0.5,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",19,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",5,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",21,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",6,"Age-specific",0.1,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",6,"Age-specific",0.1,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",78,"Age-specific",0.8,0.6,0.9,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",131,"Age-specific",1.3,1.1,1.5,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",25,"Age-specific",0.2,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",403,"Age-specific",3.9,3.5,4.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",615,"Age-specific",5.9,5.5,6.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",43,"Age-specific",0.4,0.3,0.6,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",169,"Age-specific",1.6,1.4,1.9,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",63,"Age-specific",0.6,0.5,0.8,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",32,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",13,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",12,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",95,"Age-specific",0.9,0.7,1.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",13,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",18,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",26,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",454,"Age-specific",4.4,4,4.8,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",452,"Age-specific",4.4,4,4.8,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",23,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",28,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1292,"Age-specific",12.4,11.8,13.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2200,"Age-specific",21.2,20.3,22.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",16,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",10,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",19,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",23,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",112,"Age-specific",1.1,0.9,1.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",6885,"Age-specific",66.3,64.7,67.9,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",117,"Age-specific",1.1,0.9,1.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",16,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1315,"Age-specific",12.7,12,13.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",301,"Age-specific",2.9,2.6,3.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",332,"Age-specific",3.2,2.9,3.6,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",31,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",874,"Age-specific",8.4,7.9,9,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",883,"Age-specific",8.5,8,9.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",9,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",145,"Age-specific",1.4,1.2,1.6,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",7,"Age-specific",0.1,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",80,"Age-specific",0.8,0.6,1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",19,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",298,"Age-specific",2.9,2.6,3.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",12,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",403,"Age-specific",3.9,3.5,4.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",20,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",10,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",34,"Age-specific",0.3,0.2,0.5,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",24,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",96,"Age-specific",0.9,0.7,1.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",40,"Age-specific",0.4,0.3,0.5,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",102,"Age-specific",1,0.8,1.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",277,"Age-specific",2.7,2.4,3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",114,"Age-specific",1.1,0.9,1.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",483,"Age-specific",4.7,4.2,5.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",144,"Age-specific",1.4,1.2,1.6,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",45,"Age-specific",0.4,0.3,0.6,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",180,"Age-specific",1.7,1.5,2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",3,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",60,"Age-specific",0.6,0.4,0.7,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",83,"Age-specific",0.8,0.6,1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",262,"Age-specific",2.5,2.2,2.8,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",166,"Age-specific",1.6,1.4,1.9,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",8,"Age-specific",0.1,0,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",4,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",4,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",5,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",26,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",1,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",288,"Age-specific",2.8,2.5,3.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",519,"Age-specific",5,4.6,5.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19093,"Age-specific",183.8,181.2,186.5,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",294,"Age-specific",2.8,2.5,3.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",25,"Age-specific",0.2,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",182,"Age-specific",1.8,1.5,2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",98,"Age-specific",0.9,0.8,1.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",87,"Age-specific",0.8,0.7,1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",80,"Age-specific",0.8,0.6,1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",4,"Age-specific",0,0,0.1,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",134,"Age-specific",1.3,1.1,1.5,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",62,"Age-specific",0.6,0.5,0.8,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",11,"Age-specific",0.1,0.1,0.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",49,"Age-specific",0.5,0.3,0.6,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",31,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",20,"Age-specific",0.2,0.1,0.3,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",31,"Age-specific",0.3,0.2,0.4,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",106,"Age-specific",1,0.8,1.2,""
2001,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",135,"Age-specific",1.3,1.1,1.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",208,"Age-specific",2,1.7,2.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",17131,"Age-specific",164.3,161.8,166.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",14878,"Age-specific",142.7,140.4,145,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",38475,"Age-specific",368.9,365.3,372.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",10,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",58,"Age-specific",0.6,0.4,0.7,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",7,"Age-specific",0.1,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",9,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",16,"Age-specific",0.2,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",11,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",30,"Age-specific",0.3,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",15,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",18,"Age-specific",0.2,0.1,0.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",4,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",13,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",8,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",64,"Age-specific",0.6,0.5,0.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",97,"Age-specific",0.9,0.8,1.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",29,"Age-specific",0.3,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",400,"Age-specific",3.8,3.5,4.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",631,"Age-specific",6.1,5.6,6.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",40,"Age-specific",0.4,0.3,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",191,"Age-specific",1.8,1.6,2.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",66,"Age-specific",0.6,0.5,0.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",45,"Age-specific",0.4,0.3,0.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",12,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",8,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",112,"Age-specific",1.1,0.9,1.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",5,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",8,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",22,"Age-specific",0.2,0.1,0.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",433,"Age-specific",4.2,3.8,4.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",430,"Age-specific",4.1,3.7,4.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",6,"Age-specific",0.1,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",23,"Age-specific",0.2,0.1,0.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",23,"Age-specific",0.2,0.1,0.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1225,"Age-specific",11.7,11.1,12.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2253,"Age-specific",21.6,20.7,22.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",13,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",11,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",9,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",13,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",104,"Age-specific",1,0.8,1.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",6804,"Age-specific",65.2,63.7,66.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",104,"Age-specific",1,0.8,1.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",26,"Age-specific",0.2,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1253,"Age-specific",12,11.4,12.7,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",270,"Age-specific",2.6,2.3,2.9,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",304,"Age-specific",2.9,2.6,3.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",34,"Age-specific",0.3,0.2,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",857,"Age-specific",8.2,7.7,8.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",870,"Age-specific",8.3,7.8,8.9,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",13,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",8,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",153,"Age-specific",1.5,1.2,1.7,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",10,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",0,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",67,"Age-specific",0.6,0.5,0.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",34,"Age-specific",0.3,0.2,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",7,"Age-specific",0.1,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",294,"Age-specific",2.8,2.5,3.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",9,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",446,"Age-specific",4.3,3.9,4.7,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",17,"Age-specific",0.2,0.1,0.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",11,"Age-specific",0.1,0.1,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",45,"Age-specific",0.4,0.3,0.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",31,"Age-specific",0.3,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",75,"Age-specific",0.7,0.6,0.9,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",28,"Age-specific",0.3,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",92,"Age-specific",0.9,0.7,1.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",239,"Age-specific",2.3,2,2.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",114,"Age-specific",1.1,0.9,1.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",434,"Age-specific",4.2,3.8,4.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",152,"Age-specific",1.5,1.2,1.7,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",31,"Age-specific",0.3,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",137,"Age-specific",1.3,1.1,1.6,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",5,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",62,"Age-specific",0.6,0.5,0.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",86,"Age-specific",0.8,0.7,1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",263,"Age-specific",2.5,2.2,2.8,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",167,"Age-specific",1.6,1.4,1.9,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",4,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",2,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",4,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",4,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",6,"Age-specific",0.1,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",26,"Age-specific",0.2,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",299,"Age-specific",2.9,2.6,3.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",522,"Age-specific",5,4.6,5.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19161,"Age-specific",183.7,181.1,186.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",285,"Age-specific",2.7,2.4,3.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",40,"Age-specific",0.4,0.3,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",200,"Age-specific",1.9,1.7,2.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",90,"Age-specific",0.9,0.7,1.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",96,"Age-specific",0.9,0.7,1.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",72,"Age-specific",0.7,0.5,0.9,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",3,"Age-specific",0,0,0.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",94,"Age-specific",0.9,0.7,1.1,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",58,"Age-specific",0.6,0.4,0.7,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",9,"Age-specific",0.1,0,0.2,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",41,"Age-specific",0.4,0.3,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",40,"Age-specific",0.4,0.3,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",36,"Age-specific",0.3,0.2,0.5,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",33,"Age-specific",0.3,0.2,0.4,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",113,"Age-specific",1.1,0.9,1.3,""
2002,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",117,"Age-specific",1.1,0.9,1.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",5,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",238,"Age-specific",2.3,2,2.6,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",18035,"Age-specific",172.2,169.7,174.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",15631,"Age-specific",149.3,147,151.6,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",39410,"Age-specific",376.4,372.7,380.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",7,"Age-specific",0.1,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",65,"Age-specific",0.6,0.5,0.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",8,"Age-specific",0.1,0,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",17,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",14,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",18,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",34,"Age-specific",0.3,0.2,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",11,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",35,"Age-specific",0.3,0.2,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",2,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",17,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",2,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",1,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",2,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",76,"Age-specific",0.7,0.6,0.9,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",124,"Age-specific",1.2,1,1.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",23,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",364,"Age-specific",3.5,3.1,3.9,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",617,"Age-specific",5.9,5.4,6.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",40,"Age-specific",0.4,0.3,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",213,"Age-specific",2,1.8,2.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",69,"Age-specific",0.7,0.5,0.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",43,"Age-specific",0.4,0.3,0.6,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",15,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",11,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",89,"Age-specific",0.8,0.7,1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",11,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",4,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",27,"Age-specific",0.3,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",496,"Age-specific",4.7,4.3,5.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",495,"Age-specific",4.7,4.3,5.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",13,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",8,"Age-specific",0.1,0,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",42,"Age-specific",0.4,0.3,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",25,"Age-specific",0.2,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1282,"Age-specific",12.2,11.6,12.9,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2404,"Age-specific",23,22.1,23.9,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",10,"Age-specific",0.1,0,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",22,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",10,"Age-specific",0.1,0,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",24,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",93,"Age-specific",0.9,0.7,1.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7178,"Age-specific",68.6,67,70.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",101,"Age-specific",1,0.8,1.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",30,"Age-specific",0.3,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1246,"Age-specific",11.9,11.2,12.6,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",338,"Age-specific",3.2,2.9,3.6,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",359,"Age-specific",3.4,3.1,3.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",21,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",892,"Age-specific",8.5,8,9.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",904,"Age-specific",8.6,8.1,9.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",12,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",10,"Age-specific",0.1,0,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",181,"Age-specific",1.7,1.5,2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",3,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",52,"Age-specific",0.5,0.4,0.7,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",30,"Age-specific",0.3,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",12,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",282,"Age-specific",2.7,2.4,3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",13,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",460,"Age-specific",4.4,4,4.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",13,"Age-specific",0.1,0.1,0.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",6,"Age-specific",0.1,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",37,"Age-specific",0.4,0.2,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",31,"Age-specific",0.3,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",70,"Age-specific",0.7,0.5,0.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",41,"Age-specific",0.4,0.3,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",90,"Age-specific",0.9,0.7,1.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",260,"Age-specific",2.5,2.2,2.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",123,"Age-specific",1.2,1,1.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",470,"Age-specific",4.5,4.1,4.9,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",159,"Age-specific",1.5,1.3,1.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",24,"Age-specific",0.2,0.1,0.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",164,"Age-specific",1.6,1.3,1.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",1,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",54,"Age-specific",0.5,0.4,0.7,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",88,"Age-specific",0.8,0.7,1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",309,"Age-specific",3,2.6,3.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",213,"Age-specific",2,1.8,2.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",5,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",3,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",2,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",6,"Age-specific",0.1,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",47,"Age-specific",0.4,0.3,0.6,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",6,"Age-specific",0.1,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",309,"Age-specific",3,2.6,3.3,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",517,"Age-specific",4.9,4.5,5.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19177,"Age-specific",183.1,180.6,185.8,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",287,"Age-specific",2.7,2.4,3.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",26,"Age-specific",0.2,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",187,"Age-specific",1.8,1.5,2.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",106,"Age-specific",1,0.8,1.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",108,"Age-specific",1,0.8,1.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",77,"Age-specific",0.7,0.6,0.9,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",7,"Age-specific",0.1,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",102,"Age-specific",1,0.8,1.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",40,"Age-specific",0.4,0.3,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",4,"Age-specific",0,0,0.1,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",42,"Age-specific",0.4,0.3,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",32,"Age-specific",0.3,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",40,"Age-specific",0.4,0.3,0.5,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",33,"Age-specific",0.3,0.2,0.4,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",100,"Age-specific",1,0.8,1.2,""
2003,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",122,"Age-specific",1.2,1,1.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",6,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",213,"Age-specific",2,1.8,2.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",18528,"Age-specific",175.9,173.4,178.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",15942,"Age-specific",151.4,149,153.7,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",39747,"Age-specific",377.4,373.7,381.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",12,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",42,"Age-specific",0.4,0.3,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",6,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",12,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",11,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",8,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",28,"Age-specific",0.3,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",20,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",32,"Age-specific",0.3,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",3,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",18,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",6,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",2,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",7,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",65,"Age-specific",0.6,0.5,0.8,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",134,"Age-specific",1.3,1.1,1.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",32,"Age-specific",0.3,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",407,"Age-specific",3.9,3.5,4.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",642,"Age-specific",6.1,5.6,6.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",47,"Age-specific",0.4,0.3,0.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",188,"Age-specific",1.8,1.5,2.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",50,"Age-specific",0.5,0.4,0.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",49,"Age-specific",0.5,0.3,0.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",18,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",7,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",87,"Age-specific",0.8,0.7,1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",8,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",13,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",9,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",17,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",455,"Age-specific",4.3,3.9,4.7,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",454,"Age-specific",4.3,3.9,4.7,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",5,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",6,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",22,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",19,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1438,"Age-specific",13.7,13,14.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2586,"Age-specific",24.6,23.6,25.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",10,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",10,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",10,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",22,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",102,"Age-specific",1,0.8,1.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7345,"Age-specific",69.7,68.2,71.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",94,"Age-specific",0.9,0.7,1.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",26,"Age-specific",0.2,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1271,"Age-specific",12.1,11.4,12.8,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",337,"Age-specific",3.2,2.9,3.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",361,"Age-specific",3.4,3.1,3.8,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",24,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",857,"Age-specific",8.1,7.6,8.7,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",868,"Age-specific",8.2,7.7,8.8,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",11,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",10,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",194,"Age-specific",1.8,1.6,2.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",4,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",72,"Age-specific",0.7,0.5,0.9,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",26,"Age-specific",0.2,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",10,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",271,"Age-specific",2.6,2.3,2.9,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",16,"Age-specific",0.2,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",522,"Age-specific",5,4.5,5.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",14,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",9,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",23,"Age-specific",0.2,0.1,0.3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",31,"Age-specific",0.3,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",64,"Age-specific",0.6,0.5,0.8,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",50,"Age-specific",0.5,0.4,0.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",90,"Age-specific",0.9,0.7,1.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",284,"Age-specific",2.7,2.4,3,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",120,"Age-specific",1.1,0.9,1.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",497,"Age-specific",4.7,4.3,5.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",188,"Age-specific",1.8,1.5,2.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",42,"Age-specific",0.4,0.3,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",147,"Age-specific",1.4,1.2,1.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",0,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",71,"Age-specific",0.7,0.5,0.9,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",81,"Age-specific",0.8,0.6,1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",264,"Age-specific",2.5,2.2,2.8,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",169,"Age-specific",1.6,1.4,1.9,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",10,"Age-specific",0.1,0,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",4,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",4,"Age-specific",0,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",35,"Age-specific",0.3,0.2,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",8,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",348,"Age-specific",3.3,3,3.7,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",589,"Age-specific",5.6,5.1,6.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",18789,"Age-specific",178.4,175.9,181,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",301,"Age-specific",2.9,2.5,3.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",39,"Age-specific",0.4,0.3,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",220,"Age-specific",2.1,1.8,2.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",93,"Age-specific",0.9,0.7,1.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",139,"Age-specific",1.3,1.1,1.6,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",87,"Age-specific",0.8,0.7,1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",7,"Age-specific",0.1,0,0.1,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",103,"Age-specific",1,0.8,1.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",59,"Age-specific",0.6,0.4,0.7,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",11,"Age-specific",0.1,0.1,0.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",38,"Age-specific",0.4,0.3,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",37,"Age-specific",0.4,0.2,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",39,"Age-specific",0.4,0.3,0.5,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",27,"Age-specific",0.3,0.2,0.4,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",108,"Age-specific",1,0.8,1.2,""
2004,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",137,"Age-specific",1.3,1.1,1.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",0,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",246,"Age-specific",2.3,2,2.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",19246,"Age-specific",180.5,177.9,183,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",16591,"Age-specific",155.6,153.2,158,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",41910,"Age-specific",393,389.2,396.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",10,"Age-specific",0.1,0,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",51,"Age-specific",0.5,0.4,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",5,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",18,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",24,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",18,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",36,"Age-specific",0.3,0.2,0.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",13,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",33,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",6,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",19,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",5,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",1,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",7,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",63,"Age-specific",0.6,0.5,0.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",114,"Age-specific",1.1,0.9,1.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",44,"Age-specific",0.4,0.3,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",446,"Age-specific",4.2,3.8,4.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",711,"Age-specific",6.7,6.2,7.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",60,"Age-specific",0.6,0.4,0.7,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",205,"Age-specific",1.9,1.7,2.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",68,"Age-specific",0.6,0.5,0.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",49,"Age-specific",0.5,0.3,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",13,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",14,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",104,"Age-specific",1,0.8,1.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",14,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",10,"Age-specific",0.1,0,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",8,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",29,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",464,"Age-specific",4.4,4,4.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",461,"Age-specific",4.3,3.9,4.7,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",10,"Age-specific",0.1,0,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",5,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",31,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",22,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1543,"Age-specific",14.5,13.8,15.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2655,"Age-specific",24.9,24,25.9,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",9,"Age-specific",0.1,0,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",11,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",13,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",35,"Age-specific",0.3,0.2,0.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",139,"Age-specific",1.3,1.1,1.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7534,"Age-specific",70.6,69.1,72.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",113,"Age-specific",1.1,0.9,1.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",30,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1310,"Age-specific",12.3,11.6,13,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",361,"Age-specific",3.4,3,3.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",404,"Age-specific",3.8,3.4,4.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",43,"Age-specific",0.4,0.3,0.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",858,"Age-specific",8,7.5,8.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",872,"Age-specific",8.2,7.6,8.7,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",14,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",9,"Age-specific",0.1,0,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",205,"Age-specific",1.9,1.7,2.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",6,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",85,"Age-specific",0.8,0.6,1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",39,"Age-specific",0.4,0.3,0.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",8,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",300,"Age-specific",2.8,2.5,3.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",17,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",539,"Age-specific",5.1,4.6,5.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",17,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",6,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",25,"Age-specific",0.2,0.2,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",24,"Age-specific",0.2,0.1,0.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",85,"Age-specific",0.8,0.6,1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",36,"Age-specific",0.3,0.2,0.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",82,"Age-specific",0.8,0.6,1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",260,"Age-specific",2.4,2.2,2.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",103,"Age-specific",1,0.8,1.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",443,"Age-specific",4.2,3.8,4.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",161,"Age-specific",1.5,1.3,1.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",32,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",147,"Age-specific",1.4,1.2,1.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",3,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",62,"Age-specific",0.6,0.4,0.7,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",80,"Age-specific",0.8,0.6,0.9,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",295,"Age-specific",2.8,2.5,3.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",197,"Age-specific",1.8,1.6,2.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",7,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",10,"Age-specific",0.1,0,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",7,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",11,"Age-specific",0.1,0.1,0.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",48,"Age-specific",0.5,0.3,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",4,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",426,"Age-specific",4,3.6,4.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",637,"Age-specific",6,5.5,6.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19936,"Age-specific",186.9,184.4,189.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",322,"Age-specific",3,2.7,3.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",28,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",260,"Age-specific",2.4,2.2,2.8,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",115,"Age-specific",1.1,0.9,1.3,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",135,"Age-specific",1.3,1.1,1.5,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",103,"Age-specific",1,0.8,1.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",5,"Age-specific",0,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",106,"Age-specific",1,0.8,1.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",62,"Age-specific",0.6,0.4,0.7,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",8,"Age-specific",0.1,0,0.1,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",52,"Age-specific",0.5,0.4,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",49,"Age-specific",0.5,0.3,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",45,"Age-specific",0.4,0.3,0.6,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",27,"Age-specific",0.3,0.2,0.4,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",107,"Age-specific",1,0.8,1.2,""
2005,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",177,"Age-specific",1.7,1.4,1.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",4,"Age-specific",0,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",268,"Age-specific",2.5,2.2,2.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",19917,"Age-specific",185,182.4,187.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",17171,"Age-specific",159.5,157.1,161.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",42318,"Age-specific",393.1,389.3,396.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",13,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",64,"Age-specific",0.6,0.5,0.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",4,"Age-specific",0,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",14,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",18,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",24,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",37,"Age-specific",0.3,0.2,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",12,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",44,"Age-specific",0.4,0.3,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",2,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",21,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",2,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",2,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",7,"Age-specific",0.1,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",73,"Age-specific",0.7,0.5,0.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",118,"Age-specific",1.1,0.9,1.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",44,"Age-specific",0.4,0.3,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",483,"Age-specific",4.5,4.1,4.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",766,"Age-specific",7.1,6.6,7.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",72,"Age-specific",0.7,0.5,0.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",211,"Age-specific",2,1.7,2.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",51,"Age-specific",0.5,0.4,0.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",59,"Age-specific",0.5,0.4,0.7,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",15,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",12,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",131,"Age-specific",1.2,1,1.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",13,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",12,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",11,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",27,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",0,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",467,"Age-specific",4.3,4,4.7,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",467,"Age-specific",4.3,4,4.7,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",8,"Age-specific",0.1,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",11,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",28,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",18,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1649,"Age-specific",15.3,14.6,16.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2746,"Age-specific",25.5,24.6,26.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",14,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",22,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",13,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",35,"Age-specific",0.3,0.2,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",114,"Age-specific",1.1,0.9,1.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7569,"Age-specific",70.3,68.7,71.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",134,"Age-specific",1.2,1,1.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",32,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1392,"Age-specific",12.9,12.3,13.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",392,"Age-specific",3.6,3.3,4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",428,"Age-specific",4,3.6,4.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",36,"Age-specific",0.3,0.2,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",952,"Age-specific",8.8,8.3,9.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",967,"Age-specific",9,8.4,9.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",15,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",6,"Age-specific",0.1,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",176,"Age-specific",1.6,1.4,1.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",4,"Age-specific",0,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",1,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",64,"Age-specific",0.6,0.5,0.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",27,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0.1,0,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",299,"Age-specific",2.8,2.5,3.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",15,"Age-specific",0.1,0.1,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",652,"Age-specific",6.1,5.6,6.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",17,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",21,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",24,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",36,"Age-specific",0.3,0.2,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",80,"Age-specific",0.7,0.6,0.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",34,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",78,"Age-specific",0.7,0.6,0.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",292,"Age-specific",2.7,2.4,3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",110,"Age-specific",1,0.8,1.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",456,"Age-specific",4.2,3.9,4.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",167,"Age-specific",1.6,1.3,1.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",45,"Age-specific",0.4,0.3,0.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",134,"Age-specific",1.2,1,1.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",74,"Age-specific",0.7,0.5,0.9,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",94,"Age-specific",0.9,0.7,1.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",291,"Age-specific",2.7,2.4,3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",182,"Age-specific",1.7,1.5,2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",7,"Age-specific",0.1,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",2,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",6,"Age-specific",0.1,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",9,"Age-specific",0.1,0,0.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",6,"Age-specific",0.1,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",63,"Age-specific",0.6,0.4,0.7,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",3,"Age-specific",0,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",489,"Age-specific",4.5,4.1,5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",683,"Age-specific",6.3,5.9,6.8,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19567,"Age-specific",181.7,179.2,184.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",326,"Age-specific",3,2.7,3.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",32,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",249,"Age-specific",2.3,2,2.6,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",112,"Age-specific",1,0.9,1.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",127,"Age-specific",1.2,1,1.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",108,"Age-specific",1,0.8,1.2,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",4,"Age-specific",0,0,0.1,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",137,"Age-specific",1.3,1.1,1.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",43,"Age-specific",0.4,0.3,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",17,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",34,"Age-specific",0.3,0.2,0.4,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",38,"Age-specific",0.4,0.2,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",40,"Age-specific",0.4,0.3,0.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",21,"Age-specific",0.2,0.1,0.3,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",136,"Age-specific",1.3,1.1,1.5,""
2006,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",166,"Age-specific",1.5,1.3,1.8,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",7,"Age-specific",0.1,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",272,"Age-specific",2.5,2.2,2.8,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",20547,"Age-specific",189.4,186.8,192,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",17272,"Age-specific",159.2,156.8,161.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",44322,"Age-specific",408.5,404.7,412.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",15,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",77,"Age-specific",0.7,0.6,0.9,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",6,"Age-specific",0.1,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",11,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",17,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",11,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",35,"Age-specific",0.3,0.2,0.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",13,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",47,"Age-specific",0.4,0.3,0.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",7,"Age-specific",0.1,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",20,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",2,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",2,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",2,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",58,"Age-specific",0.5,0.4,0.7,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",126,"Age-specific",1.2,1,1.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",38,"Age-specific",0.4,0.2,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",459,"Age-specific",4.2,3.9,4.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",745,"Age-specific",6.9,6.4,7.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",61,"Age-specific",0.6,0.4,0.7,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",225,"Age-specific",2.1,1.8,2.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",79,"Age-specific",0.7,0.6,0.9,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",62,"Age-specific",0.6,0.4,0.7,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",17,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",12,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",116,"Age-specific",1.1,0.9,1.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",13,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",10,"Age-specific",0.1,0,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",17,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",458,"Age-specific",4.2,3.8,4.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",456,"Age-specific",4.2,3.8,4.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",8,"Age-specific",0.1,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",10,"Age-specific",0.1,0,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",42,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",33,"Age-specific",0.3,0.2,0.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1548,"Age-specific",14.3,13.6,15,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3275,"Age-specific",30.2,29.2,31.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",12,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",16,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",18,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",34,"Age-specific",0.3,0.2,0.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",111,"Age-specific",1,0.8,1.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7546,"Age-specific",69.6,68,71.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",127,"Age-specific",1.2,1,1.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",32,"Age-specific",0.3,0.2,0.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1380,"Age-specific",12.7,12.1,13.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",424,"Age-specific",3.9,3.5,4.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",456,"Age-specific",4.2,3.8,4.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",32,"Age-specific",0.3,0.2,0.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1019,"Age-specific",9.4,8.8,10,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1035,"Age-specific",9.5,9,10.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",16,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",3,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",196,"Age-specific",1.8,1.6,2.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",75,"Age-specific",0.7,0.5,0.9,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",1,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",46,"Age-specific",0.4,0.3,0.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",5,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",333,"Age-specific",3.1,2.7,3.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",24,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",671,"Age-specific",6.2,5.7,6.7,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",18,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",11,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",20,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",44,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",56,"Age-specific",0.5,0.4,0.7,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",23,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",77,"Age-specific",0.7,0.6,0.9,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",303,"Age-specific",2.8,2.5,3.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",144,"Age-specific",1.3,1.1,1.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",511,"Age-specific",4.7,4.3,5.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",217,"Age-specific",2,1.7,2.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",42,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",108,"Age-specific",1,0.8,1.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",5,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",72,"Age-specific",0.7,0.5,0.8,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",85,"Age-specific",0.8,0.6,1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",319,"Age-specific",2.9,2.6,3.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",218,"Age-specific",2,1.8,2.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0.1,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",3,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0.1,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",5,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",11,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",72,"Age-specific",0.7,0.5,0.8,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",4,"Age-specific",0,0,0.1,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",470,"Age-specific",4.3,3.9,4.7,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",686,"Age-specific",6.3,5.9,6.8,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",20867,"Age-specific",192.3,189.7,195,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",328,"Age-specific",3,2.7,3.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",29,"Age-specific",0.3,0.2,0.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",243,"Age-specific",2.2,2,2.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",119,"Age-specific",1.1,0.9,1.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",149,"Age-specific",1.4,1.2,1.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",109,"Age-specific",1,0.8,1.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",13,"Age-specific",0.1,0.1,0.2,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",127,"Age-specific",1.2,1,1.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",54,"Age-specific",0.5,0.4,0.6,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",17,"Age-specific",0.2,0.1,0.3,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",43,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",43,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",41,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",42,"Age-specific",0.4,0.3,0.5,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",130,"Age-specific",1.2,1,1.4,""
2007,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",178,"Age-specific",1.6,1.4,1.9,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",9,"Age-specific",0.1,0,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",317,"Age-specific",2.9,2.6,3.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",22012,"Age-specific",201.5,198.9,204.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",18152,"Age-specific",166.2,163.8,168.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",47994,"Age-specific",439.4,435.5,443.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",20,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",63,"Age-specific",0.6,0.4,0.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",8,"Age-specific",0.1,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",14,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",22,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",31,"Age-specific",0.3,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",63,"Age-specific",0.6,0.4,0.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",18,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",35,"Age-specific",0.3,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",5,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",18,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",6,"Age-specific",0.1,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",2,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",74,"Age-specific",0.7,0.5,0.9,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",115,"Age-specific",1.1,0.9,1.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",40,"Age-specific",0.4,0.3,0.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",438,"Age-specific",4,3.6,4.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",737,"Age-specific",6.7,6.3,7.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",63,"Age-specific",0.6,0.4,0.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",236,"Age-specific",2.2,1.9,2.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",71,"Age-specific",0.7,0.5,0.8,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",72,"Age-specific",0.7,0.5,0.8,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",14,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",14,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",116,"Age-specific",1.1,0.9,1.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",13,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",24,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",7,"Age-specific",0.1,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",25,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",474,"Age-specific",4.3,4,4.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",471,"Age-specific",4.3,3.9,4.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",9,"Age-specific",0.1,0,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",7,"Age-specific",0.1,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",38,"Age-specific",0.3,0.2,0.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",24,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1718,"Age-specific",15.7,15,16.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3860,"Age-specific",35.3,34.2,36.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",12,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",22,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",34,"Age-specific",0.3,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",139,"Age-specific",1.3,1.1,1.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7916,"Age-specific",72.5,70.9,74.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",127,"Age-specific",1.2,1,1.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",22,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1481,"Age-specific",13.6,12.9,14.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",462,"Age-specific",4.2,3.9,4.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",495,"Age-specific",4.5,4.1,4.9,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",33,"Age-specific",0.3,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1011,"Age-specific",9.3,8.7,9.8,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1033,"Age-specific",9.5,8.9,10.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",22,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",9,"Age-specific",0.1,0,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",241,"Age-specific",2.2,1.9,2.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",7,"Age-specific",0.1,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",75,"Age-specific",0.7,0.5,0.9,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",34,"Age-specific",0.3,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",10,"Age-specific",0.1,0,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",341,"Age-specific",3.1,2.8,3.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",20,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",712,"Age-specific",6.5,6,7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",24,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",9,"Age-specific",0.1,0,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",22,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",25,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",68,"Age-specific",0.6,0.5,0.8,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",30,"Age-specific",0.3,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",64,"Age-specific",0.6,0.5,0.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",341,"Age-specific",3.1,2.8,3.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",116,"Age-specific",1.1,0.9,1.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",484,"Age-specific",4.4,4,4.8,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",220,"Age-specific",2,1.8,2.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",44,"Age-specific",0.4,0.3,0.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",104,"Age-specific",1,0.8,1.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",99,"Age-specific",0.9,0.7,1.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",92,"Age-specific",0.8,0.7,1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",310,"Age-specific",2.8,2.5,3.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",207,"Age-specific",1.9,1.6,2.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",5,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",5,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",15,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",12,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",80,"Age-specific",0.7,0.6,0.9,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",4,"Age-specific",0,0,0.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",503,"Age-specific",4.6,4.2,5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",762,"Age-specific",7,6.5,7.5,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",22645,"Age-specific",207.3,204.6,210,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",372,"Age-specific",3.4,3.1,3.8,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",27,"Age-specific",0.2,0.2,0.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",249,"Age-specific",2.3,2,2.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",122,"Age-specific",1.1,0.9,1.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",181,"Age-specific",1.7,1.4,1.9,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",130,"Age-specific",1.2,1,1.4,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",15,"Age-specific",0.1,0.1,0.2,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",155,"Age-specific",1.4,1.2,1.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",97,"Age-specific",0.9,0.7,1.1,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",24,"Age-specific",0.2,0.1,0.3,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",54,"Age-specific",0.5,0.4,0.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",50,"Age-specific",0.5,0.3,0.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",54,"Age-specific",0.5,0.4,0.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",45,"Age-specific",0.4,0.3,0.6,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",157,"Age-specific",1.4,1.2,1.7,""
2008,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",243,"Age-specific",2.2,2,2.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",8,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",322,"Age-specific",2.9,2.6,3.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",22779,"Age-specific",207.8,205.1,210.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",18879,"Age-specific",172.2,169.7,174.7,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",54387,"Age-specific",496,491.9,500.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",21,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",69,"Age-specific",0.6,0.5,0.8,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",14,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",7,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",29,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",18,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",54,"Age-specific",0.5,0.4,0.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",18,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",37,"Age-specific",0.3,0.2,0.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",7,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",20,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",6,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",8,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",6,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",63,"Age-specific",0.6,0.4,0.7,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",118,"Age-specific",1.1,0.9,1.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",37,"Age-specific",0.3,0.2,0.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",515,"Age-specific",4.7,4.3,5.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",808,"Age-specific",7.4,6.9,7.9,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",52,"Age-specific",0.5,0.4,0.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",241,"Age-specific",2.2,1.9,2.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",82,"Age-specific",0.7,0.6,0.9,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",76,"Age-specific",0.7,0.5,0.9,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",17,"Age-specific",0.2,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",11,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",121,"Age-specific",1.1,0.9,1.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",17,"Age-specific",0.2,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",16,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",7,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",31,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",528,"Age-specific",4.8,4.4,5.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",527,"Age-specific",4.8,4.4,5.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",13,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",4,"Age-specific",0,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",28,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",33,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1717,"Age-specific",15.7,14.9,16.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3900,"Age-specific",35.6,34.5,36.7,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",13,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",15,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",39,"Age-specific",0.4,0.3,0.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",135,"Age-specific",1.2,1,1.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8147,"Age-specific",74.3,72.7,75.9,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",142,"Age-specific",1.3,1.1,1.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",26,"Age-specific",0.2,0.2,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1803,"Age-specific",16.4,15.7,17.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",427,"Age-specific",3.9,3.5,4.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",467,"Age-specific",4.3,3.9,4.7,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",40,"Age-specific",0.4,0.3,0.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1018,"Age-specific",9.3,8.7,9.9,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1036,"Age-specific",9.4,8.9,10,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",18,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",12,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",241,"Age-specific",2.2,1.9,2.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",69,"Age-specific",0.6,0.5,0.8,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",30,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",12,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",305,"Age-specific",2.8,2.5,3.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",17,"Age-specific",0.2,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",741,"Age-specific",6.8,6.3,7.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",20,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",11,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",16,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",32,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",50,"Age-specific",0.5,0.3,0.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",31,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",87,"Age-specific",0.8,0.6,1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",330,"Age-specific",3,2.7,3.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",140,"Age-specific",1.3,1.1,1.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",536,"Age-specific",4.9,4.5,5.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",217,"Age-specific",2,1.7,2.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",63,"Age-specific",0.6,0.4,0.7,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",116,"Age-specific",1.1,0.9,1.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",4,"Age-specific",0,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",86,"Age-specific",0.8,0.6,1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",87,"Age-specific",0.8,0.6,1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",326,"Age-specific",3,2.7,3.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",224,"Age-specific",2,1.8,2.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",3,"Age-specific",0,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",6,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",16,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",1,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",6,"Age-specific",0.1,0,0.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",95,"Age-specific",0.9,0.7,1.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",498,"Age-specific",4.5,4.2,5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",793,"Age-specific",7.2,6.7,7.8,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",28209,"Age-specific",257.3,254.3,260.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",422,"Age-specific",3.8,3.5,4.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",33,"Age-specific",0.3,0.2,0.4,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",242,"Age-specific",2.2,1.9,2.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",104,"Age-specific",0.9,0.8,1.1,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",172,"Age-specific",1.6,1.3,1.8,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",146,"Age-specific",1.3,1.1,1.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",17,"Age-specific",0.2,0.1,0.2,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",146,"Age-specific",1.3,1.1,1.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",82,"Age-specific",0.7,0.6,0.9,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",25,"Age-specific",0.2,0.1,0.3,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",48,"Age-specific",0.4,0.3,0.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",56,"Age-specific",0.5,0.4,0.7,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",46,"Age-specific",0.4,0.3,0.6,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",39,"Age-specific",0.4,0.3,0.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",137,"Age-specific",1.2,1,1.5,""
2009,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",280,"Age-specific",2.6,2.3,2.9,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",4,"Age-specific",0,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",305,"Age-specific",2.8,2.5,3.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",23291,"Age-specific",211.4,208.7,214.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",19141,"Age-specific",173.7,171.2,176.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",48838,"Age-specific",443.2,439.3,447.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",13,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",56,"Age-specific",0.5,0.4,0.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",6,"Age-specific",0.1,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",18,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",25,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",25,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",45,"Age-specific",0.4,0.3,0.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",16,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",59,"Age-specific",0.5,0.4,0.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",5,"Age-specific",0,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",20,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",4,"Age-specific",0,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",0,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",9,"Age-specific",0.1,0,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",59,"Age-specific",0.5,0.4,0.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",144,"Age-specific",1.3,1.1,1.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",37,"Age-specific",0.3,0.2,0.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",514,"Age-specific",4.7,4.3,5.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",847,"Age-specific",7.7,7.2,8.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",64,"Age-specific",0.6,0.4,0.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",269,"Age-specific",2.4,2.2,2.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",72,"Age-specific",0.7,0.5,0.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",61,"Age-specific",0.6,0.4,0.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",23,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",15,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",126,"Age-specific",1.1,1,1.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",14,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",15,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",6,"Age-specific",0.1,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",21,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",503,"Age-specific",4.6,4.2,5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",501,"Age-specific",4.5,4.2,5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",12,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",9,"Age-specific",0.1,0,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",35,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",23,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1753,"Age-specific",15.9,15.2,16.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4150,"Age-specific",37.7,36.5,38.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",16,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",9,"Age-specific",0.1,0,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",35,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",153,"Age-specific",1.4,1.2,1.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8593,"Age-specific",78,76.3,79.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",123,"Age-specific",1.1,0.9,1.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",26,"Age-specific",0.2,0.2,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1437,"Age-specific",13,12.4,13.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",442,"Age-specific",4,3.6,4.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",468,"Age-specific",4.2,3.9,4.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",26,"Age-specific",0.2,0.2,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1043,"Age-specific",9.5,8.9,10.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1074,"Age-specific",9.7,9.2,10.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",31,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",9,"Age-specific",0.1,0,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",216,"Age-specific",2,1.7,2.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",7,"Age-specific",0.1,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",2,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",68,"Age-specific",0.6,0.5,0.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",1,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",47,"Age-specific",0.4,0.3,0.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",8,"Age-specific",0.1,0,0.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",326,"Age-specific",3,2.6,3.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",23,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",820,"Age-specific",7.4,6.9,8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",19,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",16,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",24,"Age-specific",0.2,0.1,0.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",30,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",68,"Age-specific",0.6,0.5,0.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",30,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",72,"Age-specific",0.7,0.5,0.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",347,"Age-specific",3.1,2.8,3.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",156,"Age-specific",1.4,1.2,1.7,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",547,"Age-specific",5,4.6,5.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",237,"Age-specific",2.2,1.9,2.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",54,"Age-specific",0.5,0.4,0.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",100,"Age-specific",0.9,0.7,1.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",1,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",98,"Age-specific",0.9,0.7,1.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",95,"Age-specific",0.9,0.7,1.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",314,"Age-specific",2.8,2.5,3.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",198,"Age-specific",1.8,1.6,2.1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0.1,0,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",11,"Age-specific",0.1,0,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",15,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",16,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",93,"Age-specific",0.8,0.7,1,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",14,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",503,"Age-specific",4.6,4.2,5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",747,"Age-specific",6.8,6.3,7.3,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",22269,"Age-specific",202.1,199.4,204.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",403,"Age-specific",3.7,3.3,4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",32,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",277,"Age-specific",2.5,2.2,2.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",131,"Age-specific",1.2,1,1.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",136,"Age-specific",1.2,1,1.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",139,"Age-specific",1.3,1.1,1.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",14,"Age-specific",0.1,0.1,0.2,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",126,"Age-specific",1.1,1,1.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",67,"Age-specific",0.6,0.5,0.8,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",27,"Age-specific",0.2,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",55,"Age-specific",0.5,0.4,0.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",54,"Age-specific",0.5,0.4,0.6,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",30,"Age-specific",0.3,0.2,0.4,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",45,"Age-specific",0.4,0.3,0.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",144,"Age-specific",1.3,1.1,1.5,""
2010,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",225,"Age-specific",2,1.8,2.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",9,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",283,"Age-specific",2.6,2.3,2.9,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",23284,"Age-specific",210.4,207.7,213.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",19152,"Age-specific",173,170.6,175.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",49580,"Age-specific",448,444,451.9,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",25,"Age-specific",0.2,0.1,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",60,"Age-specific",0.5,0.4,0.7,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",4,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",16,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",19,"Age-specific",0.2,0.1,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",13,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",51,"Age-specific",0.5,0.3,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",10,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",48,"Age-specific",0.4,0.3,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",4,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",17,"Age-specific",0.2,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",2,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",4,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",1,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",58,"Age-specific",0.5,0.4,0.7,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",123,"Age-specific",1.1,0.9,1.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",49,"Age-specific",0.4,0.3,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",569,"Age-specific",5.1,4.7,5.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",858,"Age-specific",7.8,7.2,8.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",54,"Age-specific",0.5,0.4,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",235,"Age-specific",2.1,1.9,2.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",102,"Age-specific",0.9,0.8,1.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",66,"Age-specific",0.6,0.5,0.8,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",24,"Age-specific",0.2,0.1,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",16,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",134,"Age-specific",1.2,1,1.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",8,"Age-specific",0.1,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",16,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",5,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",26,"Age-specific",0.2,0.2,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",434,"Age-specific",3.9,3.6,4.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",431,"Age-specific",3.9,3.5,4.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",18,"Age-specific",0.2,0.1,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",5,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",32,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",37,"Age-specific",0.3,0.2,0.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1740,"Age-specific",15.7,15,16.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4132,"Age-specific",37.3,36.2,38.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",9,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",16,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",34,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",139,"Age-specific",1.3,1.1,1.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8435,"Age-specific",76.2,74.6,77.9,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",134,"Age-specific",1.2,1,1.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",31,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1580,"Age-specific",14.3,13.6,15,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",436,"Age-specific",3.9,3.6,4.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",475,"Age-specific",4.3,3.9,4.7,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",39,"Age-specific",0.4,0.3,0.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1038,"Age-specific",9.4,8.8,10,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1071,"Age-specific",9.7,9.1,10.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",33,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",9,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",261,"Age-specific",2.4,2.1,2.7,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",4,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",70,"Age-specific",0.6,0.5,0.8,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",47,"Age-specific",0.4,0.3,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",329,"Age-specific",3,2.7,3.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",10,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",877,"Age-specific",7.9,7.4,8.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",19,"Age-specific",0.2,0.1,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",10,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",11,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",33,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",55,"Age-specific",0.5,0.4,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",22,"Age-specific",0.2,0.1,0.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",72,"Age-specific",0.7,0.5,0.8,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",330,"Age-specific",3,2.7,3.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",156,"Age-specific",1.4,1.2,1.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",580,"Age-specific",5.2,4.8,5.7,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",256,"Age-specific",2.3,2,2.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",47,"Age-specific",0.4,0.3,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",121,"Age-specific",1.1,0.9,1.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",3,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",95,"Age-specific",0.9,0.7,1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",95,"Age-specific",0.9,0.7,1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",314,"Age-specific",2.8,2.5,3.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",200,"Age-specific",1.8,1.6,2.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",4,"Age-specific",0,0,0.1,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",2,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",13,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",13,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",13,"Age-specific",0.1,0.1,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",112,"Age-specific",1,0.8,1.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",10,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",555,"Age-specific",5,4.6,5.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",898,"Age-specific",8.1,7.6,8.7,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",22791,"Age-specific",205.9,203.3,208.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",429,"Age-specific",3.9,3.5,4.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",33,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",246,"Age-specific",2.2,2,2.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",118,"Age-specific",1.1,0.9,1.3,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",148,"Age-specific",1.3,1.1,1.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",139,"Age-specific",1.3,1.1,1.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0,0.2,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",129,"Age-specific",1.2,1,1.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",84,"Age-specific",0.8,0.6,0.9,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",33,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",47,"Age-specific",0.4,0.3,0.6,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",40,"Age-specific",0.4,0.3,0.5,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",30,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",35,"Age-specific",0.3,0.2,0.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",128,"Age-specific",1.2,1,1.4,""
2011,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",267,"Age-specific",2.4,2.1,2.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",5,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",339,"Age-specific",3.1,2.7,3.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",24312,"Age-specific",219.6,216.8,222.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",19891,"Age-specific",179.7,177.2,182.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",51408,"Age-specific",464.3,460.3,468.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",17,"Age-specific",0.2,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",84,"Age-specific",0.8,0.6,0.9,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",9,"Age-specific",0.1,0,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",14,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",17,"Age-specific",0.2,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",29,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",47,"Age-specific",0.4,0.3,0.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",34,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",48,"Age-specific",0.4,0.3,0.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",7,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",15,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",3,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",7,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",65,"Age-specific",0.6,0.5,0.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",145,"Age-specific",1.3,1.1,1.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",44,"Age-specific",0.4,0.3,0.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",657,"Age-specific",5.9,5.5,6.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1005,"Age-specific",9.1,8.5,9.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",59,"Age-specific",0.5,0.4,0.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",289,"Age-specific",2.6,2.3,2.9,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",86,"Age-specific",0.8,0.6,1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",66,"Age-specific",0.6,0.5,0.8,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",15,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",18,"Age-specific",0.2,0.1,0.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",137,"Age-specific",1.2,1,1.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",18,"Age-specific",0.2,0.1,0.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",7,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",30,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",517,"Age-specific",4.7,4.3,5.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",513,"Age-specific",4.6,4.2,5.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",7,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",7,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",36,"Age-specific",0.3,0.2,0.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",28,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1786,"Age-specific",16.1,15.4,16.9,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4421,"Age-specific",39.9,38.8,41.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",14,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",9,"Age-specific",0.1,0,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",13,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",34,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",152,"Age-specific",1.4,1.2,1.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8622,"Age-specific",77.9,76.2,79.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",153,"Age-specific",1.4,1.2,1.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",21,"Age-specific",0.2,0.1,0.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1561,"Age-specific",14.1,13.4,14.8,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",463,"Age-specific",4.2,3.8,4.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",506,"Age-specific",4.6,4.2,5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",43,"Age-specific",0.4,0.3,0.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1098,"Age-specific",9.9,9.3,10.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1128,"Age-specific",10.2,9.6,10.8,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",30,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",12,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",271,"Age-specific",2.4,2.2,2.8,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",3,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",8,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",70,"Age-specific",0.6,0.5,0.8,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",52,"Age-specific",0.5,0.4,0.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",6,"Age-specific",0.1,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",322,"Age-specific",2.9,2.6,3.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",17,"Age-specific",0.2,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",962,"Age-specific",8.7,8.1,9.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",13,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",12,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",12,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",31,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",57,"Age-specific",0.5,0.4,0.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",26,"Age-specific",0.2,0.2,0.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",74,"Age-specific",0.7,0.5,0.8,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",329,"Age-specific",3,2.7,3.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",140,"Age-specific",1.3,1.1,1.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",558,"Age-specific",5,4.6,5.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",231,"Age-specific",2.1,1.8,2.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",63,"Age-specific",0.6,0.4,0.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",124,"Age-specific",1.1,0.9,1.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",115,"Age-specific",1,0.9,1.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",92,"Age-specific",0.8,0.7,1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",344,"Age-specific",3.1,2.8,3.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",235,"Age-specific",2.1,1.9,2.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",13,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",12,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",15,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",126,"Age-specific",1.1,0.9,1.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",11,"Age-specific",0.1,0,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",579,"Age-specific",5.2,4.8,5.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1067,"Age-specific",9.6,9.1,10.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",23449,"Age-specific",211.8,209.1,214.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",403,"Age-specific",3.6,3.3,4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",19,"Age-specific",0.2,0.1,0.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",297,"Age-specific",2.7,2.4,3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",120,"Age-specific",1.1,0.9,1.3,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",132,"Age-specific",1.2,1,1.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",84,"Age-specific",0.8,0.6,0.9,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",15,"Age-specific",0.1,0.1,0.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",109,"Age-specific",1,0.8,1.2,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",86,"Age-specific",0.8,0.6,1,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",39,"Age-specific",0.4,0.3,0.5,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",62,"Age-specific",0.6,0.4,0.7,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",48,"Age-specific",0.4,0.3,0.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",30,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",31,"Age-specific",0.3,0.2,0.4,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",150,"Age-specific",1.4,1.1,1.6,""
2012,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",223,"Age-specific",2,1.8,2.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",4,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",317,"Age-specific",2.9,2.6,3.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",25022,"Age-specific",226.3,223.5,229.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",20347,"Age-specific",184,181.5,186.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",53733,"Age-specific",486,481.9,490.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",26,"Age-specific",0.2,0.2,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",74,"Age-specific",0.7,0.5,0.8,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",4,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",13,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",25,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",29,"Age-specific",0.3,0.2,0.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",41,"Age-specific",0.4,0.3,0.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",17,"Age-specific",0.2,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",57,"Age-specific",0.5,0.4,0.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",3,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",16,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",3,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",3,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",2,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",72,"Age-specific",0.7,0.5,0.8,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",118,"Age-specific",1.1,0.9,1.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",47,"Age-specific",0.4,0.3,0.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",679,"Age-specific",6.1,5.7,6.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",992,"Age-specific",9,8.4,9.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",58,"Age-specific",0.5,0.4,0.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",255,"Age-specific",2.3,2,2.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",94,"Age-specific",0.9,0.7,1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",73,"Age-specific",0.7,0.5,0.8,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",19,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",18,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",156,"Age-specific",1.4,1.2,1.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",7,"Age-specific",0.1,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",16,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",9,"Age-specific",0.1,0,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",27,"Age-specific",0.2,0.2,0.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",449,"Age-specific",4.1,3.7,4.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",447,"Age-specific",4,3.7,4.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",18,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",5,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",43,"Age-specific",0.4,0.3,0.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",39,"Age-specific",0.4,0.3,0.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1872,"Age-specific",16.9,16.2,17.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4675,"Age-specific",42.3,41.1,43.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",10,"Age-specific",0.1,0,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",6,"Age-specific",0.1,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",5,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",32,"Age-specific",0.3,0.2,0.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",157,"Age-specific",1.4,1.2,1.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8871,"Age-specific",80.2,78.6,81.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",124,"Age-specific",1.1,0.9,1.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",20,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1642,"Age-specific",14.9,14.1,15.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",499,"Age-specific",4.5,4.1,4.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",525,"Age-specific",4.7,4.4,5.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",26,"Age-specific",0.2,0.2,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1085,"Age-specific",9.8,9.2,10.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1112,"Age-specific",10.1,9.5,10.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",27,"Age-specific",0.2,0.2,0.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",17,"Age-specific",0.2,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",318,"Age-specific",2.9,2.6,3.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",4,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",78,"Age-specific",0.7,0.6,0.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",1,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",49,"Age-specific",0.4,0.3,0.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",14,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",349,"Age-specific",3.2,2.8,3.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",22,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1042,"Age-specific",9.4,8.9,10,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",12,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",14,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",5,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",27,"Age-specific",0.2,0.2,0.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",41,"Age-specific",0.4,0.3,0.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",79,"Age-specific",0.7,0.6,0.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",18,"Age-specific",0.2,0.1,0.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",340,"Age-specific",3.1,2.8,3.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",133,"Age-specific",1.2,1,1.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",514,"Age-specific",4.6,4.3,5.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",223,"Age-specific",2,1.8,2.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",58,"Age-specific",0.5,0.4,0.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",89,"Age-specific",0.8,0.6,1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",11,"Age-specific",0.1,0,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",40,"Age-specific",0.4,0.3,0.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",116,"Age-specific",1,0.9,1.3,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",108,"Age-specific",1,0.8,1.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",336,"Age-specific",3,2.7,3.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",208,"Age-specific",1.9,1.6,2.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",12,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",5,"Age-specific",0,0,0.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",12,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",16,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",136,"Age-specific",1.2,1,1.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",10,"Age-specific",0.1,0,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",653,"Age-specific",5.9,5.5,6.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1225,"Age-specific",11.1,10.5,11.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",24660,"Age-specific",223.1,220.3,225.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",394,"Age-specific",3.6,3.2,3.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",66,"Age-specific",0.6,0.5,0.8,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",340,"Age-specific",3.1,2.8,3.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",145,"Age-specific",1.3,1.1,1.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",162,"Age-specific",1.5,1.2,1.7,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",98,"Age-specific",0.9,0.7,1.1,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",13,"Age-specific",0.1,0.1,0.2,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",185,"Age-specific",1.7,1.4,1.9,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",50,"Age-specific",0.5,0.3,0.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",46,"Age-specific",0.4,0.3,0.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",70,"Age-specific",0.6,0.5,0.8,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",53,"Age-specific",0.5,0.4,0.6,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",28,"Age-specific",0.3,0.2,0.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",45,"Age-specific",0.4,0.3,0.5,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",132,"Age-specific",1.2,1,1.4,""
2013,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",184,"Age-specific",1.7,1.4,1.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",6,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",328,"Age-specific",3,2.7,3.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",25189,"Age-specific",228.1,225.3,230.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",20264,"Age-specific",183.5,181,186.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",54319,"Age-specific",491.9,487.8,496.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",21,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",83,"Age-specific",0.8,0.6,0.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",9,"Age-specific",0.1,0,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",17,"Age-specific",0.2,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",27,"Age-specific",0.2,0.2,0.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",15,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",55,"Age-specific",0.5,0.4,0.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",15,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",54,"Age-specific",0.5,0.4,0.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",6,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",13,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",5,"Age-specific",0,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",2,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",61,"Age-specific",0.6,0.4,0.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",129,"Age-specific",1.2,1,1.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",48,"Age-specific",0.4,0.3,0.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",650,"Age-specific",5.9,5.4,6.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",969,"Age-specific",8.8,8.2,9.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",56,"Age-specific",0.5,0.4,0.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",263,"Age-specific",2.4,2.1,2.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",98,"Age-specific",0.9,0.7,1.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",80,"Age-specific",0.7,0.6,0.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",19,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",13,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",140,"Age-specific",1.3,1.1,1.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",17,"Age-specific",0.2,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",9,"Age-specific",0.1,0,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",24,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",495,"Age-specific",4.5,4.1,4.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",494,"Age-specific",4.5,4.1,4.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",14,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",5,"Age-specific",0,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",35,"Age-specific",0.3,0.2,0.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",31,"Age-specific",0.3,0.2,0.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1907,"Age-specific",17.3,16.5,18.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4925,"Age-specific",44.6,43.4,45.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",7,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",5,"Age-specific",0,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",7,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",24,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",176,"Age-specific",1.6,1.4,1.8,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8636,"Age-specific",78.2,76.6,79.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",120,"Age-specific",1.1,0.9,1.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",28,"Age-specific",0.3,0.2,0.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1656,"Age-specific",15,14.3,15.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",528,"Age-specific",4.8,4.4,5.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",543,"Age-specific",4.9,4.5,5.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",15,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1097,"Age-specific",9.9,9.4,10.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1128,"Age-specific",10.2,9.6,10.8,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",31,"Age-specific",0.3,0.2,0.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",16,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",321,"Age-specific",2.9,2.6,3.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",7,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",5,"Age-specific",0,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",76,"Age-specific",0.7,0.5,0.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",1,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",59,"Age-specific",0.5,0.4,0.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",7,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",395,"Age-specific",3.6,3.2,3.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",26,"Age-specific",0.2,0.2,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1012,"Age-specific",9.2,8.6,9.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",16,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",18,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",5,"Age-specific",0,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",24,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",40,"Age-specific",0.4,0.3,0.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",73,"Age-specific",0.7,0.5,0.8,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",7,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",342,"Age-specific",3.1,2.8,3.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",115,"Age-specific",1,0.9,1.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",516,"Age-specific",4.7,4.3,5.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",249,"Age-specific",2.3,2,2.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",59,"Age-specific",0.5,0.4,0.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",80,"Age-specific",0.7,0.6,0.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",13,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",36,"Age-specific",0.3,0.2,0.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",114,"Age-specific",1,0.9,1.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",86,"Age-specific",0.8,0.6,1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",369,"Age-specific",3.3,3,3.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",249,"Age-specific",2.3,2,2.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",9,"Age-specific",0.1,0,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",15,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",10,"Age-specific",0.1,0,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",17,"Age-specific",0.2,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",23,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",133,"Age-specific",1.2,1,1.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0.1,0.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",719,"Age-specific",6.5,6,7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1321,"Age-specific",12,11.3,12.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",24963,"Age-specific",226.1,223.3,228.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",378,"Age-specific",3.4,3.1,3.8,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",78,"Age-specific",0.7,0.6,0.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",363,"Age-specific",3.3,3,3.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",159,"Age-specific",1.4,1.2,1.7,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",180,"Age-specific",1.6,1.4,1.9,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",113,"Age-specific",1,0.8,1.2,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",8,"Age-specific",0.1,0,0.1,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",140,"Age-specific",1.3,1.1,1.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",34,"Age-specific",0.3,0.2,0.4,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",36,"Age-specific",0.3,0.2,0.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",73,"Age-specific",0.7,0.5,0.8,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",46,"Age-specific",0.4,0.3,0.6,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",22,"Age-specific",0.2,0.1,0.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",36,"Age-specific",0.3,0.2,0.5,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",125,"Age-specific",1.1,0.9,1.3,""
2014,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",168,"Age-specific",1.5,1.3,1.8,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",2,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",333,"Age-specific",3,2.7,3.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",25021,"Age-specific",226.6,223.8,229.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",20141,"Age-specific",182.4,179.9,185,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",53590,"Age-specific",485.4,481.3,489.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",31,"Age-specific",0.3,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",67,"Age-specific",0.6,0.5,0.8,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",6,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",9,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",19,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",23,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",59,"Age-specific",0.5,0.4,0.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",14,"Age-specific",0.1,0.1,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",68,"Age-specific",0.6,0.5,0.8,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",6,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",15,"Age-specific",0.1,0.1,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",6,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",7,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",1,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",58,"Age-specific",0.5,0.4,0.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",128,"Age-specific",1.2,1,1.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",57,"Age-specific",0.5,0.4,0.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",732,"Age-specific",6.6,6.2,7.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1069,"Age-specific",9.7,9.1,10.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",56,"Age-specific",0.5,0.4,0.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",281,"Age-specific",2.5,2.3,2.9,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",121,"Age-specific",1.1,0.9,1.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",79,"Age-specific",0.7,0.6,0.9,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",17,"Age-specific",0.2,0.1,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",18,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",155,"Age-specific",1.4,1.2,1.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",8,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",19,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",5,"Age-specific",0,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",25,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",517,"Age-specific",4.7,4.3,5.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",514,"Age-specific",4.7,4.3,5.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",19,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",5,"Age-specific",0,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",42,"Age-specific",0.4,0.3,0.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",22,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1805,"Age-specific",16.4,15.6,17.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4880,"Age-specific",44.2,43,45.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",6,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",9,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",9,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",29,"Age-specific",0.3,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",157,"Age-specific",1.4,1.2,1.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8604,"Age-specific",77.9,76.3,79.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",113,"Age-specific",1,0.8,1.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",27,"Age-specific",0.2,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1623,"Age-specific",14.7,14,15.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",455,"Age-specific",4.1,3.8,4.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",473,"Age-specific",4.3,3.9,4.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",18,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1032,"Age-specific",9.3,8.8,9.9,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1069,"Age-specific",9.7,9.1,10.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",37,"Age-specific",0.3,0.2,0.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",13,"Age-specific",0.1,0.1,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",328,"Age-specific",3,2.7,3.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",7,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",64,"Age-specific",0.6,0.4,0.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",60,"Age-specific",0.5,0.4,0.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",11,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",398,"Age-specific",3.6,3.3,4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",22,"Age-specific",0.2,0.1,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1072,"Age-specific",9.7,9.1,10.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",28,"Age-specific",0.3,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",10,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",2,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",26,"Age-specific",0.2,0.2,0.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",31,"Age-specific",0.3,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",77,"Age-specific",0.7,0.6,0.9,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",332,"Age-specific",3,2.7,3.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",124,"Age-specific",1.1,0.9,1.3,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",499,"Age-specific",4.5,4.1,4.9,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",232,"Age-specific",2.1,1.8,2.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",50,"Age-specific",0.5,0.3,0.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",80,"Age-specific",0.7,0.6,0.9,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",13,"Age-specific",0.1,0.1,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",44,"Age-specific",0.4,0.3,0.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",87,"Age-specific",0.8,0.6,1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",100,"Age-specific",0.9,0.7,1.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",376,"Age-specific",3.4,3.1,3.8,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",253,"Age-specific",2.3,2,2.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",7,"Age-specific",0.1,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",11,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",5,"Age-specific",0,0,0.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",27,"Age-specific",0.2,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",15,"Age-specific",0.1,0.1,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",148,"Age-specific",1.3,1.1,1.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",11,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",721,"Age-specific",6.5,6.1,7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1313,"Age-specific",11.9,11.3,12.6,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",24336,"Age-specific",220.4,217.7,223.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",374,"Age-specific",3.4,3.1,3.7,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",98,"Age-specific",0.9,0.7,1.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",398,"Age-specific",3.6,3.3,4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",145,"Age-specific",1.3,1.1,1.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",196,"Age-specific",1.8,1.5,2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",99,"Age-specific",0.9,0.7,1.1,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",10,"Age-specific",0.1,0,0.2,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",143,"Age-specific",1.3,1.1,1.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",30,"Age-specific",0.3,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",39,"Age-specific",0.4,0.3,0.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",71,"Age-specific",0.6,0.5,0.8,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",43,"Age-specific",0.4,0.3,0.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",28,"Age-specific",0.3,0.2,0.4,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",41,"Age-specific",0.4,0.3,0.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",141,"Age-specific",1.3,1.1,1.5,""
2015,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",169,"Age-specific",1.5,1.3,1.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",7,"Age-specific",0.1,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",356,"Age-specific",3.2,2.9,3.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",25345,"Age-specific",229.9,227.1,232.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",20369,"Age-specific",184.8,182.3,187.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",50575,"Age-specific",458.8,454.8,462.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",38,"Age-specific",0.3,0.2,0.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",78,"Age-specific",0.7,0.6,0.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",13,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",12,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",22,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",12,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",53,"Age-specific",0.5,0.4,0.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",14,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",69,"Age-specific",0.6,0.5,0.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",3,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",24,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",3,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",7,"Age-specific",0.1,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",1,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",58,"Age-specific",0.5,0.4,0.7,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",124,"Age-specific",1.1,0.9,1.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",53,"Age-specific",0.5,0.4,0.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",752,"Age-specific",6.8,6.3,7.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1090,"Age-specific",9.9,9.3,10.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",54,"Age-specific",0.5,0.4,0.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",284,"Age-specific",2.6,2.3,2.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",105,"Age-specific",1,0.8,1.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",66,"Age-specific",0.6,0.5,0.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",26,"Age-specific",0.2,0.2,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",15,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",152,"Age-specific",1.4,1.2,1.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",6,"Age-specific",0.1,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",12,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",4,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",25,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",448,"Age-specific",4.1,3.7,4.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",447,"Age-specific",4.1,3.7,4.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",20,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",5,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",44,"Age-specific",0.4,0.3,0.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",24,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1911,"Age-specific",17.3,16.6,18.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4976,"Age-specific",45.1,43.9,46.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",14,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",9,"Age-specific",0.1,0,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",9,"Age-specific",0.1,0,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",30,"Age-specific",0.3,0.2,0.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",155,"Age-specific",1.4,1.2,1.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8612,"Age-specific",78.1,76.5,79.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",103,"Age-specific",0.9,0.8,1.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",27,"Age-specific",0.2,0.2,0.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1616,"Age-specific",14.7,14,15.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",494,"Age-specific",4.5,4.1,4.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",516,"Age-specific",4.7,4.3,5.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",22,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1088,"Age-specific",9.9,9.3,10.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1134,"Age-specific",10.3,9.7,10.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",46,"Age-specific",0.4,0.3,0.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",21,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",341,"Age-specific",3.1,2.8,3.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",4,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",1,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",66,"Age-specific",0.6,0.5,0.8,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",51,"Age-specific",0.5,0.3,0.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",19,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",397,"Age-specific",3.6,3.3,4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",16,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1175,"Age-specific",10.7,10.1,11.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",14,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",5,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",3,"Age-specific",0,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",15,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",25,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",89,"Age-specific",0.8,0.6,1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",341,"Age-specific",3.1,2.8,3.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",110,"Age-specific",1,0.8,1.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",510,"Age-specific",4.6,4.2,5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",227,"Age-specific",2.1,1.8,2.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",60,"Age-specific",0.5,0.4,0.7,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",94,"Age-specific",0.9,0.7,1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",19,"Age-specific",0.2,0.1,0.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",36,"Age-specific",0.3,0.2,0.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",103,"Age-specific",0.9,0.8,1.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",109,"Age-specific",1,0.8,1.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",337,"Age-specific",3.1,2.7,3.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",211,"Age-specific",1.9,1.7,2.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",8,"Age-specific",0.1,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",7,"Age-specific",0.1,0,0.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",2,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",27,"Age-specific",0.2,0.2,0.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",17,"Age-specific",0.2,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",147,"Age-specific",1.3,1.1,1.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",10,"Age-specific",0.1,0,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",686,"Age-specific",6.2,5.8,6.7,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1289,"Age-specific",11.7,11.1,12.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",21017,"Age-specific",190.7,188.1,193.3,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",351,"Age-specific",3.2,2.9,3.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",89,"Age-specific",0.8,0.6,1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",388,"Age-specific",3.5,3.2,3.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",176,"Age-specific",1.6,1.4,1.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",180,"Age-specific",1.6,1.4,1.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",146,"Age-specific",1.3,1.1,1.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",13,"Age-specific",0.1,0.1,0.2,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",95,"Age-specific",0.9,0.7,1.1,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",27,"Age-specific",0.2,0.2,0.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",60,"Age-specific",0.5,0.4,0.7,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",83,"Age-specific",0.8,0.6,0.9,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",47,"Age-specific",0.4,0.3,0.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",29,"Age-specific",0.3,0.2,0.4,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",38,"Age-specific",0.3,0.2,0.5,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",154,"Age-specific",1.4,1.2,1.6,""
2016,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",188,"Age-specific",1.7,1.5,2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",5,"Age-specific",0,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",322,"Age-specific",2.9,2.6,3.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",24574,"Age-specific",223.4,220.6,226.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",19873,"Age-specific",180.7,178.2,183.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",48858,"Age-specific",444.2,440.3,448.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",24,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",90,"Age-specific",0.8,0.7,1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",8,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",6,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",23,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",25,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",38,"Age-specific",0.3,0.2,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",12,"Age-specific",0.1,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",59,"Age-specific",0.5,0.4,0.7,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",2,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",23,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",2,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",5,"Age-specific",0,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",49,"Age-specific",0.4,0.3,0.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",130,"Age-specific",1.2,1,1.4,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",68,"Age-specific",0.6,0.5,0.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",633,"Age-specific",5.8,5.3,6.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1020,"Age-specific",9.3,8.7,9.9,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",77,"Age-specific",0.7,0.6,0.9,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",310,"Age-specific",2.8,2.5,3.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",107,"Age-specific",1,0.8,1.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",75,"Age-specific",0.7,0.5,0.9,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",26,"Age-specific",0.2,0.2,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",16,"Age-specific",0.1,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",141,"Age-specific",1.3,1.1,1.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",22,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",6,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",37,"Age-specific",0.3,0.2,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",0,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",418,"Age-specific",3.8,3.4,4.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",418,"Age-specific",3.8,3.4,4.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",23,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",6,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",28,"Age-specific",0.3,0.2,0.4,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",38,"Age-specific",0.3,0.2,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1742,"Age-specific",15.8,15.1,16.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4701,"Age-specific",42.7,41.5,44,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",11,"Age-specific",0.1,0,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",7,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",29,"Age-specific",0.3,0.2,0.4,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",146,"Age-specific",1.3,1.1,1.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8473,"Age-specific",77,75.4,78.7,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",99,"Age-specific",0.9,0.7,1.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",28,"Age-specific",0.3,0.2,0.4,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1610,"Age-specific",14.6,13.9,15.4,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",517,"Age-specific",4.7,4.3,5.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",531,"Age-specific",4.8,4.4,5.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",14,"Age-specific",0.1,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1034,"Age-specific",9.4,8.8,10,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1072,"Age-specific",9.7,9.2,10.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",38,"Age-specific",0.3,0.2,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",22,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",322,"Age-specific",2.9,2.6,3.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",3,"Age-specific",0,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",50,"Age-specific",0.5,0.3,0.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",1,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",53,"Age-specific",0.5,0.4,0.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",7,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",381,"Age-specific",3.5,3.1,3.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",17,"Age-specific",0.2,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1158,"Age-specific",10.5,9.9,11.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",24,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",18,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",2,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",12,"Age-specific",0.1,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",41,"Age-specific",0.4,0.3,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",73,"Age-specific",0.7,0.5,0.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",1,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",358,"Age-specific",3.3,2.9,3.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",123,"Age-specific",1.1,0.9,1.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",479,"Age-specific",4.4,4,4.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",206,"Age-specific",1.9,1.6,2.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",53,"Age-specific",0.5,0.4,0.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",86,"Age-specific",0.8,0.6,1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",11,"Age-specific",0.1,0,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",41,"Age-specific",0.4,0.3,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",118,"Age-specific",1.1,0.9,1.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",94,"Age-specific",0.9,0.7,1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",362,"Age-specific",3.3,3,3.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",248,"Age-specific",2.3,2,2.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",8,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",6,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",18,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",17,"Age-specific",0.2,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",113,"Age-specific",1,0.8,1.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",7,"Age-specific",0.1,0,0.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",692,"Age-specific",6.3,5.8,6.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1318,"Age-specific",12,11.3,12.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19826,"Age-specific",180.2,177.7,182.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",449,"Age-specific",4.1,3.7,4.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",84,"Age-specific",0.8,0.6,0.9,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",405,"Age-specific",3.7,3.3,4.1,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",174,"Age-specific",1.6,1.4,1.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",159,"Age-specific",1.4,1.2,1.7,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",261,"Age-specific",2.4,2.1,2.7,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0.1,0,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",118,"Age-specific",1.1,0.9,1.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",14,"Age-specific",0.1,0.1,0.2,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",47,"Age-specific",0.4,0.3,0.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",65,"Age-specific",0.6,0.5,0.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",46,"Age-specific",0.4,0.3,0.6,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",21,"Age-specific",0.2,0.1,0.3,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",43,"Age-specific",0.4,0.3,0.5,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",173,"Age-specific",1.6,1.3,1.8,""
2017,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",241,"Age-specific",2.2,1.9,2.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",2,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",344,"Age-specific",3.1,2.8,3.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",24850,"Age-specific",226.3,223.5,229.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",20191,"Age-specific",183.9,181.4,186.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",48401,"Age-specific",440.8,436.9,444.8,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",41,"Age-specific",0.4,0.3,0.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",70,"Age-specific",0.6,0.5,0.8,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",4,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",28,"Age-specific",0.3,0.2,0.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",14,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",54,"Age-specific",0.5,0.4,0.6,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",18,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",66,"Age-specific",0.6,0.5,0.8,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",3,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",19,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0.1,0,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",76,"Age-specific",0.7,0.5,0.9,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",133,"Age-specific",1.2,1,1.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",62,"Age-specific",0.6,0.4,0.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",662,"Age-specific",6,5.6,6.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1064,"Age-specific",9.7,9.1,10.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",64,"Age-specific",0.6,0.4,0.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",338,"Age-specific",3.1,2.8,3.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",90,"Age-specific",0.8,0.7,1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",82,"Age-specific",0.7,0.6,0.9,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",16,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",19,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",157,"Age-specific",1.4,1.2,1.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",4,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",16,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",15,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",29,"Age-specific",0.3,0.2,0.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",501,"Age-specific",4.6,4.2,5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",499,"Age-specific",4.5,4.2,5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",26,"Age-specific",0.2,0.2,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",3,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",31,"Age-specific",0.3,0.2,0.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",25,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1868,"Age-specific",17,16.2,17.8,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4659,"Age-specific",42.4,41.2,43.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",11,"Age-specific",0.1,0,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",4,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",7,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",24,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",146,"Age-specific",1.3,1.1,1.6,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8448,"Age-specific",76.9,75.3,78.6,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",137,"Age-specific",1.2,1,1.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",19,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1623,"Age-specific",14.8,14.1,15.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",537,"Age-specific",4.9,4.5,5.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",550,"Age-specific",5,4.6,5.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",13,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1055,"Age-specific",9.6,9,10.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1091,"Age-specific",9.9,9.4,10.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",36,"Age-specific",0.3,0.2,0.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",16,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",319,"Age-specific",2.9,2.6,3.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",1,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",67,"Age-specific",0.6,0.5,0.8,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",51,"Age-specific",0.5,0.3,0.6,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",367,"Age-specific",3.3,3,3.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",23,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1192,"Age-specific",10.9,10.2,11.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",20,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",11,"Age-specific",0.1,0,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",12,"Age-specific",0.1,0.1,0.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",33,"Age-specific",0.3,0.2,0.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",84,"Age-specific",0.8,0.6,0.9,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",338,"Age-specific",3.1,2.8,3.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",107,"Age-specific",1,0.8,1.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",454,"Age-specific",4.1,3.8,4.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",216,"Age-specific",2,1.7,2.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",39,"Age-specific",0.4,0.3,0.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",85,"Age-specific",0.8,0.6,1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",7,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",44,"Age-specific",0.4,0.3,0.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",119,"Age-specific",1.1,0.9,1.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",108,"Age-specific",1,0.8,1.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",371,"Age-specific",3.4,3,3.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",235,"Age-specific",2.1,1.9,2.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",19,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",1,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",21,"Age-specific",0.2,0.1,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",26,"Age-specific",0.2,0.2,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",121,"Age-specific",1.1,0.9,1.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",8,"Age-specific",0.1,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",748,"Age-specific",6.8,6.3,7.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1297,"Age-specific",11.8,11.2,12.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19088,"Age-specific",173.8,171.4,176.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",416,"Age-specific",3.8,3.4,4.2,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",83,"Age-specific",0.8,0.6,0.9,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",400,"Age-specific",3.6,3.3,4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",142,"Age-specific",1.3,1.1,1.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",173,"Age-specific",1.6,1.3,1.8,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",263,"Age-specific",2.4,2.1,2.7,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",3,"Age-specific",0,0,0.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",133,"Age-specific",1.2,1,1.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",26,"Age-specific",0.2,0.2,0.3,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",39,"Age-specific",0.4,0.3,0.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",79,"Age-specific",0.7,0.6,0.9,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",47,"Age-specific",0.4,0.3,0.6,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",28,"Age-specific",0.3,0.2,0.4,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",36,"Age-specific",0.3,0.2,0.5,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",200,"Age-specific",1.8,1.6,2.1,""
2018,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",193,"Age-specific",1.8,1.5,2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",3,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",327,"Age-specific",3,2.7,3.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",24948,"Age-specific",227.9,225.1,230.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",20430,"Age-specific",186.6,184.1,189.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",48722,"Age-specific",445.1,441.2,449.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",37,"Age-specific",0.3,0.2,0.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",61,"Age-specific",0.6,0.4,0.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",10,"Age-specific",0.1,0,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",10,"Age-specific",0.1,0,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",23,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",21,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",48,"Age-specific",0.4,0.3,0.6,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",13,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",65,"Age-specific",0.6,0.5,0.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",8,"Age-specific",0.1,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",14,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",3,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",11,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",51,"Age-specific",0.5,0.3,0.6,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",154,"Age-specific",1.4,1.2,1.6,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",72,"Age-specific",0.7,0.5,0.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",694,"Age-specific",6.3,5.9,6.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1102,"Age-specific",10.1,9.5,10.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",60,"Age-specific",0.5,0.4,0.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",348,"Age-specific",3.2,2.9,3.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",117,"Age-specific",1.1,0.9,1.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",89,"Age-specific",0.8,0.7,1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",24,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",17,"Age-specific",0.2,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",165,"Age-specific",1.5,1.3,1.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",5,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",18,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",14,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",19,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",470,"Age-specific",4.3,3.9,4.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",468,"Age-specific",4.3,3.9,4.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",18,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",4,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",41,"Age-specific",0.4,0.3,0.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",35,"Age-specific",0.3,0.2,0.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1864,"Age-specific",17,16.3,17.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",4518,"Age-specific",41.3,40.1,42.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",8,"Age-specific",0.1,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",2,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",12,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",26,"Age-specific",0.2,0.2,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",151,"Age-specific",1.4,1.2,1.6,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",8504,"Age-specific",77.7,76,79.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",141,"Age-specific",1.3,1.1,1.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",23,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1655,"Age-specific",15.1,14.4,15.9,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",543,"Age-specific",5,4.6,5.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",551,"Age-specific",5,4.6,5.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",8,"Age-specific",0.1,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",1024,"Age-specific",9.4,8.8,9.9,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",1070,"Age-specific",9.8,9.2,10.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",46,"Age-specific",0.4,0.3,0.6,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",29,"Age-specific",0.3,0.2,0.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",344,"Age-specific",3.1,2.8,3.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",5,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",68,"Age-specific",0.6,0.5,0.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",60,"Age-specific",0.5,0.4,0.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",11,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",340,"Age-specific",3.1,2.8,3.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",21,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1224,"Age-specific",11.2,10.6,11.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",28,"Age-specific",0.3,0.2,0.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",22,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",9,"Age-specific",0.1,0,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",12,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",23,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",61,"Age-specific",0.6,0.4,0.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",366,"Age-specific",3.3,3,3.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",128,"Age-specific",1.2,1,1.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",532,"Age-specific",4.9,4.5,5.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",214,"Age-specific",2,1.7,2.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",65,"Age-specific",0.6,0.5,0.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",110,"Age-specific",1,0.8,1.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",15,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",35,"Age-specific",0.3,0.2,0.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",112,"Age-specific",1,0.8,1.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",107,"Age-specific",1,0.8,1.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",346,"Age-specific",3.2,2.8,3.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",216,"Age-specific",2,1.7,2.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",8,"Age-specific",0.1,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",12,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",3,"Age-specific",0,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",28,"Age-specific",0.3,0.2,0.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",24,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",157,"Age-specific",1.4,1.2,1.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",7,"Age-specific",0.1,0,0.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",780,"Age-specific",7.1,6.6,7.6,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",1291,"Age-specific",11.8,11.2,12.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",19174,"Age-specific",175.2,172.7,177.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",475,"Age-specific",4.3,4,4.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",103,"Age-specific",0.9,0.8,1.1,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",383,"Age-specific",3.5,3.2,3.9,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",124,"Age-specific",1.1,0.9,1.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",189,"Age-specific",1.7,1.5,2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",235,"Age-specific",2.1,1.9,2.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0.1,0.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",140,"Age-specific",1.3,1.1,1.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",20,"Age-specific",0.2,0.1,0.3,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",58,"Age-specific",0.5,0.4,0.7,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",67,"Age-specific",0.6,0.5,0.8,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",37,"Age-specific",0.3,0.2,0.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",29,"Age-specific",0.3,0.2,0.4,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",36,"Age-specific",0.3,0.2,0.5,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",214,"Age-specific",2,1.7,2.2,""
2019,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",218,"Age-specific",2,1.7,2.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",255,"Age-specific",2.3,2.1,2.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",21806,"Age-specific",200,197.4,202.7,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",18169,"Age-specific",166.6,164.2,169.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",40950,"Age-specific",375.6,372,379.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",33,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",54,"Age-specific",0.5,0.4,0.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",6,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",8,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",16,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",13,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",32,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",13,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",45,"Age-specific",0.4,0.3,0.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",7,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",16,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",44,"Age-specific",0.4,0.3,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",115,"Age-specific",1.1,0.9,1.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",44,"Age-specific",0.4,0.3,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",658,"Age-specific",6,5.6,6.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1003,"Age-specific",9.2,8.6,9.8,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",63,"Age-specific",0.6,0.4,0.7,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",282,"Age-specific",2.6,2.3,2.9,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",102,"Age-specific",0.9,0.8,1.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",104,"Age-specific",1,0.8,1.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",18,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",17,"Age-specific",0.2,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",141,"Age-specific",1.3,1.1,1.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",5,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",13,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",7,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",21,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",430,"Age-specific",3.9,3.6,4.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",426,"Age-specific",3.9,3.5,4.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",28,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",10,"Age-specific",0.1,0,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",38,"Age-specific",0.3,0.2,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",34,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1537,"Age-specific",14.1,13.4,14.8,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3637,"Age-specific",33.4,32.3,34.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",9,"Age-specific",0.1,0,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",8,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",30,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",135,"Age-specific",1.2,1,1.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",7746,"Age-specific",71,69.5,72.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C51","Malignant neoplasm of vulva",116,"Age-specific",1.1,0.9,1.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C52","Malignant neoplasm of vagina",29,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C53","Malignant neoplasm of cervix uteri",1372,"Age-specific",12.6,11.9,13.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54","Malignant neoplasm of corpus uteri",497,"Age-specific",4.6,4.2,5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C54-C55","Malignant neoplasm of corpus uteri and uterus, part unspecified",514,"Age-specific",4.7,4.3,5.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C55","Malignant neoplasm of uterus, part unspecified",17,"Age-specific",0.2,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56","Malignant neoplasm of ovary",945,"Age-specific",8.7,8.1,9.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C56-C57","Malignant neoplasm of ovary and other unspecified female genital organs",989,"Age-specific",9.1,8.5,9.7,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C57","Malignant neoplasm of other and unspecified female genital organs",44,"Age-specific",0.4,0.3,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C58","Malignant neoplasm of placenta",23,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",270,"Age-specific",2.5,2.2,2.8,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",7,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",55,"Age-specific",0.5,0.4,0.7,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",44,"Age-specific",0.4,0.3,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0.1,0,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",313,"Age-specific",2.9,2.6,3.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",17,"Age-specific",0.2,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",1092,"Age-specific",10,9.4,10.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",23,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",25,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",7,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",11,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",26,"Age-specific",0.2,0.2,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",69,"Age-specific",0.6,0.5,0.8,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",363,"Age-specific",3.3,3,3.7,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",92,"Age-specific",0.8,0.7,1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",395,"Age-specific",3.6,3.3,4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",178,"Age-specific",1.6,1.4,1.9,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",33,"Age-specific",0.3,0.2,0.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",80,"Age-specific",0.7,0.6,0.9,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",12,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",38,"Age-specific",0.3,0.2,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",103,"Age-specific",0.9,0.8,1.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",104,"Age-specific",1,0.8,1.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",333,"Age-specific",3.1,2.7,3.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",212,"Age-specific",1.9,1.7,2.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",4,"Age-specific",0,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",12,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",1,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",18,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",10,"Age-specific",0.1,0,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",139,"Age-specific",1.3,1.1,1.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0.1,0.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",539,"Age-specific",4.9,4.5,5.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",978,"Age-specific",9,8.4,9.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D06","Carcinoma in situ of cervix uteri",15497,"Age-specific",142.1,139.9,144.4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",400,"Age-specific",3.7,3.3,4,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",76,"Age-specific",0.7,0.5,0.9,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",324,"Age-specific",3,2.7,3.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",105,"Age-specific",1,0.8,1.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",113,"Age-specific",1,0.9,1.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",190,"Age-specific",1.7,1.5,2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",7,"Age-specific",0.1,0,0.1,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D39","Neoplasm of uncertain or unknown behaviour of female genital organs",110,"Age-specific",1,0.8,1.2,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",19,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",62,"Age-specific",0.6,0.4,0.7,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",53,"Age-specific",0.5,0.4,0.6,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",41,"Age-specific",0.4,0.3,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",22,"Age-specific",0.2,0.1,0.3,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",43,"Age-specific",0.4,0.3,0.5,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",174,"Age-specific",1.6,1.4,1.9,""
2020,"Female","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",230,"Age-specific",2.1,1.8,2.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",23,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",424,"Age-specific",4.1,3.7,4.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",10163,"Age-specific",98.6,96.7,100.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",8217,"Age-specific",79.7,78,81.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",11330,"Age-specific",109.9,107.9,112,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",32,"Age-specific",0.3,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",79,"Age-specific",0.8,0.6,1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",21,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",37,"Age-specific",0.4,0.3,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",14,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",20,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",36,"Age-specific",0.3,0.2,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",12,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",85,"Age-specific",0.8,0.7,1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",8,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",25,"Age-specific",0.2,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",8,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",15,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",192,"Age-specific",1.9,1.6,2.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",203,"Age-specific",2,1.7,2.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",31,"Age-specific",0.3,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",352,"Age-specific",3.4,3.1,3.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",658,"Age-specific",6.4,5.9,6.9,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",59,"Age-specific",0.6,0.4,0.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",247,"Age-specific",2.4,2.1,2.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",31,"Age-specific",0.3,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",100,"Age-specific",1,0.8,1.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",4,"Age-specific",0,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",9,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",159,"Age-specific",1.5,1.3,1.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",11,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",19,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",16,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",94,"Age-specific",0.9,0.7,1.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",547,"Age-specific",5.3,4.9,5.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",545,"Age-specific",5.3,4.9,5.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",8,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",16,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",38,"Age-specific",0.4,0.3,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",29,"Age-specific",0.3,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",797,"Age-specific",7.7,7.2,8.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",1946,"Age-specific",18.9,18,19.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",30,"Age-specific",0.3,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",47,"Age-specific",0.5,0.3,0.6,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",12,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",21,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",109,"Age-specific",1.1,0.9,1.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",16,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",56,"Age-specific",0.5,0.4,0.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",157,"Age-specific",1.5,1.3,1.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1403,"Age-specific",13.6,12.9,14.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",6,"Age-specific",0.1,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",283,"Age-specific",2.7,2.4,3.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",16,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",180,"Age-specific",1.7,1.5,2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",37,"Age-specific",0.4,0.3,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",6,"Age-specific",0.1,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",466,"Age-specific",4.5,4.1,5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",13,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",119,"Age-specific",1.2,1,1.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",11,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",14,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",30,"Age-specific",0.3,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",36,"Age-specific",0.3,0.2,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",75,"Age-specific",0.7,0.6,0.9,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",36,"Age-specific",0.3,0.2,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",95,"Age-specific",0.9,0.7,1.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",382,"Age-specific",3.7,3.3,4.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",130,"Age-specific",1.3,1.1,1.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",665,"Age-specific",6.5,6,7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",237,"Age-specific",2.3,2,2.6,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",53,"Age-specific",0.5,0.4,0.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",245,"Age-specific",2.4,2.1,2.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",91,"Age-specific",0.9,0.7,1.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",137,"Age-specific",1.3,1.1,1.6,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",404,"Age-specific",3.9,3.5,4.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",244,"Age-specific",2.4,2.1,2.7,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",8,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",7,"Age-specific",0.1,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",8,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",5,"Age-specific",0,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",5,"Age-specific",0,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",22,"Age-specific",0.2,0.1,0.3,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",5,"Age-specific",0,0,0.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",144,"Age-specific",1.4,1.2,1.6,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",2,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",40,"Age-specific",0.4,0.3,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",89,"Age-specific",0.9,0.7,1.1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",69,"Age-specific",0.7,0.5,0.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",118,"Age-specific",1.1,0.9,1.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",74,"Age-specific",0.7,0.6,0.9,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",39,"Age-specific",0.4,0.3,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0.1,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",43,"Age-specific",0.4,0.3,0.6,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",167,"Age-specific",1.6,1.4,1.9,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",8,"Age-specific",0.1,0,0.2,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",66,"Age-specific",0.6,0.5,0.8,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",35,"Age-specific",0.3,0.2,0.5,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",48,"Age-specific",0.5,0.3,0.6,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",25,"Age-specific",0.2,0.2,0.4,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",80,"Age-specific",0.8,0.6,1,""
2001,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",77,"Age-specific",0.7,0.6,0.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",28,"Age-specific",0.3,0.2,0.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",454,"Age-specific",4.4,4,4.8,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",10063,"Age-specific",97.2,95.3,99.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",8099,"Age-specific",78.2,76.6,80,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",11258,"Age-specific",108.8,106.8,110.8,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",35,"Age-specific",0.3,0.2,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",87,"Age-specific",0.8,0.7,1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",13,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",23,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",22,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",24,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",36,"Age-specific",0.3,0.2,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",14,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",89,"Age-specific",0.9,0.7,1.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",10,"Age-specific",0.1,0,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",43,"Age-specific",0.4,0.3,0.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",15,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",2,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",13,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",207,"Age-specific",2,1.7,2.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",226,"Age-specific",2.2,1.9,2.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",32,"Age-specific",0.3,0.2,0.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",371,"Age-specific",3.6,3.2,4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",694,"Age-specific",6.7,6.2,7.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",55,"Age-specific",0.5,0.4,0.7,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",268,"Age-specific",2.6,2.3,2.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",39,"Age-specific",0.4,0.3,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",90,"Age-specific",0.9,0.7,1.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",3,"Age-specific",0,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",23,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",129,"Age-specific",1.2,1,1.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",12,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",14,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",11,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",87,"Age-specific",0.8,0.7,1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",502,"Age-specific",4.9,4.4,5.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",498,"Age-specific",4.8,4.4,5.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",16,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",22,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",32,"Age-specific",0.3,0.2,0.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",38,"Age-specific",0.4,0.3,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",804,"Age-specific",7.8,7.2,8.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",1964,"Age-specific",19,18.1,19.8,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",24,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",45,"Age-specific",0.4,0.3,0.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",13,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",10,"Age-specific",0.1,0,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",134,"Age-specific",1.3,1.1,1.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",15,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",40,"Age-specific",0.4,0.3,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",170,"Age-specific",1.6,1.4,1.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1278,"Age-specific",12.3,11.7,13,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",3,"Age-specific",0,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",318,"Age-specific",3.1,2.7,3.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",13,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",161,"Age-specific",1.6,1.3,1.8,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",6,"Age-specific",0.1,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",35,"Age-specific",0.3,0.2,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",6,"Age-specific",0.1,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",467,"Age-specific",4.5,4.1,4.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",15,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",115,"Age-specific",1.1,0.9,1.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",10,"Age-specific",0.1,0,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",13,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",47,"Age-specific",0.5,0.3,0.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",46,"Age-specific",0.4,0.3,0.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",70,"Age-specific",0.7,0.5,0.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",26,"Age-specific",0.3,0.2,0.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",89,"Age-specific",0.9,0.7,1.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",397,"Age-specific",3.8,3.5,4.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",112,"Age-specific",1.1,0.9,1.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",629,"Age-specific",6.1,5.6,6.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",236,"Age-specific",2.3,2,2.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",50,"Age-specific",0.5,0.4,0.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",231,"Age-specific",2.2,2,2.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",88,"Age-specific",0.9,0.7,1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",138,"Age-specific",1.3,1.1,1.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",366,"Age-specific",3.5,3.2,3.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",209,"Age-specific",2,1.8,2.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",11,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0.1,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",9,"Age-specific",0.1,0,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",12,"Age-specific",0.1,0.1,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",19,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",4,"Age-specific",0,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",139,"Age-specific",1.3,1.1,1.6,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",4,"Age-specific",0,0,0.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",41,"Age-specific",0.4,0.3,0.5,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",92,"Age-specific",0.9,0.7,1.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",56,"Age-specific",0.5,0.4,0.7,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",117,"Age-specific",1.1,0.9,1.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",73,"Age-specific",0.7,0.6,0.9,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",53,"Age-specific",0.5,0.4,0.7,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",8,"Age-specific",0.1,0,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",26,"Age-specific",0.3,0.2,0.4,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",158,"Age-specific",1.5,1.3,1.8,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",9,"Age-specific",0.1,0,0.2,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",59,"Age-specific",0.6,0.4,0.7,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",23,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",113,"Age-specific",1.1,0.9,1.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",22,"Age-specific",0.2,0.1,0.3,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",92,"Age-specific",0.9,0.7,1.1,""
2002,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",75,"Age-specific",0.7,0.6,0.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",11,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",453,"Age-specific",4.4,4,4.8,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",10186,"Age-specific",97.9,96.1,99.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",8094,"Age-specific",77.8,76.1,79.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",11393,"Age-specific",109.6,107.5,111.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",37,"Age-specific",0.4,0.3,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",85,"Age-specific",0.8,0.7,1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",10,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",37,"Age-specific",0.4,0.3,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",20,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",26,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",26,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",8,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",101,"Age-specific",1,0.8,1.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",10,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",43,"Age-specific",0.4,0.3,0.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",22,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",4,"Age-specific",0,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",13,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",197,"Age-specific",1.9,1.6,2.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",208,"Age-specific",2,1.7,2.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",40,"Age-specific",0.4,0.3,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",400,"Age-specific",3.8,3.5,4.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",718,"Age-specific",6.9,6.4,7.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",51,"Age-specific",0.5,0.4,0.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",267,"Age-specific",2.6,2.3,2.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",34,"Age-specific",0.3,0.2,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",101,"Age-specific",1,0.8,1.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",4,"Age-specific",0,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",20,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",138,"Age-specific",1.3,1.1,1.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",13,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",18,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",13,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",92,"Age-specific",0.9,0.7,1.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",462,"Age-specific",4.4,4,4.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",460,"Age-specific",4.4,4,4.8,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",9,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",22,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",31,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",33,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",779,"Age-specific",7.5,7,8,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2092,"Age-specific",20.1,19.3,21,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",32,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",61,"Age-specific",0.6,0.4,0.8,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",13,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",15,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",128,"Age-specific",1.2,1,1.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",19,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",48,"Age-specific",0.5,0.3,0.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",171,"Age-specific",1.6,1.4,1.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1311,"Age-specific",12.6,11.9,13.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",7,"Age-specific",0.1,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",315,"Age-specific",3,2.7,3.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",8,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",145,"Age-specific",1.4,1.2,1.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",34,"Age-specific",0.3,0.2,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",7,"Age-specific",0.1,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",426,"Age-specific",4.1,3.7,4.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",11,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",150,"Age-specific",1.4,1.2,1.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",8,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",21,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",32,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",40,"Age-specific",0.4,0.3,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",57,"Age-specific",0.5,0.4,0.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",23,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",74,"Age-specific",0.7,0.6,0.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",340,"Age-specific",3.3,2.9,3.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",109,"Age-specific",1,0.9,1.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",662,"Age-specific",6.4,5.9,6.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",297,"Age-specific",2.9,2.5,3.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",52,"Age-specific",0.5,0.4,0.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",204,"Age-specific",2,1.7,2.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",8,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",119,"Age-specific",1.1,0.9,1.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",154,"Age-specific",1.5,1.3,1.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",408,"Age-specific",3.9,3.6,4.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",238,"Age-specific",2.3,2,2.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",5,"Age-specific",0,0,0.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",10,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",9,"Age-specific",0.1,0,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",12,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",44,"Age-specific",0.4,0.3,0.6,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",156,"Age-specific",1.5,1.3,1.8,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",2,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",27,"Age-specific",0.3,0.2,0.4,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",84,"Age-specific",0.8,0.6,1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",77,"Age-specific",0.7,0.6,0.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",117,"Age-specific",1.1,0.9,1.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",81,"Age-specific",0.8,0.6,1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",56,"Age-specific",0.5,0.4,0.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",2,"Age-specific",NA,NA,NA,"s"
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",39,"Age-specific",0.4,0.3,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",152,"Age-specific",1.5,1.2,1.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",11,"Age-specific",0.1,0.1,0.2,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",54,"Age-specific",0.5,0.4,0.7,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",35,"Age-specific",0.3,0.2,0.5,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",90,"Age-specific",0.9,0.7,1.1,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",23,"Age-specific",0.2,0.1,0.3,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",74,"Age-specific",0.7,0.6,0.9,""
2003,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",59,"Age-specific",0.6,0.4,0.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",474,"Age-specific",4.5,4.1,5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",10716,"Age-specific",102.4,100.5,104.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",8506,"Age-specific",81.3,79.6,83,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",11968,"Age-specific",114.4,112.3,116.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",41,"Age-specific",0.4,0.3,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",87,"Age-specific",0.8,0.7,1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",15,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",36,"Age-specific",0.3,0.2,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",25,"Age-specific",0.2,0.2,0.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",22,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",36,"Age-specific",0.3,0.2,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",13,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",94,"Age-specific",0.9,0.7,1.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",15,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",40,"Age-specific",0.4,0.3,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",17,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",7,"Age-specific",0.1,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",15,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",206,"Age-specific",2,1.7,2.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",187,"Age-specific",1.8,1.5,2.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",38,"Age-specific",0.4,0.3,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",427,"Age-specific",4.1,3.7,4.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",771,"Age-specific",7.4,6.9,7.9,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",65,"Age-specific",0.6,0.5,0.8,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",279,"Age-specific",2.7,2.4,3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",51,"Age-specific",0.5,0.4,0.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",97,"Age-specific",0.9,0.8,1.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",16,"Age-specific",0.2,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",121,"Age-specific",1.2,1,1.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",9,"Age-specific",0.1,0,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",7,"Age-specific",0.1,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",75,"Age-specific",0.7,0.6,0.9,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",507,"Age-specific",4.8,4.4,5.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",504,"Age-specific",4.8,4.4,5.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",12,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",18,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",32,"Age-specific",0.3,0.2,0.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",46,"Age-specific",0.4,0.3,0.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",966,"Age-specific",9.2,8.7,9.8,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2210,"Age-specific",21.1,20.2,22,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",34,"Age-specific",0.3,0.2,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",55,"Age-specific",0.5,0.4,0.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",17,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",17,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",154,"Age-specific",1.5,1.2,1.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",24,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",45,"Age-specific",0.4,0.3,0.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",212,"Age-specific",2,1.8,2.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1363,"Age-specific",13,12.3,13.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",8,"Age-specific",0.1,0,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",298,"Age-specific",2.8,2.5,3.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",6,"Age-specific",0.1,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",161,"Age-specific",1.5,1.3,1.8,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",33,"Age-specific",0.3,0.2,0.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",2,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",446,"Age-specific",4.3,3.9,4.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",18,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",141,"Age-specific",1.3,1.1,1.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",14,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",39,"Age-specific",0.4,0.3,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",42,"Age-specific",0.4,0.3,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",69,"Age-specific",0.7,0.5,0.8,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",30,"Age-specific",0.3,0.2,0.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",80,"Age-specific",0.8,0.6,1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",365,"Age-specific",3.5,3.1,3.9,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",125,"Age-specific",1.2,1,1.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",656,"Age-specific",6.3,5.8,6.8,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",285,"Age-specific",2.7,2.4,3.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",52,"Age-specific",0.5,0.4,0.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",194,"Age-specific",1.9,1.6,2.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",6,"Age-specific",0.1,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",96,"Age-specific",0.9,0.7,1.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",150,"Age-specific",1.4,1.2,1.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",385,"Age-specific",3.7,3.3,4.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",217,"Age-specific",2.1,1.8,2.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",4,"Age-specific",0,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",12,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",14,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",45,"Age-specific",0.4,0.3,0.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",148,"Age-specific",1.4,1.2,1.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",2,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",45,"Age-specific",0.4,0.3,0.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",93,"Age-specific",0.9,0.7,1.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",71,"Age-specific",0.7,0.5,0.9,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",94,"Age-specific",0.9,0.7,1.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",111,"Age-specific",1.1,0.9,1.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",57,"Age-specific",0.5,0.4,0.7,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",4,"Age-specific",0,0,0.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",39,"Age-specific",0.4,0.3,0.5,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",172,"Age-specific",1.6,1.4,1.9,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",11,"Age-specific",0.1,0.1,0.2,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",47,"Age-specific",0.4,0.3,0.6,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",24,"Age-specific",0.2,0.1,0.3,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",94,"Age-specific",0.9,0.7,1.1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",28,"Age-specific",0.3,0.2,0.4,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",89,"Age-specific",0.9,0.7,1,""
2004,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",52,"Age-specific",0.5,0.4,0.7,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.2,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",487,"Age-specific",4.6,4.2,5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",11218,"Age-specific",105.9,103.9,107.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",8928,"Age-specific",84.3,82.5,86,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",12729,"Age-specific",120.1,118.1,122.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",40,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",90,"Age-specific",0.8,0.7,1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",12,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",39,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",20,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",28,"Age-specific",0.3,0.2,0.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",37,"Age-specific",0.3,0.2,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",13,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",105,"Age-specific",1,0.8,1.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",14,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",40,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",18,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",7,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",8,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",174,"Age-specific",1.6,1.4,1.9,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",176,"Age-specific",1.7,1.4,1.9,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",31,"Age-specific",0.3,0.2,0.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",468,"Age-specific",4.4,4,4.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",804,"Age-specific",7.6,7.1,8.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",64,"Age-specific",0.6,0.5,0.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",272,"Age-specific",2.6,2.3,2.9,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",48,"Age-specific",0.5,0.3,0.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",110,"Age-specific",1,0.9,1.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",5,"Age-specific",0,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",18,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",145,"Age-specific",1.4,1.2,1.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",15,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",17,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",12,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",82,"Age-specific",0.8,0.6,1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",504,"Age-specific",4.8,4.4,5.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",501,"Age-specific",4.7,4.3,5.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",9,"Age-specific",0.1,0,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",25,"Age-specific",0.2,0.2,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",42,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",43,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",968,"Age-specific",9.1,8.6,9.7,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2290,"Age-specific",21.6,20.7,22.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",19,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",77,"Age-specific",0.7,0.6,0.9,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",19,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",21,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",138,"Age-specific",1.3,1.1,1.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",16,"Age-specific",0.2,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",65,"Age-specific",0.6,0.5,0.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",228,"Age-specific",2.2,1.9,2.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1461,"Age-specific",13.8,13.1,14.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",5,"Age-specific",0,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",315,"Age-specific",3,2.7,3.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",13,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",6,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",153,"Age-specific",1.4,1.2,1.7,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",7,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",35,"Age-specific",0.3,0.2,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",6,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",487,"Age-specific",4.6,4.2,5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",10,"Age-specific",0.1,0,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",161,"Age-specific",1.5,1.3,1.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",17,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",18,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",28,"Age-specific",0.3,0.2,0.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",44,"Age-specific",0.4,0.3,0.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",75,"Age-specific",0.7,0.6,0.9,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",34,"Age-specific",0.3,0.2,0.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",82,"Age-specific",0.8,0.6,1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",376,"Age-specific",3.5,3.2,3.9,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",124,"Age-specific",1.2,1,1.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",742,"Age-specific",7,6.5,7.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",348,"Age-specific",3.3,2.9,3.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",43,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",227,"Age-specific",2.1,1.9,2.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",3,"Age-specific",0,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",121,"Age-specific",1.1,0.9,1.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",167,"Age-specific",1.6,1.3,1.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",418,"Age-specific",3.9,3.6,4.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",231,"Age-specific",2.2,1.9,2.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",2,"Age-specific",NA,NA,NA,"s"
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",7,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",11,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",13,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",12,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",40,"Age-specific",0.4,0.3,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",8,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",202,"Age-specific",1.9,1.7,2.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",6,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",45,"Age-specific",0.4,0.3,0.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",105,"Age-specific",1,0.8,1.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",71,"Age-specific",0.7,0.5,0.8,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",120,"Age-specific",1.1,0.9,1.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",108,"Age-specific",1,0.8,1.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",49,"Age-specific",0.5,0.3,0.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",11,"Age-specific",0.1,0.1,0.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",30,"Age-specific",0.3,0.2,0.4,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",216,"Age-specific",2,1.8,2.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",7,"Age-specific",0.1,0,0.1,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",60,"Age-specific",0.6,0.4,0.7,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",36,"Age-specific",0.3,0.2,0.5,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",144,"Age-specific",1.4,1.1,1.6,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",24,"Age-specific",0.2,0.1,0.3,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",104,"Age-specific",1,0.8,1.2,""
2005,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",113,"Age-specific",1.1,0.9,1.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",23,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",532,"Age-specific",5,4.6,5.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",11530,"Age-specific",108,106,109.9,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",9176,"Age-specific",85.9,84.2,87.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",13043,"Age-specific",122.1,120,124.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",48,"Age-specific",0.4,0.3,0.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",89,"Age-specific",0.8,0.7,1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",10,"Age-specific",0.1,0,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",30,"Age-specific",0.3,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",23,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",29,"Age-specific",0.3,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",37,"Age-specific",0.3,0.2,0.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",6,"Age-specific",0.1,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",135,"Age-specific",1.3,1.1,1.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",15,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",47,"Age-specific",0.4,0.3,0.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",18,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",8,"Age-specific",0.1,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",14,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",192,"Age-specific",1.8,1.6,2.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",196,"Age-specific",1.8,1.6,2.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",39,"Age-specific",0.4,0.3,0.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",491,"Age-specific",4.6,4.2,5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",849,"Age-specific",7.9,7.4,8.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",55,"Age-specific",0.5,0.4,0.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",303,"Age-specific",2.8,2.5,3.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",44,"Age-specific",0.4,0.3,0.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",121,"Age-specific",1.1,0.9,1.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",5,"Age-specific",0,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",20,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",138,"Age-specific",1.3,1.1,1.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",11,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",13,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",14,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",97,"Age-specific",0.9,0.7,1.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",509,"Age-specific",4.8,4.4,5.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",508,"Age-specific",4.8,4.4,5.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",13,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",23,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",44,"Age-specific",0.4,0.3,0.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",32,"Age-specific",0.3,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1040,"Age-specific",9.7,9.2,10.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2354,"Age-specific",22,21.2,23,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",34,"Age-specific",0.3,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",92,"Age-specific",0.9,0.7,1.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",15,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",23,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",137,"Age-specific",1.3,1.1,1.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",23,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",57,"Age-specific",0.5,0.4,0.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",247,"Age-specific",2.3,2,2.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1447,"Age-specific",13.5,12.9,14.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",8,"Age-specific",0.1,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",357,"Age-specific",3.3,3,3.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",2,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",137,"Age-specific",1.3,1.1,1.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",9,"Age-specific",0.1,0,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",38,"Age-specific",0.4,0.3,0.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0.1,0,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",490,"Age-specific",4.6,4.2,5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",23,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",152,"Age-specific",1.4,1.2,1.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",16,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",11,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",21,"Age-specific",0.2,0.1,0.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",53,"Age-specific",0.5,0.4,0.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",80,"Age-specific",0.7,0.6,0.9,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",34,"Age-specific",0.3,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",81,"Age-specific",0.8,0.6,0.9,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",390,"Age-specific",3.7,3.3,4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",141,"Age-specific",1.3,1.1,1.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",712,"Age-specific",6.7,6.2,7.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",312,"Age-specific",2.9,2.6,3.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",76,"Age-specific",0.7,0.6,0.9,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",183,"Age-specific",1.7,1.5,2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",5,"Age-specific",0,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",113,"Age-specific",1.1,0.9,1.3,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",152,"Age-specific",1.4,1.2,1.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",407,"Age-specific",3.8,3.4,4.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",241,"Age-specific",2.3,2,2.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",2,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",0,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",12,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",12,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",26,"Age-specific",0.2,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",57,"Age-specific",0.5,0.4,0.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",11,"Age-specific",0.1,0.1,0.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",209,"Age-specific",2,1.7,2.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",5,"Age-specific",0,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",56,"Age-specific",0.5,0.4,0.7,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",99,"Age-specific",0.9,0.8,1.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",66,"Age-specific",0.6,0.5,0.8,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",129,"Age-specific",1.2,1,1.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",97,"Age-specific",0.9,0.7,1.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",91,"Age-specific",0.9,0.7,1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",7,"Age-specific",0.1,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",29,"Age-specific",0.3,0.2,0.4,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",208,"Age-specific",1.9,1.7,2.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",7,"Age-specific",0.1,0,0.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",67,"Age-specific",0.6,0.5,0.8,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",48,"Age-specific",0.4,0.3,0.6,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",107,"Age-specific",1,0.8,1.2,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",37,"Age-specific",0.3,0.2,0.5,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",93,"Age-specific",0.9,0.7,1.1,""
2006,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",64,"Age-specific",0.6,0.5,0.8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",14,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",540,"Age-specific",5,4.6,5.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",11859,"Age-specific",110.1,108.2,112.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",9117,"Age-specific",84.7,82.9,86.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",13333,"Age-specific",123.8,121.7,126,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",47,"Age-specific",0.4,0.3,0.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",89,"Age-specific",0.8,0.7,1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",4,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",43,"Age-specific",0.4,0.3,0.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",25,"Age-specific",0.2,0.2,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",32,"Age-specific",0.3,0.2,0.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",42,"Age-specific",0.4,0.3,0.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",9,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",136,"Age-specific",1.3,1.1,1.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",20,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",50,"Age-specific",0.5,0.3,0.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",11,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",9,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",221,"Age-specific",2.1,1.8,2.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",175,"Age-specific",1.6,1.4,1.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",55,"Age-specific",0.5,0.4,0.7,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",450,"Age-specific",4.2,3.8,4.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",802,"Age-specific",7.4,6.9,8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",75,"Age-specific",0.7,0.5,0.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",277,"Age-specific",2.6,2.3,2.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",44,"Age-specific",0.4,0.3,0.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",110,"Age-specific",1,0.8,1.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",4,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",24,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",153,"Age-specific",1.4,1.2,1.7,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",13,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",17,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",17,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",81,"Age-specific",0.8,0.6,0.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",4,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",486,"Age-specific",4.5,4.1,4.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",482,"Age-specific",4.5,4.1,4.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",15,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",19,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",41,"Age-specific",0.4,0.3,0.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",48,"Age-specific",0.4,0.3,0.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",987,"Age-specific",9.2,8.6,9.8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2742,"Age-specific",25.5,24.5,26.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",25,"Age-specific",0.2,0.2,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",93,"Age-specific",0.9,0.7,1.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",12,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",22,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",146,"Age-specific",1.4,1.1,1.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",13,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",66,"Age-specific",0.6,0.5,0.8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",243,"Age-specific",2.3,2,2.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1412,"Age-specific",13.1,12.4,13.8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",9,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",390,"Age-specific",3.6,3.3,4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",10,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",132,"Age-specific",1.2,1,1.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",35,"Age-specific",0.3,0.2,0.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",489,"Age-specific",4.5,4.1,5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",22,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",175,"Age-specific",1.6,1.4,1.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",14,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",18,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",24,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",46,"Age-specific",0.4,0.3,0.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",62,"Age-specific",0.6,0.4,0.7,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",29,"Age-specific",0.3,0.2,0.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",68,"Age-specific",0.6,0.5,0.8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",418,"Age-specific",3.9,3.5,4.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",147,"Age-specific",1.4,1.2,1.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",764,"Age-specific",7.1,6.6,7.6,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",343,"Age-specific",3.2,2.9,3.5,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",88,"Age-specific",0.8,0.7,1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",186,"Age-specific",1.7,1.5,2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",4,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",104,"Age-specific",1,0.8,1.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",157,"Age-specific",1.5,1.2,1.7,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",391,"Age-specific",3.6,3.3,4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",221,"Age-specific",2.1,1.8,2.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",5,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0.1,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",11,"Age-specific",0.1,0.1,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",25,"Age-specific",0.2,0.2,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",62,"Age-specific",0.6,0.4,0.7,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",9,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",210,"Age-specific",2,1.7,2.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",3,"Age-specific",0,0,0.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",65,"Age-specific",0.6,0.5,0.8,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",93,"Age-specific",0.9,0.7,1.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",84,"Age-specific",0.8,0.6,1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",131,"Age-specific",1.2,1,1.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",107,"Age-specific",1,0.8,1.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",78,"Age-specific",0.7,0.6,0.9,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",10,"Age-specific",0.1,0,0.2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",32,"Age-specific",0.3,0.2,0.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",182,"Age-specific",1.7,1.5,2,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",17,"Age-specific",0.2,0.1,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",54,"Age-specific",0.5,0.4,0.7,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",27,"Age-specific",0.3,0.2,0.4,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",87,"Age-specific",0.8,0.6,1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",25,"Age-specific",0.2,0.2,0.3,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",94,"Age-specific",0.9,0.7,1.1,""
2007,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",79,"Age-specific",0.7,0.6,0.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",15,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",566,"Age-specific",5.2,4.8,5.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",12905,"Age-specific",119,117,121.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",9643,"Age-specific",88.9,87.2,90.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",14775,"Age-specific",136.3,134.1,138.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",48,"Age-specific",0.4,0.3,0.6,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",109,"Age-specific",1,0.8,1.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",10,"Age-specific",0.1,0,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",41,"Age-specific",0.4,0.3,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",27,"Age-specific",0.2,0.2,0.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",32,"Age-specific",0.3,0.2,0.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",38,"Age-specific",0.4,0.2,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",16,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",139,"Age-specific",1.3,1.1,1.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",17,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",36,"Age-specific",0.3,0.2,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",14,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0.1,0,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",15,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",202,"Age-specific",1.9,1.6,2.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",193,"Age-specific",1.8,1.5,2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",58,"Age-specific",0.5,0.4,0.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",503,"Age-specific",4.6,4.2,5.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",866,"Age-specific",8,7.5,8.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",73,"Age-specific",0.7,0.5,0.8,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",290,"Age-specific",2.7,2.4,3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",48,"Age-specific",0.4,0.3,0.6,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",145,"Age-specific",1.3,1.1,1.6,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",5,"Age-specific",0,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",22,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",166,"Age-specific",1.5,1.3,1.8,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",14,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",20,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",9,"Age-specific",0.1,0,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",104,"Age-specific",1,0.8,1.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",0,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",484,"Age-specific",4.5,4.1,4.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",484,"Age-specific",4.5,4.1,4.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",13,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",21,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",50,"Age-specific",0.5,0.3,0.6,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",43,"Age-specific",0.4,0.3,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1035,"Age-specific",9.5,9,10.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3262,"Age-specific",30.1,29.1,31.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",23,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",95,"Age-specific",0.9,0.7,1.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",19,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",15,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",170,"Age-specific",1.6,1.3,1.8,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",27,"Age-specific",0.2,0.2,0.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",43,"Age-specific",0.4,0.3,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",300,"Age-specific",2.8,2.5,3.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1521,"Age-specific",14,13.3,14.8,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",7,"Age-specific",0.1,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",394,"Age-specific",3.6,3.3,4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",10,"Age-specific",0.1,0,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",8,"Age-specific",0.1,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",159,"Age-specific",1.5,1.2,1.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",2,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",40,"Age-specific",0.4,0.3,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",6,"Age-specific",0.1,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",503,"Age-specific",4.6,4.2,5.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",21,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",182,"Age-specific",1.7,1.4,1.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",17,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",19,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",25,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",48,"Age-specific",0.4,0.3,0.6,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",58,"Age-specific",0.5,0.4,0.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",22,"Age-specific",0.2,0.1,0.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",69,"Age-specific",0.6,0.5,0.8,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",403,"Age-specific",3.7,3.4,4.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",178,"Age-specific",1.6,1.4,1.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",777,"Age-specific",7.2,6.7,7.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",367,"Age-specific",3.4,3,3.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",76,"Age-specific",0.7,0.6,0.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",156,"Age-specific",1.4,1.2,1.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",125,"Age-specific",1.2,1,1.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",183,"Age-specific",1.7,1.5,2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",460,"Age-specific",4.2,3.9,4.6,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",261,"Age-specific",2.4,2.1,2.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",4,"Age-specific",0,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",0,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",12,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",8,"Age-specific",0.1,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",13,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",64,"Age-specific",0.6,0.5,0.8,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",8,"Age-specific",0.1,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",282,"Age-specific",2.6,2.3,2.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",6,"Age-specific",0.1,0,0.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",79,"Age-specific",0.7,0.6,0.9,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",94,"Age-specific",0.9,0.7,1.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",101,"Age-specific",0.9,0.8,1.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",128,"Age-specific",1.2,1,1.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",123,"Age-specific",1.1,0.9,1.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",96,"Age-specific",0.9,0.7,1.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",13,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",33,"Age-specific",0.3,0.2,0.4,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",220,"Age-specific",2,1.8,2.3,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",13,"Age-specific",0.1,0.1,0.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",56,"Age-specific",0.5,0.4,0.7,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",39,"Age-specific",0.4,0.3,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",199,"Age-specific",1.8,1.6,2.1,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",42,"Age-specific",0.4,0.3,0.5,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",106,"Age-specific",1,0.8,1.2,""
2008,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",155,"Age-specific",1.4,1.2,1.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",18,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",562,"Age-specific",5.2,4.8,5.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",13166,"Age-specific",121.1,119.1,123.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",9959,"Age-specific",91.6,89.8,93.4,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",14942,"Age-specific",137.4,135.3,139.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",50,"Age-specific",0.5,0.3,0.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",116,"Age-specific",1.1,0.9,1.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",14,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",34,"Age-specific",0.3,0.2,0.4,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",23,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",38,"Age-specific",0.3,0.2,0.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",33,"Age-specific",0.3,0.2,0.4,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",17,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",139,"Age-specific",1.3,1.1,1.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",19,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",43,"Age-specific",0.4,0.3,0.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",8,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",4,"Age-specific",0,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",6,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",221,"Age-specific",2,1.8,2.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",203,"Age-specific",1.9,1.6,2.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",54,"Age-specific",0.5,0.4,0.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",503,"Age-specific",4.6,4.2,5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",903,"Age-specific",8.3,7.8,8.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",60,"Age-specific",0.6,0.4,0.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",340,"Age-specific",3.1,2.8,3.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",49,"Age-specific",0.5,0.3,0.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",159,"Age-specific",1.5,1.2,1.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",7,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",25,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",179,"Age-specific",1.6,1.4,1.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",16,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",32,"Age-specific",0.3,0.2,0.4,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",11,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",90,"Age-specific",0.8,0.7,1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",489,"Age-specific",4.5,4.1,4.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",486,"Age-specific",4.5,4.1,4.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",11,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",16,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",43,"Age-specific",0.4,0.3,0.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",56,"Age-specific",0.5,0.4,0.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1109,"Age-specific",10.2,9.6,10.8,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3207,"Age-specific",29.5,28.5,30.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",18,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",66,"Age-specific",0.6,0.5,0.8,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",21,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",17,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",163,"Age-specific",1.5,1.3,1.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",24,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",40,"Age-specific",0.4,0.3,0.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",387,"Age-specific",3.6,3.2,3.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1516,"Age-specific",13.9,13.3,14.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",8,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",412,"Age-specific",3.8,3.4,4.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",16,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",5,"Age-specific",0,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",162,"Age-specific",1.5,1.3,1.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",6,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",35,"Age-specific",0.3,0.2,0.4,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",10,"Age-specific",0.1,0,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",496,"Age-specific",4.6,4.2,5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",22,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",219,"Age-specific",2,1.8,2.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",16,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",15,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",21,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",59,"Age-specific",0.5,0.4,0.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",58,"Age-specific",0.5,0.4,0.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",24,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",56,"Age-specific",0.5,0.4,0.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",420,"Age-specific",3.9,3.5,4.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",149,"Age-specific",1.4,1.2,1.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",784,"Age-specific",7.2,6.7,7.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",370,"Age-specific",3.4,3.1,3.8,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",90,"Age-specific",0.8,0.7,1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",175,"Age-specific",1.6,1.4,1.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",6,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",150,"Age-specific",1.4,1.2,1.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",188,"Age-specific",1.7,1.5,2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",463,"Age-specific",4.3,3.9,4.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",255,"Age-specific",2.3,2.1,2.7,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",4,"Age-specific",0,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",2,"Age-specific",NA,NA,NA,"s"
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",14,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",9,"Age-specific",0.1,0,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",15,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",78,"Age-specific",0.7,0.6,0.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",17,"Age-specific",0.2,0.1,0.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",253,"Age-specific",2.3,2,2.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",4,"Age-specific",0,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",80,"Age-specific",0.7,0.6,0.9,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",111,"Age-specific",1,0.8,1.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",90,"Age-specific",0.8,0.7,1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",110,"Age-specific",1,0.8,1.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",94,"Age-specific",0.9,0.7,1.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",112,"Age-specific",1,0.8,1.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",8,"Age-specific",0.1,0,0.1,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",41,"Age-specific",0.4,0.3,0.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",215,"Age-specific",2,1.7,2.3,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",14,"Age-specific",0.1,0.1,0.2,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",64,"Age-specific",0.6,0.5,0.8,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",41,"Age-specific",0.4,0.3,0.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",141,"Age-specific",1.3,1.1,1.5,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",45,"Age-specific",0.4,0.3,0.6,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",124,"Age-specific",1.1,0.9,1.4,""
2009,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",118,"Age-specific",1.1,0.9,1.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",593,"Age-specific",5.4,5,5.9,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",13484,"Age-specific",123.3,121.3,125.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10083,"Age-specific",92.2,90.4,94.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",15185,"Age-specific",138.9,136.7,141.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",59,"Age-specific",0.5,0.4,0.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",112,"Age-specific",1,0.8,1.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",12,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",31,"Age-specific",0.3,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",28,"Age-specific",0.3,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",28,"Age-specific",0.3,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",38,"Age-specific",0.3,0.2,0.5,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",18,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",162,"Age-specific",1.5,1.3,1.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",20,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",34,"Age-specific",0.3,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",13,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",9,"Age-specific",0.1,0,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",13,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",233,"Age-specific",2.1,1.9,2.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",211,"Age-specific",1.9,1.7,2.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",47,"Age-specific",0.4,0.3,0.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",496,"Age-specific",4.5,4.1,5,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",856,"Age-specific",7.8,7.3,8.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",53,"Age-specific",0.5,0.4,0.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",307,"Age-specific",2.8,2.5,3.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",56,"Age-specific",0.5,0.4,0.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",157,"Age-specific",1.4,1.2,1.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",4,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",21,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",170,"Age-specific",1.6,1.3,1.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",11,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",26,"Age-specific",0.2,0.2,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",13,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",92,"Age-specific",0.8,0.7,1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",529,"Age-specific",4.8,4.4,5.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",528,"Age-specific",4.8,4.4,5.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",10,"Age-specific",0.1,0,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",19,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",52,"Age-specific",0.5,0.4,0.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",54,"Age-specific",0.5,0.4,0.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1066,"Age-specific",9.8,9.2,10.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3401,"Age-specific",31.1,30.1,32.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",17,"Age-specific",0.2,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",69,"Age-specific",0.6,0.5,0.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",21,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",13,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",180,"Age-specific",1.6,1.4,1.9,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",25,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",73,"Age-specific",0.7,0.5,0.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",364,"Age-specific",3.3,3,3.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1560,"Age-specific",14.3,13.6,15,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",4,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",470,"Age-specific",4.3,3.9,4.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",16,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",154,"Age-specific",1.4,1.2,1.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",47,"Age-specific",0.4,0.3,0.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",8,"Age-specific",0.1,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",469,"Age-specific",4.3,3.9,4.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",25,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",232,"Age-specific",2.1,1.9,2.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",12,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",16,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",19,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",44,"Age-specific",0.4,0.3,0.5,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",53,"Age-specific",0.5,0.4,0.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",19,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",68,"Age-specific",0.6,0.5,0.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",447,"Age-specific",4.1,3.7,4.5,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",181,"Age-specific",1.7,1.4,1.9,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",814,"Age-specific",7.4,6.9,8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",407,"Age-specific",3.7,3.4,4.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",74,"Age-specific",0.7,0.5,0.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",152,"Age-specific",1.4,1.2,1.6,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",3,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",125,"Age-specific",1.1,1,1.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",182,"Age-specific",1.7,1.4,1.9,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",475,"Age-specific",4.3,4,4.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",266,"Age-specific",2.4,2.1,2.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",4,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",3,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",20,"Age-specific",0.2,0.1,0.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",14,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",27,"Age-specific",0.2,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",69,"Age-specific",0.6,0.5,0.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",16,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",283,"Age-specific",2.6,2.3,2.9,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",4,"Age-specific",0,0,0.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",63,"Age-specific",0.6,0.4,0.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",104,"Age-specific",1,0.8,1.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",63,"Age-specific",0.6,0.4,0.7,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",115,"Age-specific",1.1,0.9,1.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",122,"Age-specific",1.1,0.9,1.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",75,"Age-specific",0.7,0.5,0.9,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0.1,0,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",30,"Age-specific",0.3,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",227,"Age-specific",2.1,1.8,2.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",14,"Age-specific",0.1,0.1,0.2,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",68,"Age-specific",0.6,0.5,0.8,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",40,"Age-specific",0.4,0.3,0.5,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",117,"Age-specific",1.1,0.9,1.3,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",34,"Age-specific",0.3,0.2,0.4,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",100,"Age-specific",0.9,0.7,1.1,""
2010,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",121,"Age-specific",1.1,0.9,1.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",19,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",621,"Age-specific",5.6,5.2,6.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",13631,"Age-specific",123.8,121.7,125.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10073,"Age-specific",91.5,89.7,93.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",15393,"Age-specific",139.8,137.6,142,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",57,"Age-specific",0.5,0.4,0.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",148,"Age-specific",1.3,1.1,1.6,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",12,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",32,"Age-specific",0.3,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",28,"Age-specific",0.3,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",32,"Age-specific",0.3,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",41,"Age-specific",0.4,0.3,0.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",12,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",141,"Age-specific",1.3,1.1,1.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",17,"Age-specific",0.2,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",41,"Age-specific",0.4,0.3,0.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",16,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",8,"Age-specific",0.1,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",17,"Age-specific",0.2,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",181,"Age-specific",1.6,1.4,1.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",188,"Age-specific",1.7,1.5,2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",60,"Age-specific",0.5,0.4,0.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",588,"Age-specific",5.3,4.9,5.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",967,"Age-specific",8.8,8.2,9.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",64,"Age-specific",0.6,0.4,0.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",315,"Age-specific",2.9,2.6,3.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",57,"Age-specific",0.5,0.4,0.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",111,"Age-specific",1,0.8,1.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",9,"Age-specific",0.1,0,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",22,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",168,"Age-specific",1.5,1.3,1.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",10,"Age-specific",0.1,0,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",16,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",8,"Age-specific",0.1,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",95,"Age-specific",0.9,0.7,1.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",489,"Age-specific",4.4,4.1,4.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",487,"Age-specific",4.4,4,4.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",21,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",22,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",35,"Age-specific",0.3,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",39,"Age-specific",0.4,0.3,0.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1086,"Age-specific",9.9,9.3,10.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3558,"Age-specific",32.3,31.3,33.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",16,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",74,"Age-specific",0.7,0.5,0.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",15,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",173,"Age-specific",1.6,1.3,1.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",21,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",55,"Age-specific",0.5,0.4,0.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",414,"Age-specific",3.8,3.4,4.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1488,"Age-specific",13.5,12.8,14.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",8,"Age-specific",0.1,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",463,"Age-specific",4.2,3.8,4.6,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",13,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",5,"Age-specific",0,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",141,"Age-specific",1.3,1.1,1.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",5,"Age-specific",0,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",34,"Age-specific",0.3,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",9,"Age-specific",0.1,0,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",514,"Age-specific",4.7,4.3,5.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",31,"Age-specific",0.3,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",262,"Age-specific",2.4,2.1,2.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",11,"Age-specific",0.1,0,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",17,"Age-specific",0.2,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",12,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",53,"Age-specific",0.5,0.4,0.6,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",50,"Age-specific",0.5,0.3,0.6,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",27,"Age-specific",0.2,0.2,0.4,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",83,"Age-specific",0.8,0.6,0.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",449,"Age-specific",4.1,3.7,4.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",185,"Age-specific",1.7,1.4,1.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",794,"Age-specific",7.2,6.7,7.7,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",388,"Age-specific",3.5,3.2,3.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",70,"Age-specific",0.6,0.5,0.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",151,"Age-specific",1.4,1.2,1.6,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",2,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",144,"Age-specific",1.3,1.1,1.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",188,"Age-specific",1.7,1.5,2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",457,"Age-specific",4.2,3.8,4.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",256,"Age-specific",2.3,2,2.6,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",5,"Age-specific",0,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",1,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0.1,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",13,"Age-specific",0.1,0.1,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",25,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",87,"Age-specific",0.8,0.6,1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",18,"Age-specific",0.2,0.1,0.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",275,"Age-specific",2.5,2.2,2.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",4,"Age-specific",0,0,0.1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",88,"Age-specific",0.8,0.6,1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",94,"Age-specific",0.9,0.7,1,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",73,"Age-specific",0.7,0.5,0.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",110,"Age-specific",1,0.8,1.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",113,"Age-specific",1,0.8,1.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",82,"Age-specific",0.7,0.6,0.9,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0.1,0,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",36,"Age-specific",0.3,0.2,0.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",227,"Age-specific",2.1,1.8,2.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",10,"Age-specific",0.1,0,0.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",74,"Age-specific",0.7,0.5,0.8,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",36,"Age-specific",0.3,0.2,0.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",105,"Age-specific",1,0.8,1.2,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",41,"Age-specific",0.4,0.3,0.5,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",117,"Age-specific",1.1,0.9,1.3,""
2011,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",138,"Age-specific",1.3,1.1,1.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",20,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",639,"Age-specific",5.8,5.4,6.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14117,"Age-specific",128.3,126.2,130.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10365,"Age-specific",94.2,92.4,96,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",15849,"Age-specific",144,141.8,146.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",54,"Age-specific",0.5,0.4,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",110,"Age-specific",1,0.8,1.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",18,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",40,"Age-specific",0.4,0.3,0.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",33,"Age-specific",0.3,0.2,0.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",38,"Age-specific",0.3,0.2,0.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",41,"Age-specific",0.4,0.3,0.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",11,"Age-specific",0.1,0,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",174,"Age-specific",1.6,1.4,1.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",15,"Age-specific",0.1,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",46,"Age-specific",0.4,0.3,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",22,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",8,"Age-specific",0.1,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",9,"Age-specific",0.1,0,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",225,"Age-specific",2,1.8,2.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",193,"Age-specific",1.8,1.5,2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",58,"Age-specific",0.5,0.4,0.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",615,"Age-specific",5.6,5.2,6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1060,"Age-specific",9.6,9.1,10.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",56,"Age-specific",0.5,0.4,0.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",389,"Age-specific",3.5,3.2,3.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",37,"Age-specific",0.3,0.2,0.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",144,"Age-specific",1.3,1.1,1.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",5,"Age-specific",0,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",21,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",179,"Age-specific",1.6,1.4,1.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",12,"Age-specific",0.1,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",23,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",18,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",88,"Age-specific",0.8,0.6,1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",489,"Age-specific",4.4,4.1,4.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",488,"Age-specific",4.4,4,4.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",13,"Age-specific",0.1,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",26,"Age-specific",0.2,0.2,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",52,"Age-specific",0.5,0.4,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",47,"Age-specific",0.4,0.3,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1106,"Age-specific",10,9.5,10.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3752,"Age-specific",34.1,33,35.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",22,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",67,"Age-specific",0.6,0.5,0.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",13,"Age-specific",0.1,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",17,"Age-specific",0.2,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",166,"Age-specific",1.5,1.3,1.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",19,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",71,"Age-specific",0.6,0.5,0.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",410,"Age-specific",3.7,3.4,4.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1548,"Age-specific",14.1,13.4,14.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",11,"Age-specific",0.1,0,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",504,"Age-specific",4.6,4.2,5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",5,"Age-specific",0,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",145,"Age-specific",1.3,1.1,1.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",5,"Age-specific",0,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",49,"Age-specific",0.4,0.3,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",3,"Age-specific",0,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",498,"Age-specific",4.5,4.1,4.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",29,"Age-specific",0.3,0.2,0.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",270,"Age-specific",2.5,2.2,2.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",17,"Age-specific",0.2,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",14,"Age-specific",0.1,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",6,"Age-specific",0.1,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",47,"Age-specific",0.4,0.3,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",49,"Age-specific",0.4,0.3,0.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",23,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",59,"Age-specific",0.5,0.4,0.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",411,"Age-specific",3.7,3.4,4.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",157,"Age-specific",1.4,1.2,1.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",837,"Age-specific",7.6,7.1,8.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",422,"Age-specific",3.8,3.5,4.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",100,"Age-specific",0.9,0.7,1.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",158,"Age-specific",1.4,1.2,1.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",0,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",6,"Age-specific",0.1,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",154,"Age-specific",1.4,1.2,1.6,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",182,"Age-specific",1.7,1.4,1.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",438,"Age-specific",4,3.6,4.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",240,"Age-specific",2.2,1.9,2.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",5,"Age-specific",0,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",8,"Age-specific",0.1,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",8,"Age-specific",0.1,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",38,"Age-specific",0.3,0.2,0.5,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",108,"Age-specific",1,0.8,1.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0.1,0.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",302,"Age-specific",2.7,2.4,3.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",2,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",85,"Age-specific",0.8,0.6,1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",62,"Age-specific",0.6,0.4,0.7,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",69,"Age-specific",0.6,0.5,0.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",115,"Age-specific",1,0.9,1.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",96,"Age-specific",0.9,0.7,1.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",69,"Age-specific",0.6,0.5,0.8,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",8,"Age-specific",0.1,0,0.1,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",34,"Age-specific",0.3,0.2,0.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",292,"Age-specific",2.7,2.4,3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",25,"Age-specific",0.2,0.1,0.3,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",76,"Age-specific",0.7,0.5,0.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",31,"Age-specific",0.3,0.2,0.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",79,"Age-specific",0.7,0.6,0.9,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",29,"Age-specific",0.3,0.2,0.4,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",111,"Age-specific",1,0.8,1.2,""
2012,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",89,"Age-specific",0.8,0.6,1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",25,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",656,"Age-specific",6,5.5,6.4,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14249,"Age-specific",129.5,127.4,131.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10548,"Age-specific",95.9,94.1,97.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16193,"Age-specific",147.2,144.9,149.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",55,"Age-specific",0.5,0.4,0.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",123,"Age-specific",1.1,0.9,1.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",14,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",37,"Age-specific",0.3,0.2,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",30,"Age-specific",0.3,0.2,0.4,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",33,"Age-specific",0.3,0.2,0.4,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",57,"Age-specific",0.5,0.4,0.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",15,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",171,"Age-specific",1.6,1.3,1.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",19,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",49,"Age-specific",0.4,0.3,0.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",17,"Age-specific",0.2,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",7,"Age-specific",0.1,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",4,"Age-specific",0,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",192,"Age-specific",1.7,1.5,2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",177,"Age-specific",1.6,1.4,1.9,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",72,"Age-specific",0.7,0.5,0.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",621,"Age-specific",5.6,5.2,6.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1036,"Age-specific",9.4,8.9,10,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",58,"Age-specific",0.5,0.4,0.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",357,"Age-specific",3.2,2.9,3.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",47,"Age-specific",0.4,0.3,0.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",144,"Age-specific",1.3,1.1,1.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",10,"Age-specific",0.1,0,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",14,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",185,"Age-specific",1.7,1.4,1.9,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",8,"Age-specific",0.1,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",27,"Age-specific",0.2,0.2,0.4,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",17,"Age-specific",0.2,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",92,"Age-specific",0.8,0.7,1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",483,"Age-specific",4.4,4,4.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",482,"Age-specific",4.4,4,4.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",24,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",24,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",39,"Age-specific",0.4,0.3,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",37,"Age-specific",0.3,0.2,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1162,"Age-specific",10.6,10,11.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3701,"Age-specific",33.6,32.6,34.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",12,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",71,"Age-specific",0.6,0.5,0.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",4,"Age-specific",0,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",14,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",202,"Age-specific",1.8,1.6,2.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",18,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",45,"Age-specific",0.4,0.3,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",414,"Age-specific",3.8,3.4,4.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1597,"Age-specific",14.5,13.8,15.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",6,"Age-specific",0.1,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",547,"Age-specific",5,4.6,5.4,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",21,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",7,"Age-specific",0.1,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",139,"Age-specific",1.3,1.1,1.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",11,"Age-specific",0.1,0,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",49,"Age-specific",0.4,0.3,0.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",4,"Age-specific",0,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",528,"Age-specific",4.8,4.4,5.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",25,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",276,"Age-specific",2.5,2.2,2.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",11,"Age-specific",0.1,0,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",26,"Age-specific",0.2,0.2,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",9,"Age-specific",0.1,0,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",52,"Age-specific",0.5,0.4,0.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",41,"Age-specific",0.4,0.3,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",74,"Age-specific",0.7,0.5,0.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",24,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",416,"Age-specific",3.8,3.4,4.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",160,"Age-specific",1.5,1.2,1.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",742,"Age-specific",6.7,6.3,7.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",392,"Age-specific",3.6,3.2,3.9,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",63,"Age-specific",0.6,0.4,0.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",112,"Age-specific",1,0.8,1.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",15,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",40,"Age-specific",0.4,0.3,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",175,"Age-specific",1.6,1.4,1.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",187,"Age-specific",1.7,1.5,2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",479,"Age-specific",4.4,4,4.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",270,"Age-specific",2.5,2.2,2.8,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",12,"Age-specific",0.1,0.1,0.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",7,"Age-specific",0.1,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",23,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",36,"Age-specific",0.3,0.2,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",98,"Age-specific",0.9,0.7,1.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",20,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",312,"Age-specific",2.8,2.5,3.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",3,"Age-specific",0,0,0.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",96,"Age-specific",0.9,0.7,1.1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",249,"Age-specific",2.3,2,2.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",90,"Age-specific",0.8,0.7,1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",142,"Age-specific",1.3,1.1,1.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",148,"Age-specific",1.3,1.1,1.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",2,"Age-specific",NA,NA,NA,"s"
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",79,"Age-specific",0.7,0.6,0.9,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",18,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",31,"Age-specific",0.3,0.2,0.4,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",136,"Age-specific",1.2,1,1.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",20,"Age-specific",0.2,0.1,0.3,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",89,"Age-specific",0.8,0.6,1,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",50,"Age-specific",0.5,0.3,0.6,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",58,"Age-specific",0.5,0.4,0.7,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",45,"Age-specific",0.4,0.3,0.5,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",112,"Age-specific",1,0.8,1.2,""
2013,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",110,"Age-specific",1,0.8,1.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",17,"Age-specific",0.2,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",634,"Age-specific",5.8,5.3,6.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14736,"Age-specific",133.8,131.7,136,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10758,"Age-specific",97.7,95.9,99.6,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16671,"Age-specific",151.4,149.1,153.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",73,"Age-specific",0.7,0.5,0.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",128,"Age-specific",1.2,1,1.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",22,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",36,"Age-specific",0.3,0.2,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",23,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",28,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",40,"Age-specific",0.4,0.3,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",12,"Age-specific",0.1,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",164,"Age-specific",1.5,1.3,1.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",14,"Age-specific",0.1,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",51,"Age-specific",0.5,0.3,0.6,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",17,"Age-specific",0.2,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",6,"Age-specific",0.1,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",191,"Age-specific",1.7,1.5,2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",186,"Age-specific",1.7,1.5,2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",57,"Age-specific",0.5,0.4,0.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",668,"Age-specific",6.1,5.6,6.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1064,"Age-specific",9.7,9.1,10.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",63,"Age-specific",0.6,0.4,0.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",333,"Age-specific",3,2.7,3.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",53,"Age-specific",0.5,0.4,0.6,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",170,"Age-specific",1.5,1.3,1.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",12,"Age-specific",0.1,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",32,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",199,"Age-specific",1.8,1.6,2.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",5,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",31,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",5,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",80,"Age-specific",0.7,0.6,0.9,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",3,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",471,"Age-specific",4.3,3.9,4.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",468,"Age-specific",4.3,3.9,4.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",16,"Age-specific",0.1,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",30,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",40,"Age-specific",0.4,0.3,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",31,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1217,"Age-specific",11.1,10.4,11.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3978,"Age-specific",36.1,35,37.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",12,"Age-specific",0.1,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",70,"Age-specific",0.6,0.5,0.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",7,"Age-specific",0.1,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",7,"Age-specific",0.1,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",204,"Age-specific",1.9,1.6,2.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",17,"Age-specific",0.2,0.1,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",67,"Age-specific",0.6,0.5,0.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",479,"Age-specific",4.4,4,4.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1623,"Age-specific",14.7,14,15.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",9,"Age-specific",0.1,0,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",607,"Age-specific",5.5,5.1,6,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",11,"Age-specific",0.1,0,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",4,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",144,"Age-specific",1.3,1.1,1.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",52,"Age-specific",0.5,0.4,0.6,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",4,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",503,"Age-specific",4.6,4.2,5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",31,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",292,"Age-specific",2.7,2.4,3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",9,"Age-specific",0.1,0,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",22,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",4,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",31,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",33,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",71,"Age-specific",0.6,0.5,0.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",5,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",441,"Age-specific",4,3.6,4.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",148,"Age-specific",1.3,1.1,1.6,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",720,"Age-specific",6.5,6.1,7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",398,"Age-specific",3.6,3.3,4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",65,"Age-specific",0.6,0.5,0.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",91,"Age-specific",0.8,0.7,1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",18,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",40,"Age-specific",0.4,0.3,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",142,"Age-specific",1.3,1.1,1.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",220,"Age-specific",2,1.7,2.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",549,"Age-specific",5,4.6,5.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",306,"Age-specific",2.8,2.5,3.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0.1,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",7,"Age-specific",0.1,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",10,"Age-specific",0.1,0,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",21,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",44,"Age-specific",0.4,0.3,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",105,"Age-specific",1,0.8,1.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",18,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",316,"Age-specific",2.9,2.6,3.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",4,"Age-specific",0,0,0.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",78,"Age-specific",0.7,0.6,0.9,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",289,"Age-specific",2.6,2.3,2.9,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",106,"Age-specific",1,0.8,1.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",172,"Age-specific",1.6,1.3,1.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",160,"Age-specific",1.5,1.2,1.7,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",1,"Age-specific",NA,NA,NA,"s"
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",73,"Age-specific",0.7,0.5,0.8,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0.1,0,0.2,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",21,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",116,"Age-specific",1.1,0.9,1.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",21,"Age-specific",0.2,0.1,0.3,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",90,"Age-specific",0.8,0.7,1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",33,"Age-specific",0.3,0.2,0.4,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",40,"Age-specific",0.4,0.3,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",40,"Age-specific",0.4,0.3,0.5,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",101,"Age-specific",0.9,0.7,1.1,""
2014,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",98,"Age-specific",0.9,0.7,1.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",16,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",613,"Age-specific",5.6,5.1,6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14511,"Age-specific",131.5,129.4,133.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10578,"Age-specific",95.9,94,97.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16479,"Age-specific",149.3,147.1,151.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",54,"Age-specific",0.5,0.4,0.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",128,"Age-specific",1.2,1,1.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",12,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",35,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",31,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",41,"Age-specific",0.4,0.3,0.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",30,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",11,"Age-specific",0.1,0,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",177,"Age-specific",1.6,1.4,1.9,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",15,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",31,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",20,"Age-specific",0.2,0.1,0.3,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",5,"Age-specific",0,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",7,"Age-specific",0.1,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",178,"Age-specific",1.6,1.4,1.9,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",188,"Age-specific",1.7,1.5,2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",59,"Age-specific",0.5,0.4,0.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",620,"Age-specific",5.6,5.2,6.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1017,"Age-specific",9.2,8.7,9.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",58,"Age-specific",0.5,0.4,0.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",339,"Age-specific",3.1,2.8,3.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",61,"Age-specific",0.6,0.4,0.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",145,"Age-specific",1.3,1.1,1.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",3,"Age-specific",0,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",33,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",168,"Age-specific",1.5,1.3,1.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",3,"Age-specific",0,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",32,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",13,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",89,"Age-specific",0.8,0.6,1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",463,"Age-specific",4.2,3.8,4.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",461,"Age-specific",4.2,3.8,4.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",29,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",16,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",49,"Age-specific",0.4,0.3,0.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",40,"Age-specific",0.4,0.3,0.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1179,"Age-specific",10.7,10.1,11.3,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3933,"Age-specific",35.6,34.5,36.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",13,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",62,"Age-specific",0.6,0.4,0.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",7,"Age-specific",0.1,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",18,"Age-specific",0.2,0.1,0.3,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",190,"Age-specific",1.7,1.5,2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",25,"Age-specific",0.2,0.1,0.3,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",59,"Age-specific",0.5,0.4,0.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",455,"Age-specific",4.1,3.8,4.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1564,"Age-specific",14.2,13.5,14.9,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",7,"Age-specific",0.1,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",592,"Age-specific",5.4,4.9,5.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",14,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",10,"Age-specific",0.1,0,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",133,"Age-specific",1.2,1,1.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",6,"Age-specific",0.1,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",53,"Age-specific",0.5,0.4,0.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",2,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",545,"Age-specific",4.9,4.5,5.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",28,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",301,"Age-specific",2.7,2.4,3.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",10,"Age-specific",0.1,0,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",17,"Age-specific",0.2,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",3,"Age-specific",0,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",45,"Age-specific",0.4,0.3,0.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",32,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",71,"Age-specific",0.6,0.5,0.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",489,"Age-specific",4.4,4,4.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",154,"Age-specific",1.4,1.2,1.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",739,"Age-specific",6.7,6.2,7.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",414,"Age-specific",3.8,3.4,4.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",71,"Age-specific",0.6,0.5,0.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",79,"Age-specific",0.7,0.6,0.9,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",21,"Age-specific",0.2,0.1,0.3,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",37,"Age-specific",0.3,0.2,0.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",147,"Age-specific",1.3,1.1,1.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",217,"Age-specific",2,1.7,2.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",510,"Age-specific",4.6,4.2,5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",268,"Age-specific",2.4,2.1,2.7,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",8,"Age-specific",0.1,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",11,"Age-specific",0.1,0,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",6,"Age-specific",0.1,0,0.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",16,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",54,"Age-specific",0.5,0.4,0.6,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",132,"Age-specific",1.2,1,1.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",11,"Age-specific",0.1,0,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",349,"Age-specific",3.2,2.8,3.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",2,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",96,"Age-specific",0.9,0.7,1.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",293,"Age-specific",2.7,2.4,3,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",100,"Age-specific",0.9,0.7,1.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",169,"Age-specific",1.5,1.3,1.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",128,"Age-specific",1.2,1,1.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",68,"Age-specific",0.6,0.5,0.8,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",16,"Age-specific",0.1,0.1,0.2,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",32,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",91,"Age-specific",0.8,0.7,1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",30,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",88,"Age-specific",0.8,0.6,1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",45,"Age-specific",0.4,0.3,0.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",36,"Age-specific",0.3,0.2,0.5,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",33,"Age-specific",0.3,0.2,0.4,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",100,"Age-specific",0.9,0.7,1.1,""
2015,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",94,"Age-specific",0.9,0.7,1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",18,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",601,"Age-specific",5.4,5,5.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14630,"Age-specific",132.1,130,134.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10737,"Age-specific",97,95.1,98.8,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16526,"Age-specific",149.2,147,151.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",78,"Age-specific",0.7,0.6,0.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",94,"Age-specific",0.8,0.7,1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",16,"Age-specific",0.1,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",36,"Age-specific",0.3,0.2,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",22,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",31,"Age-specific",0.3,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",31,"Age-specific",0.3,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",12,"Age-specific",0.1,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",177,"Age-specific",1.6,1.4,1.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",19,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",43,"Age-specific",0.4,0.3,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",8,"Age-specific",0.1,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",16,"Age-specific",0.1,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",209,"Age-specific",1.9,1.6,2.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",163,"Age-specific",1.5,1.3,1.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",66,"Age-specific",0.6,0.5,0.8,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",700,"Age-specific",6.3,5.9,6.8,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1136,"Age-specific",10.3,9.7,10.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",63,"Age-specific",0.6,0.4,0.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",373,"Age-specific",3.4,3,3.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",54,"Age-specific",0.5,0.4,0.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",155,"Age-specific",1.4,1.2,1.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",4,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",29,"Age-specific",0.3,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",200,"Age-specific",1.8,1.6,2.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",8,"Age-specific",0.1,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",28,"Age-specific",0.3,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",17,"Age-specific",0.2,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",68,"Age-specific",0.6,0.5,0.8,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",0,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",518,"Age-specific",4.7,4.3,5.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",518,"Age-specific",4.7,4.3,5.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",23,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",19,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",37,"Age-specific",0.3,0.2,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",34,"Age-specific",0.3,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1120,"Age-specific",10.1,9.5,10.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3893,"Age-specific",35.2,34.1,36.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",13,"Age-specific",0.1,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",65,"Age-specific",0.6,0.5,0.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",7,"Age-specific",0.1,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",17,"Age-specific",0.2,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",223,"Age-specific",2,1.8,2.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",17,"Age-specific",0.2,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",46,"Age-specific",0.4,0.3,0.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",473,"Age-specific",4.3,3.9,4.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1599,"Age-specific",14.4,13.7,15.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",5,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",622,"Age-specific",5.6,5.2,6.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",12,"Age-specific",0.1,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",10,"Age-specific",0.1,0,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",124,"Age-specific",1.1,0.9,1.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",5,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",61,"Age-specific",0.6,0.4,0.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",7,"Age-specific",0.1,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",542,"Age-specific",4.9,4.5,5.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",23,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",301,"Age-specific",2.7,2.4,3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",26,"Age-specific",0.2,0.2,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",11,"Age-specific",0.1,0,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",2,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",40,"Age-specific",0.4,0.3,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",27,"Age-specific",0.2,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",78,"Age-specific",0.7,0.6,0.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",448,"Age-specific",4,3.7,4.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",149,"Age-specific",1.3,1.1,1.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",737,"Age-specific",6.7,6.2,7.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",389,"Age-specific",3.5,3.2,3.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",85,"Age-specific",0.8,0.6,0.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",95,"Age-specific",0.9,0.7,1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",19,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",46,"Age-specific",0.4,0.3,0.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",138,"Age-specific",1.2,1,1.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",211,"Age-specific",1.9,1.7,2.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",500,"Age-specific",4.5,4.1,4.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",267,"Age-specific",2.4,2.1,2.7,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",5,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",13,"Age-specific",0.1,0.1,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",4,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",23,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",42,"Age-specific",0.4,0.3,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",121,"Age-specific",1.1,0.9,1.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",18,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",326,"Age-specific",2.9,2.6,3.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",3,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",90,"Age-specific",0.8,0.7,1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",297,"Age-specific",2.7,2.4,3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",94,"Age-specific",0.8,0.7,1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",151,"Age-specific",1.4,1.2,1.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",97,"Age-specific",0.9,0.7,1.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",3,"Age-specific",0,0,0.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",96,"Age-specific",0.9,0.7,1.1,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0.1,0,0.2,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",36,"Age-specific",0.3,0.2,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",67,"Age-specific",0.6,0.5,0.8,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",22,"Age-specific",0.2,0.1,0.3,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",77,"Age-specific",0.7,0.5,0.9,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",30,"Age-specific",0.3,0.2,0.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",47,"Age-specific",0.4,0.3,0.6,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",40,"Age-specific",0.4,0.3,0.5,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",126,"Age-specific",1.1,0.9,1.4,""
2016,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",104,"Age-specific",0.9,0.8,1.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",11,"Age-specific",0.1,0,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",627,"Age-specific",5.7,5.2,6.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14228,"Age-specific",128.7,126.6,130.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10487,"Age-specific",94.9,93.1,96.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16351,"Age-specific",148,145.7,150.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",68,"Age-specific",0.6,0.5,0.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",112,"Age-specific",1,0.8,1.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",21,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",37,"Age-specific",0.3,0.2,0.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",25,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",41,"Age-specific",0.4,0.3,0.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",44,"Age-specific",0.4,0.3,0.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",11,"Age-specific",0.1,0,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",188,"Age-specific",1.7,1.5,2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",14,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",28,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",21,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",4,"Age-specific",0,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",2,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",200,"Age-specific",1.8,1.6,2.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",155,"Age-specific",1.4,1.2,1.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",59,"Age-specific",0.5,0.4,0.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",633,"Age-specific",5.7,5.3,6.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1064,"Age-specific",9.6,9.1,10.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",71,"Age-specific",0.6,0.5,0.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",360,"Age-specific",3.3,2.9,3.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",67,"Age-specific",0.6,0.5,0.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",146,"Age-specific",1.3,1.1,1.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",12,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",25,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",178,"Age-specific",1.6,1.4,1.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",7,"Age-specific",0.1,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",25,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",12,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",71,"Age-specific",0.6,0.5,0.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",437,"Age-specific",4,3.6,4.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",437,"Age-specific",4,3.6,4.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",32,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",16,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",44,"Age-specific",0.4,0.3,0.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",34,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1105,"Age-specific",10,9.4,10.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3741,"Age-specific",33.9,32.8,35,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",15,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",57,"Age-specific",0.5,0.4,0.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",8,"Age-specific",0.1,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",15,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",198,"Age-specific",1.8,1.6,2.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",20,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",61,"Age-specific",0.6,0.4,0.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",489,"Age-specific",4.4,4,4.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1484,"Age-specific",13.4,12.8,14.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",14,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",652,"Age-specific",5.9,5.5,6.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",7,"Age-specific",0.1,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",111,"Age-specific",1,0.8,1.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",3,"Age-specific",0,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",51,"Age-specific",0.5,0.3,0.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",4,"Age-specific",0,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",539,"Age-specific",4.9,4.5,5.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",27,"Age-specific",0.2,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",306,"Age-specific",2.8,2.5,3.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",9,"Age-specific",0.1,0,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",18,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",24,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",27,"Age-specific",0.2,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",80,"Age-specific",0.7,0.6,0.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",500,"Age-specific",4.5,4.1,4.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",152,"Age-specific",1.4,1.2,1.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",706,"Age-specific",6.4,5.9,6.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",359,"Age-specific",3.2,2.9,3.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",83,"Age-specific",0.8,0.6,0.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",84,"Age-specific",0.8,0.6,0.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",28,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",57,"Age-specific",0.5,0.4,0.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",144,"Age-specific",1.3,1.1,1.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",221,"Age-specific",2,1.7,2.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",516,"Age-specific",4.7,4.3,5.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",272,"Age-specific",2.5,2.2,2.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",3,"Age-specific",0,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",18,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",2,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",20,"Age-specific",0.2,0.1,0.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",37,"Age-specific",0.3,0.2,0.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",120,"Age-specific",1.1,0.9,1.3,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",13,"Age-specific",0.1,0.1,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",367,"Age-specific",3.3,3,3.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",8,"Age-specific",0.1,0,0.1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",79,"Age-specific",0.7,0.6,0.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",282,"Age-specific",2.6,2.3,2.9,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",108,"Age-specific",1,0.8,1.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",193,"Age-specific",1.7,1.5,2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",148,"Age-specific",1.3,1.1,1.6,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",165,"Age-specific",1.5,1.3,1.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",9,"Age-specific",0.1,0,0.2,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",34,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",67,"Age-specific",0.6,0.5,0.8,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",30,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",86,"Age-specific",0.8,0.6,1,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",32,"Age-specific",0.3,0.2,0.4,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",58,"Age-specific",0.5,0.4,0.7,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",38,"Age-specific",0.3,0.2,0.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",144,"Age-specific",1.3,1.1,1.5,""
2017,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",105,"Age-specific",1,0.8,1.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",18,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",588,"Age-specific",5.3,4.9,5.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14321,"Age-specific",129.7,127.6,131.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10676,"Age-specific",96.7,94.8,98.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16399,"Age-specific",148.5,146.2,150.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",77,"Age-specific",0.7,0.6,0.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",99,"Age-specific",0.9,0.7,1.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",20,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",35,"Age-specific",0.3,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",18,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",32,"Age-specific",0.3,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",49,"Age-specific",0.4,0.3,0.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",15,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",150,"Age-specific",1.4,1.1,1.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",18,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",28,"Age-specific",0.3,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",12,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",13,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",4,"Age-specific",0,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",189,"Age-specific",1.7,1.5,2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",165,"Age-specific",1.5,1.3,1.7,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",74,"Age-specific",0.7,0.5,0.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",659,"Age-specific",6,5.5,6.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1141,"Age-specific",10.3,9.7,10.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",76,"Age-specific",0.7,0.5,0.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",406,"Age-specific",3.7,3.3,4.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",45,"Age-specific",0.4,0.3,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",126,"Age-specific",1.1,1,1.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",4,"Age-specific",0,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",22,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",199,"Age-specific",1.8,1.6,2.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",4,"Age-specific",0,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",27,"Age-specific",0.2,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",18,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",85,"Age-specific",0.8,0.6,1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",1,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",495,"Age-specific",4.5,4.1,4.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",494,"Age-specific",4.5,4.1,4.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",29,"Age-specific",0.3,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",27,"Age-specific",0.2,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",50,"Age-specific",0.5,0.3,0.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",45,"Age-specific",0.4,0.3,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1065,"Age-specific",9.6,9.1,10.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3645,"Age-specific",33,31.9,34.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",8,"Age-specific",0.1,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",46,"Age-specific",0.4,0.3,0.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",21,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",165,"Age-specific",1.5,1.3,1.7,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",25,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",50,"Age-specific",0.5,0.3,0.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",535,"Age-specific",4.8,4.4,5.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1669,"Age-specific",15.1,14.4,15.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",5,"Age-specific",0,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",610,"Age-specific",5.5,5.1,6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",25,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",3,"Age-specific",0,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",114,"Age-specific",1,0.9,1.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",5,"Age-specific",0,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",42,"Age-specific",0.4,0.3,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",2,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",537,"Age-specific",4.9,4.5,5.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",26,"Age-specific",0.2,0.2,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",337,"Age-specific",3.1,2.7,3.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",13,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",17,"Age-specific",0.2,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",2,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",29,"Age-specific",0.3,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",26,"Age-specific",0.2,0.2,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",71,"Age-specific",0.6,0.5,0.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",1,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",468,"Age-specific",4.2,3.9,4.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",143,"Age-specific",1.3,1.1,1.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",694,"Age-specific",6.3,5.8,6.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",353,"Age-specific",3.2,2.9,3.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",59,"Age-specific",0.5,0.4,0.7,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",115,"Age-specific",1,0.9,1.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",24,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",46,"Age-specific",0.4,0.3,0.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",142,"Age-specific",1.3,1.1,1.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",216,"Age-specific",2,1.7,2.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",503,"Age-specific",4.6,4.2,5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",259,"Age-specific",2.3,2.1,2.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0.1,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",16,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",6,"Age-specific",0.1,0,0.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",27,"Age-specific",0.2,0.2,0.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",42,"Age-specific",0.4,0.3,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",119,"Age-specific",1.1,0.9,1.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",12,"Age-specific",0.1,0.1,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",369,"Age-specific",3.3,3,3.7,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",2,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",93,"Age-specific",0.8,0.7,1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",303,"Age-specific",2.7,2.4,3.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",103,"Age-specific",0.9,0.8,1.1,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",168,"Age-specific",1.5,1.3,1.8,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",122,"Age-specific",1.1,0.9,1.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",1,"Age-specific",NA,NA,NA,"s"
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",157,"Age-specific",1.4,1.2,1.7,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",10,"Age-specific",0.1,0,0.2,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",36,"Age-specific",0.3,0.2,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",42,"Age-specific",0.4,0.3,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",37,"Age-specific",0.3,0.2,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",83,"Age-specific",0.8,0.6,0.9,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",22,"Age-specific",0.2,0.1,0.3,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",55,"Age-specific",0.5,0.4,0.6,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",39,"Age-specific",0.4,0.3,0.5,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",133,"Age-specific",1.2,1,1.4,""
2018,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",130,"Age-specific",1.2,1,1.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",13,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",575,"Age-specific",5.2,4.8,5.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",14154,"Age-specific",128.5,126.4,130.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",10654,"Age-specific",96.7,94.9,98.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",16259,"Age-specific",147.6,145.3,149.9,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",63,"Age-specific",0.6,0.4,0.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",87,"Age-specific",0.8,0.6,1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",10,"Age-specific",0.1,0,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",22,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",33,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",26,"Age-specific",0.2,0.2,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",51,"Age-specific",0.5,0.3,0.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",10,"Age-specific",0.1,0,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",163,"Age-specific",1.5,1.3,1.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",34,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",38,"Age-specific",0.3,0.2,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",12,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",10,"Age-specific",0.1,0,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",3,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",186,"Age-specific",1.7,1.5,1.9,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",197,"Age-specific",1.8,1.5,2.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",83,"Age-specific",0.8,0.6,0.9,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",684,"Age-specific",6.2,5.8,6.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1188,"Age-specific",10.8,10.2,11.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",67,"Age-specific",0.6,0.5,0.8,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",437,"Age-specific",4,3.6,4.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",49,"Age-specific",0.4,0.3,0.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",130,"Age-specific",1.2,1,1.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",11,"Age-specific",0.1,0,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",26,"Age-specific",0.2,0.2,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",187,"Age-specific",1.7,1.5,2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",5,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",30,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",13,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",74,"Age-specific",0.7,0.5,0.8,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",464,"Age-specific",4.2,3.8,4.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",462,"Age-specific",4.2,3.8,4.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",30,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",15,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",0,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",44,"Age-specific",0.4,0.3,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",43,"Age-specific",0.4,0.3,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",1023,"Age-specific",9.3,8.7,9.9,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",3500,"Age-specific",31.8,30.7,32.8,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",15,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",44,"Age-specific",0.4,0.3,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",25,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",190,"Age-specific",1.7,1.5,2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",28,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",63,"Age-specific",0.6,0.4,0.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",535,"Age-specific",4.9,4.5,5.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1608,"Age-specific",14.6,13.9,15.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",5,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",609,"Age-specific",5.5,5.1,6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",9,"Age-specific",0.1,0,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",8,"Age-specific",0.1,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",137,"Age-specific",1.2,1,1.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",0,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",70,"Age-specific",0.6,0.5,0.8,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",4,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",527,"Age-specific",4.8,4.4,5.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",21,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",345,"Age-specific",3.1,2.8,3.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",39,"Age-specific",0.4,0.3,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",41,"Age-specific",0.4,0.3,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",3,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",22,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",21,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",84,"Age-specific",0.8,0.6,0.9,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",1,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",456,"Age-specific",4.1,3.8,4.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",142,"Age-specific",1.3,1.1,1.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",681,"Age-specific",6.2,5.7,6.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",355,"Age-specific",3.2,2.9,3.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",73,"Age-specific",0.7,0.5,0.8,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",94,"Age-specific",0.9,0.7,1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",17,"Age-specific",0.2,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",35,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",142,"Age-specific",1.3,1.1,1.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",182,"Age-specific",1.7,1.4,1.9,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",476,"Age-specific",4.3,3.9,4.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",265,"Age-specific",2.4,2.1,2.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",6,"Age-specific",0.1,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",19,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",4,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",23,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",48,"Age-specific",0.4,0.3,0.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",128,"Age-specific",1.2,1,1.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",13,"Age-specific",0.1,0.1,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",378,"Age-specific",3.4,3.1,3.8,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",3,"Age-specific",0,0,0.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",96,"Age-specific",0.9,0.7,1.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",320,"Age-specific",2.9,2.6,3.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",96,"Age-specific",0.9,0.7,1.1,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",140,"Age-specific",1.3,1.1,1.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",126,"Age-specific",1.1,1,1.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",164,"Age-specific",1.5,1.3,1.7,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",10,"Age-specific",0.1,0,0.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",39,"Age-specific",0.4,0.3,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",35,"Age-specific",0.3,0.2,0.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",24,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",105,"Age-specific",1,0.8,1.2,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",25,"Age-specific",0.2,0.1,0.3,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",50,"Age-specific",0.5,0.3,0.6,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",38,"Age-specific",0.3,0.2,0.5,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",129,"Age-specific",1.2,1,1.4,""
2019,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",138,"Age-specific",1.3,1.1,1.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00","Malignant neoplasm of lip",23,"Age-specific",0.2,0.1,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C14","Malignant neoplasm of lip, oral cavity and pharynx",542,"Age-specific",4.9,4.5,5.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97","All malignant cancers",12017,"Age-specific",109.1,107.1,111,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97 excl. C44","All maligant cancers excluding non-melanoma skin cancer (NMSC)",9315,"Age-specific",84.5,82.8,86.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C00-C97, D00-D48","All registrations",13796,"Age-specific",125.2,123.1,127.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C01","Malignant neoplasm of base of tongue",57,"Age-specific",0.5,0.4,0.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C02","Malignant neoplasm of other and unspecified parts of tongue",71,"Age-specific",0.6,0.5,0.8,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C03","Malignant neoplasm of gum",11,"Age-specific",0.1,0,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C04","Malignant neoplasm of floor of mouth",28,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C05","Malignant neoplasm of palate",20,"Age-specific",0.2,0.1,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C06","Malignant neoplasm of other and unspecified parts of mouth",34,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C07","Malignant neoplasm of parotid gland",32,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C08","Malignant neoplasm of other and unspecified major salivary glands",9,"Age-specific",0.1,0,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C09","Malignant neoplasm of tonsil",155,"Age-specific",1.4,1.2,1.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C10","Malignant neoplasm of oropharynx",48,"Age-specific",0.4,0.3,0.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C11","Malignant neoplasm of nasopharynx",41,"Age-specific",0.4,0.3,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C12","Malignant neoplasm of piriform sinus",7,"Age-specific",0.1,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C13","Malignant neoplasm of hypopharynx",6,"Age-specific",0.1,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C14","Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx",0,"Age-specific",NA,NA,NA,"s"
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C15","Malignant neoplasm of oesophagus",168,"Age-specific",1.5,1.3,1.8,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C16","Malignant neoplasm of stomach",185,"Age-specific",1.7,1.4,1.9,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C17","Malignant neoplasm of small intestine",58,"Age-specific",0.5,0.4,0.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18","Malignant neoplasm of colon",629,"Age-specific",5.7,5.3,6.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C18-C20","Malignant neoplasm of colon and rectum",1056,"Age-specific",9.6,9,10.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C19","Malignant neoplasm of rectosigmoid junction",48,"Age-specific",0.4,0.3,0.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C20","Malignant neoplasm of rectum",379,"Age-specific",3.4,3.1,3.8,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C21","Malignant neoplasm of anus and anal canal",36,"Age-specific",0.3,0.2,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C22","Malignant neoplasm of liver and intrahepatic bile ducts",125,"Age-specific",1.1,0.9,1.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C23","Malignant neoplasm of gallbladder",10,"Age-specific",0.1,0,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C24","Malignant neoplasm of other and unspecified parts of biliary tract",26,"Age-specific",0.2,0.2,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C25","Malignant neoplasm of pancreas",190,"Age-specific",1.7,1.5,2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C26","Malignant neoplasm of other and ill-defined digestive organs",4,"Age-specific",0,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C30","Malignant neoplasm of nasal cavity and middle ear",33,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C31","Malignant neoplasm of accessory sinuses",16,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C32","Malignant neoplasm of larynx",53,"Age-specific",0.5,0.4,0.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33","Malignant neoplasm of trachea",2,"Age-specific",NA,NA,NA,"s"
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C33-C34","Malignant neoplasm of trachea, bronchus and lung",430,"Age-specific",3.9,3.5,4.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C34","Malignant neoplasm of bronchus and lung",428,"Age-specific",3.9,3.5,4.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C37","Malignant neoplasm of thymus",40,"Age-specific",0.4,0.3,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C38","Malignant neoplasm of heart, mediastinum and pleura",15,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C39","Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs",1,"Age-specific",NA,NA,NA,"s"
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C40","Malignant neoplasm of bone and articular cartilage of limbs",50,"Age-specific",0.5,0.3,0.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C41","Malignant neoplasm of bone and articular cartilage of other and unspecified sites",35,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C43","Malignant melanoma of skin",792,"Age-specific",7.2,6.7,7.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C44","Other malignant neoplasms of skin",2702,"Age-specific",24.5,23.6,25.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C45","Mesothelioma",7,"Age-specific",0.1,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C46","Kaposi sarcoma",33,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C47","Malignant neoplasm of peripheral nerves and autonomic nervous system",14,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C48","Malignant neoplasm of retroperitoneum and peritoneum",15,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C49","Malignant neoplasm of other connective and soft tissue",149,"Age-specific",1.4,1.1,1.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C50","Malignant neoplasm of breast",26,"Age-specific",0.2,0.2,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C60","Malignant neoplasm of penis",41,"Age-specific",0.4,0.3,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C61","Malignant neoplasm of prostate",398,"Age-specific",3.6,3.3,4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C62","Malignant neoplasm of testis",1465,"Age-specific",13.3,12.6,14,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C63","Malignant neoplasm of other and unspecified male genital organs",4,"Age-specific",0,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C64","Malignant neoplasm of kidney, except renal pelvis",462,"Age-specific",4.2,3.8,4.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C65","Malignant neoplasm of renal pelvis",13,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C66","Malignant neoplasm of ureter",12,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C67","Malignant neoplasm of bladder",112,"Age-specific",1,0.8,1.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C68","Malignant neoplasm of other and unspecified urinary organs",4,"Age-specific",0,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C69","Malignant neoplasm of eye and adnexa",57,"Age-specific",0.5,0.4,0.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C70","Malignant neoplasm of meninges",4,"Age-specific",0,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C71","Malignant neoplasm of brain",442,"Age-specific",4,3.6,4.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C72","Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system",17,"Age-specific",0.2,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C73","Malignant neoplasm of thyroid gland",290,"Age-specific",2.6,2.3,3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C74","Malignant neoplasm of adrenal gland",15,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C75","Malignant neoplasm of other endocrine glands and related structures",23,"Age-specific",0.2,0.1,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C76","Malignant neoplasm of other and ill-defined sites",3,"Age-specific",0,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C77","Secondary and unspecified malignant neoplasm of lymph nodes",13,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C78","Secondary malignant neoplasm of respiratory and digestive organs",15,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C79","Secondary malignant neoplasm of other and unspecified sites",71,"Age-specific",0.6,0.5,0.8,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C80","Malignant neoplasm, without specification of site",5,"Age-specific",0,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C81","Hodgkin lymphoma",450,"Age-specific",4.1,3.7,4.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82","Follicular lymphoma",135,"Age-specific",1.2,1,1.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C82-C86","Non-Hodgkin lymphoma",684,"Age-specific",6.2,5.8,6.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C83","Non-follicular lymphoma",373,"Age-specific",3.4,3.1,3.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C84","Mature T/NK-cell lymphomas",59,"Age-specific",0.5,0.4,0.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C85","Other and unspecified types of non-Hodgkin lymphoma",96,"Age-specific",0.9,0.7,1.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C86","Other specified types of T/NK-cell lymphoma",21,"Age-specific",0.2,0.1,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C88","Malignant immunoproliferative diseases",31,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C90","Multiple myeloma and malignant plasma cell neoplasms",107,"Age-specific",1,0.8,1.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91","Lymphoid leukaemia",177,"Age-specific",1.6,1.4,1.9,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C91-C95","Leukaemia",447,"Age-specific",4.1,3.7,4.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C92","Myeloid leukaemia",237,"Age-specific",2.2,1.9,2.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C93","Monocytic leukaemia",11,"Age-specific",0.1,0,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C94","Other leukaemias of specified cell type",13,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C95","Leukaemia of unspecified cell type",9,"Age-specific",0.1,0,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C96","Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue",21,"Age-specific",0.2,0.1,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","C97","Malignant neoplasms of independent (primary) multiple sites",0,"Age-specific",NA,NA,NA,"s"
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D00","Carcinoma in situ of oral cavity, oesophagus and stomach",38,"Age-specific",0.3,0.2,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D01","Carcinoma in situ of other and unspecified digestive organs",161,"Age-specific",1.5,1.2,1.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D02","Carcinoma in situ of middle ear and respiratory system",11,"Age-specific",0.1,0,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D03","Melanoma in situ",250,"Age-specific",2.3,2,2.6,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D05","Carcinoma in situ of breast",6,"Age-specific",0.1,0,0.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D07","Carcinoma in situ of other and unspecified genital organs",115,"Age-specific",1,0.9,1.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D09","Carcinoma in situ of other and unspecified sites",263,"Age-specific",2.4,2.1,2.7,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D32","Benign neoplasm of meninges",103,"Age-specific",0.9,0.8,1.1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D33","Benign neoplasm of brain and other parts of central nervous system",115,"Age-specific",1,0.9,1.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D352","Benign neoplasm: Pituitary gland",88,"Age-specific",0.8,0.6,1,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D353","Benign neoplasm: Craniopharyngeal duct",0,"Age-specific",NA,NA,NA,"s"
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D354","Benign neoplasm: Pineal gland",0,"Age-specific",NA,NA,NA,"s"
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D37","Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs",126,"Age-specific",1.1,1,1.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D38","Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs",17,"Age-specific",0.2,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D40","Neoplasm of uncertain or unknown behaviour of male genital organs",35,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D41","Neoplasm of uncertain or unknown behaviour of urinary organs",29,"Age-specific",0.3,0.2,0.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D42","Neoplasm of uncertain or unknown behaviour of meninges",25,"Age-specific",0.2,0.1,0.3,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D43","Neoplasm of uncertain or unknown behaviour of brain and central nervous system",76,"Age-specific",0.7,0.5,0.9,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D44","Neoplasm of uncertain or unknown behaviour of endocrine glands",12,"Age-specific",0.1,0.1,0.2,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D45","Polycythaemia vera",37,"Age-specific",0.3,0.2,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D46","Myelodysplastic syndromes",39,"Age-specific",0.4,0.3,0.5,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D47","Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue",126,"Age-specific",1.1,1,1.4,""
2020,"Male","20 to 24, 25 to 29, 30 to 34, 35 to 39, 40 to 44, 45 to 49","E92000001","England","D48","Neoplasm of uncertain or unknown behaviour of other and unspecified sites",107,"Age-specific",1,0.8,1.2,""
